Screening of bacterial molecules with antagonistic or adjuvant activity by Fregolino, Eleonora
UNIVERSITA’ DEGLI STUDI DI NAPOLI FEDERICO II 
 
 
 
FACOLTA’ DI SCIENZE MATEMATICHE FISICHE E NATURALI 
PhD IN CHEMISTRY 
XXIII CYCLE 
 
 
SCREENING OF BACTERIAL 
MOLECULES WITH ANTAGONISTIC OR 
ADJUVANT ACTIVITY 
 
Eleonora Fregolino 
 
TUTOR 
Dott.ssa  
Cristina De Castro
SUPERVISOR 
Prof.ssa 
Paola Giardina
 
i 
 
Index 
 
Abstract                                                                                                                                       v 
 
PART I: INTRODUCTION 
 
Chapter I: Structures and functions of polysaccharide components of the Gram-negative 
bacteria Outer Membrane 
 
1.1 Bacterial Cell Envelope                                                                                                                    1  
1.2 General architecture, function and biosynthesis of the Lipopolysaccharide (LPS)                             2 
1.3 The Core oligosaccharide and O-Specific Side Chain                                                                        5 
1.4 Structure and biological activity of Lipid A                                                                                     6 
1.5 Capsular polysaccharides (CPSs) and glycoconjugate vaccines                                                    10 
 
Chapter II: General aspects  
 
2.1 Rhizobium radiobacter RV3 as a source of oligosaccharide with potential use for HIV  
vaccine production                                                                                                                            12 
2.2 Cupriavidus necator                                                                                                                        13  
2.3 Acinetobacter baumannii                                                                                                                    13  
2.4 Virulence factors of Escherichia coli  and the Enterobacterial common antigen                             14  
 
PART II: RESULTS AND DISCUSSION 
 
Chapter III: Synthesis of new neoglycoprotein using mannan oligosaccharide from 
Rhizobium radiobacter RV3  
 
3.1 LOS chemical analyses                                                                                                                       16 
3.2 NMR analysis of Core oligosaccharide                                                                                                   17 
3.3 Characterization of OS-BSA conjugate                                                                                               22 
3.4 Conclusions                                                                                                                                        27 
 
Chapter IV: Characterization of the O-Chain and Lipid A portions of the LPS from 
Cupriavidus necator DSM 13523 
 
4.1 Chemical analyses of the Lipopolysaccharide                                                                                28 
4.2 Structural characterization of Lipid A                                                                                                     29 
4.3 Spectroscopic analysis of the O-Chain                                                                                                   32 
4.4 Conclusions                                                                                                                                       36 
 
Chapter V: Lipooligosaccharide structural characterization of a clinical isolate of 
Acinetobacter baumannii, strain SMAL 
  
5.1 Chemical analyses of the Lipooligosaccharide                                                                               37 
5.2 Mass spectrometry analysis of the intact and ammonia-deacylated Lipid A from the 
growth in Luria Broth at 28 °C                                                                                                         38 
5.3 Structural variation of Lipid A under different growth conditions                                                 42 
5.4 Spectroscopic characterization of Core oligosaccharide from the growth in Luria Broth 
at 28 °C                                                                                                                                             44 
5.5 Conclusions                                                                                                                                              47 
 
 
 
ii 
 
Chapter VI: Identification and structural determination of the Capsular polysaccharides 
from two clinical isolates of Acinetobacter baumannii, strains SMAL and MG1 
 
6.1 Isolation and chemical analyses of ultracentrifuge supernatants and sediment                              49 
6.2 Electrophoretic and Western blot analysis of ultracentrifuge supernatant and sediment                  50 
6.3 Spectroscopic characterization of the CPS from A. baumannii strain MG1                                   51 
6.4 Spectroscopic characterization of the CPS from A. baumannii strain SMAL                                55 
6.5 Conclusions                                                                                                                                     59 
 
Chapter VII: LPS analysis and isolation of two forms of cyclic Enterobacterial common 
antigen (ECA) from the enterohaemorrhagic Escherichia coli O157:H- 
 
7.1 Screening of phenol and water extracts of E. coli O157:H-at 37°C and 20°C                                60 
7.2 Purification and immunodetection analysis of LPS in water extracts                                                 62 
7.3 Characterization of the two cyclic forms of the Enterobacterial common antigen                          65 
7.4 Conclusions                                                                                                                                      68 
 
PART III: MATERIALS AND METHODS 
 
Chapter VIII: Isolations of Lipopolysaccharides and Capsular Polysaccharides 
 
8.1 Rhizobium radiobacter RV3                                                                                                           70 
8.2 Cupriavidus necator DSM 13513                                                                                                   70 
8.3 Acinetobacter baumannii clinical isolates SMAL and MG1                                                          71 
8.4 Escherichia coli O157:H-                                                                                                                                                                                72 
 
Chapter IX: General and analytical methods 
  
9.1 Electrophoretic and chemical analyses                                                                                              73  
9.2 Immunodetection analyses                                                                                                                    74 
9.3 Isolation of oligosaccharides from LOS of Rhizobium radiobacter RV3                                          75 
9.4 Preparation of the carbohydrate component of the neoglycoprotein                                                75 
9.5 Synthesis and characterization of OS-BSA conjugate                                                                     75 
9.6 Isolation of the 4-deoxy--D-arabinohexose                                                                                  77 
9.7 Isolation of oligosaccharides from LOS of A. baumannii strain SMAL                                            77 
9.8 Chemical treatments on CPSs from A. baumannii strains SMAL and MG1                                  77 
9.9 LPS purification and isolation of the Enterobacterial common antigen from  
E. coli O157:H-                                                                                                                                  78 
 
Chapter X: Mass Spectrometry 
 
10.1 Preparations of Lipid As                                                                                                               79 
10.2 Electrospray Ionization Fourier-Transform Ion Cyclotron Resonance  
Mass Spectrometry                                                                                                                       79 
10.3 MALDI-TOF Mass Spectrometry                                                                                                80 
 
Chapter XI: NMR spectroscopy 
 
11.1 Oligosaccharides from Rhizobium radiobacter Rv3                                                                        81 
11.2 O-Chain from Cupriadivus necator                                                                                                     81 
11.3 Oligosaccharides from Acinetobacter baumannii SMAL and MG1                                              81 
11.4 Capsular polysaccharides from Acinetobacter baumannii SMAL and MG1                               82 
11.5 O-Chain and the Enterobacterial common antigen from E. coli O157: H-                                                       82 
 
iii 
 
PART IV: STRUCTURAL CHARACTERIZATION OF MENB OMVS MEMBRANE CONSTITUENTS1 
 
1 Introduction                                                                                                                                        83 
1.1 Neisseria meningitidis and the new vaccine approach against group B based  
on Outer Membrane Vesicles (OMVs)                                                                                      83 
2 Results and discussions                                                                                                                      85 
2.1 Structural characterization of the polysaccharide components on Outer Membrane  
Vesicles (OMVs) of Neisseria meningitidis serogroup B (MenB)                                            85 
2.1.1 NMR analyses of native Capsular polysaccharide and of intact OMVs                            86 
2.1.2 Electrophoretic and Spectroscopic analyses of LOS and CPS extracted from  
OMVs                                                                                                                                 87 
2.1.3 GC-MS quantification of LOS immunotypes                                                                    89 
2.1.4 MALDI MS spectrometry characterization of Lipid A                                                          94 
2.1.5 Chemical and electrophoretic analyses to determine the content of LOS and  
CPS outside the OMVs                                                                                                      98 
 
3 Materials and Methods                                                                                                                   100 
3.1 Isolations of Lipopolysaccharide and Capsular polysaccharide                                              100 
3.1.1 Outer Membrane vesicles of Neisseria meningitidis serogroup B                                    
3.2 General and analytical methods                                                                                               101 
3.2.1 SDS-PAGE and chemical analyses of LOS and CPS from OMVs 
3.3 Preparations and Mass Spectrometry of Lipid A                                                                     102 
3.3.1 MALDI MS spectrometry of intact Lipid A  from N. meningitidis  
serogroup B 
3.4 NMR spectroscopy                                                                                                                  102 
3.4.1 Capsular polysaccharide of Neisseria meningitidis serogroup B 
 
References                                                                                                                                          103 
 
 
  
                                                        
1 This part of the thesis regards a project developed in collaboration with the Novartis Vaccines Diagnostic of Siena and it is reported as 
accepted by a clearance process. 
 
iv 
 
 
v 
 
Abstract 
 
The Lipopolysaccharides (LPSs) are the major constituents of the outer membrane of Gram-negative 
bacteria and the interest in their chemical characterization is motivated by the close correlation 
existing between the structure and the biological activity of these molecules.1 In particular, the 
glycolipid portion of the LPS, the Lipid A, is the real endotoxic principle since it triggers the innate 
immune system of infected organism.2 The intrinsic structural variability of the Lipid A is on the basis 
of its different biological activity, ranging from the activation to the inhibition of an inflammatory 
process, and for this reason a Lipid A is classified as agonist or antagonist.3 The ability of Lipid A to 
stimulate the innate immune system that in turn activates the adaptive immunity, makes this molecule 
a useful vaccine adjuvant. 
The present thesis deals with the structural study of Lipopolysaccharides and Capsular polysaccharides 
(CPSs) from different Gram-negative bacteria: 
The Lipooligosaccharide (LOS) structure produced by Rhyzobium radiobacter Rv3 was determined 
through spectroscopic studies. It shows the occurrence of a mannose oligosaccharide analogue to the 
D1 arm of the gp120 oligosaccharide shield, recognized by the broadly neutralizing human anti-HIV 
antibody 2G12.4 This discovery opened the attractive way to the use of this bacterium for potential 
HIV vaccine development: a new neoglycoprotein was realized, possessing as antigen portion the 
modified LOS linked, through a spacer, to the commercial Bovine Serum Albumin (BSA).   
In order to find a Lipid A with a potential antagonistic activity, structural features of this molecule, 
produced by the non-pathogen Cupriavidus necator 5 DSM 13523, were explored. This choice starts 
from the assumption that structural moieties of organisms that do not enter in contact with humans, 
may be not or poorly recognized by the immune system; so it is likely that they have low, no toxic or 
antagonistic activity. Cupriavidus necator produces mainly a symmetric hexa-acyl Lipid A made up of 
a diphosphorylated disaccharide glucosamine backbone, peculiarly substituted only by fourteen 
carbons chains: the tetradecanoic, the 2- and 3- hydroxytetradecanoic acid. Different Lipid As from 
non-pathogenic bacteria as Rhodobacter capsulatus, Rhodobacter spheroids and Chromobacter 
violaceum were described as antagonists;3 in particular, the Lipid A from Chromobacter violaceum 
possessed an hexa-acyl symmetric structure, similarly to that found for Cupriavidus necator. These 
assumptions increase the interest to the investigation of the biological activity of Cupriavidus necator 
Lipid A. The O-polysaccharide repeating unit produced by Cupriavidus necator 6 DSM 13523 was 
                                                     
1 Raetz, C.R.H and Whitfield, C. Ann. Rev. Biochem., 2002, 71, 635. 
2 Miyake, K. Trends Microbiol. 2004, 12, 186. 
3 Seydel,U.; Oikawa, M.; Koichi Fukase, K.;  Kusumoto, S. and Brandenburg, K. Eur. J. Biochem., 2000, 267, 3032. 
4 Pantophlet, R. and Burton, D. Ann. Rev. Immunol., 2006, 24, 739. 
5 Zeph, L. R. and Casida, Jr..Appl. Environ. Microbiol., 1986, 52, 819. 
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also disclosed through spectroscopic analyses and it consisted only of deoxy sugars: four rhamnose 
units and one 4-deoxy--D-arabinohexose unit. 
The complete structural characterization of the Lipooligosaccharide produced by a clinical isolate of 
Acinetobater baumannii strain SMAL was determined to provide valuable information on the 
mechanism activity adopted by this emerging pathogen. The Core oligosaccharide is formed of twelve 
sugar residues, organized in a highly branched inner Core moiety. It was found to be similar to that of 
Acinetobacter baumannii ATCC 19606,7 although the LOS from the strain SMAL presented an 
enhanced zwitterionic character. The features presented by this structure, might reflect the adaptation 
of the bacterium to the host environment; in particular, the presence of cationic amino sugars decrease 
the net negative charge of the Core region and thus might shield the bacterial membrane from the 
effect of host defence agents, like the cationic antimicrobial peptides. Regarding to the Lipid A 
structure, mass spectrometry experiments revealed that it is composed of a heterogeneous blend of 
molecules differing for type and degree of acylation. The proportion among the differently acylated 
species changed in response to the growth conditions: predominance of the hepta-acylated species was 
observed when the bacterium was grown in Fetal Bovine Serum at 37°C (chosen as a mimic of the 
host environment), whereas the hexa-acylated molecular species resulted more abundant using Luria 
Broth as growth medium. The results would suggest that the production of the hepta-acyl  Lipid A is a 
mechanism of adaptation to the mammalian host, and also able to confer antibiotic resistance to the 
bacterium. 
The structure of Capsular Polysaccharides by two clinical isolates of A. baumannii strains SMAL and 
MG1 was elucidated. Hot phenol/water extractions of the dry biomasses, followed by enzymatic 
digestions and repeated ultracentrifugations led to the isolation of capsular material: these 
polysaccharides were negative to Western Blot analysis with anti-lipid A antibodies, and their 
structures were established through spectroscopic and chemical analyses. The A. baumannii MG1 CPS 
consisted of a linear aminopolysaccharide and it is quite similar to the O-Chain of the LPS from 
A.baumannii strain 24.8 The repeating unit of the CPS produced by strain SMAL comprised a 
branched pentasaccharide backbone, which was previously described as the O-antigen of another 
Acinetobacter baumannii species (strain ATCC 17961)9, while here it occurs as a capsule. These 
results highline that care must be taken in the development of these diagnostic devices, because similar 
if not identical polysaccharides might be constituents of the Lipopolysaccharides O-antigen or of the 
bacterial envelope capsule, as reported for A. baumannii SMAL and MG1. Furthermore, this study 
may contribute significantly to the establishment of serotyping scheme for this bacterium. 
The study conducted on the LPS produced by the enterohaemorrhagic E.coli O157:H-, subject of a 
collaboration, demonstrated that it is was not affected by the phenomenon of the phase variation but 
                                                     
7 Vinogradov, E. V.; Duus, J. Ø.; Brade, H. and Holst, O. Eur. J. Biochem., 2002, 269, 422. 
8 Vinogradov, E. V.; Brade, L.; Brade H. and O. Holst. Carbohydr. Res., 2003, 338, 2751. 
9 MacLean, L.;. Perry, M. B.; Chen, W. and Vinogradov, E. V. Carbohydr. Res., 2009, 344, 474. 
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also that it produced two cyclic forms of the Enterobacterial common antigen:10 the tetrameric 
ECACYC and the pentameric ECBCYC. The presence of ECACYC for a pathogenic strain of E.coli 
together with the pentameric form, ECBCYC, represents a new datum and further studies will be 
focused on the study of biological functions of these molecules and eventually on their implication as 
a virulence factor. 
The last part of the thesis is the result of a collaboration with the  Novartis Vaccines Diagnostic of 
Siena concerning the analyses of the polysaccharide components on the Outer Membrane Vesicles 
(OMVs) of Neisseria meningitidis group B (MenB). In particular, one of the target was focused on the 
isolation and structural characterization of the Lipooligosaccharide in order to define the LOS 
immunotypes of the strain used for vaccine production. The Lipid A family of the strain was also 
structurally defined through MALDI mass spectrometry and the penta-acyl Lipid A resulted the 
predominant specie. Finally, the content of LOS and CPS outside vesicles was determined, as well. 
 
 
Parts of this thesis has been adapted from the following articles: 
 
Fregolino, E.; Fugazza, G.; Galano, E.; Gargiulo, V.; Landini, P.; Lanzetta, R.; Lindner, B.; Pagani, 
L.; Parrilli, M.; Holst, O. and De Castro, C. Complete Lipooligosaccharide Structure of the Clinical 
Isolate Acinetobacter baumannii, Strain SMAL. Eur. J. Org. Chem. 2010, 7, 1345-1352 
 
Fregolino E., Gargiulo V., Lanzetta R., Parrilli M., Holst O., De Castro C. Identification and structural 
determination of the capsular polysaccharides from two Acinetobacter baumannii clinical isolates, 
MG1 and SMAL. (Submitted to Organic & Biomolecular Chemistry in September 2010). 
 
  
                                                     
10 Erbel, P.J; Barr, K.; Gao, N.; Gerwig, J.G.; Rick, P.D. and Gardner, K.H. J. Bacteriol., 2003,185, 1995. 
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PART I: INTRODUCTION 
 
CHAPTER I  
 
STRUCTURES AND FUNCTIONS OF POLYSACCHARIDE COMPONENTS OF THE 
GRAM-NEGATIVE BACTERIA OUTER MEMBRANE  
 
1.1 Bacterial Cell Envelope 
 
Bacteria have evolved a sophisticated cell envelope or membrane that protects the cytoplasm and 
contains a wide variety of biological molecules involved in many cellular processes. Cell envelope is 
composed by a series of layers, and their organization allows the distinction of two different families 
of bacteria: Gram-positives and Gram-negatives (figure 1.1.1). 
 
 
 
Three principals layers are individuated in Gram-negative cell envelope: the outer membrane (OM), 
the periplasm and the inner membrane (IM). The OM has a peculiar asymmetrical organization, it 
consists of glycerophospholipids and lipoproteins in the inner leaflet and of Lipopolysaccharides 
(LPSs) in the outer leaflet. The OM contains several integral, transmembrane proteins, outer 
membrane proteins (OMPs), and some of these such as the porins allow the passive diffusion of small 
molecules such as mono- , disaccharides and amino acids across the OM. 
The OM is stapled to underlying Peptidoglycan layer by peculiar lipoprotein called Braun’s 
lipoproteins or murein lipoproteins. Peptidoglycan is made up of repeating units of the disaccharide N-
acetyl- glucosamine and N-acetyl muramic acid cross-linked by tetrapeptide side chains (Vollmer et 
al., 2008) and because of its rigidity, it determines the cell shape. The IM is made up of phospholipid 
bilayer, mainly phosphatidyl ethanolamine and phosphatidyl glycerol, arranged so that hydrophobic 
hydrocarbons chains are shielded from the surrounding polar fluid with polar heads oriented towards 
the extracellular face. Other minor lipids include polyisoprenoid carriers, whose function is the 
translocation of activated sugar intermediates required for envelope biogenesis.  
 
Figure 1.1.1:Depiction of the cell envelope in Gram-positive and Gram-negative bacteria
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Bacteria lack of intracellular organelles like mithocondria, smooth and rough endoplasmatic reticulum 
that perform a number of essential cellular processes; so many of the functions of eukaryotic 
organelles are performed in the IM. The OM and IM delimit an aqueous cellular compartment called 
the periplasm, densely packed with proteins and more viscous than the cytoplasm. 
The Gram-positive cell envelope differs in several key ways from that of Gram-negative. The major 
differences regard the absence of the outer membrane in Gram-positives and the Peptidoglycan 
thickness. The Gram-negative Peptidoglycan is only a few nanometers thick, the Gram-positive is 30 – 
100 nm thick and the most notable structural difference relates to the peptide cross-links between 
glycan strands (Vollmer, 2008). The OM of Gram-negative bacteria plays a major role in protecting 
the organisms from the environment by excluding toxic molecules and providing an additional 
stabilizing layer around the cell, and because it indirectly helps to stabilize the inner membrane, the 
Peptidoglycan mesh surrounding Gram-negative cell is relatively thin. Threading through the 
Peptidoglycan layers of Gram-positive bacteria, there are long anionic polymers, called Teichoic acids 
(TAs), which are composed largely of glycerol phosphate, glucosyl phosphate, or ribitol phosphate. 
One class of these polymers, the wall Teichoic acids (WTAs), are covalently attached to 
Peptidoglycan; another class, the Lipoteichoic acids (LTAs), are anchored to the head groups of 
membrane lipids (Neuhaus, 2003). Collectively, these polymers can account for over 60% of the mass 
of the Gram-positive cell wall, making them major contributors to envelope structure and function. 
In the case of virulent Gram-positive and Gram-negative bacterial strains, the macromolecules 
constituting the cell envelope are strongly involved in mechanisms of adhesion, colonization, infection 
of host organisms. In particular Peptidoglycan, Teichoic acids for Gram positive, Lipopolysaccharides 
for Gram negative bacteria perform the rule of antigens because they are recognized by specific 
receptors of system immune cells.  
 
1.2 General architecture, function and biosynthesis of the Lipopolysaccharide (LPS) 
 
LPS is the most abundant surface molecule and ubiquitous in all Gram negative bacteria (Alexander 
and Rietschel, 2001). It is schematically represented as a tripartite amphipatic molecule comprising 
glycolipid moiety, termed Lipid A, covalently linked to the Core oligosaccharide (OS). In the 
“Smooth-type” LPS (S-LPS) (figure 1.2.1) the Core is glycosylated by a polysaccharide termed the O-
antigen or O-Specific Side Chain; while the “Rough-type” (R-LPS) is composed only by Lipid A and 
Core region, in this case LPS is also called as Lipooligosacchaide (LOS). Lipid A, is made up of 2-
amino-2-deoxy-D-glucose (glucosamine, GlcN) disaccharide backbone, which is phosphorylated and 
acylated with a variable number of fatty and hydroxy-fatty acid chains. This hydrophobic portion is 
embedded in the phospholipid bilayer and forms the majority of the outer lipid leaflet of the OM 
providing the anchorage  of the LPS to the outer membrane.  
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The Core is composed by one to three residues of 2-keto-3-deoxy-D-manno-octulosonic acid (Kdo), a 
distinctive acid monosaccharide for all bacterial Core oligosaccharide, residues of heptoses and 
hexoses. The O-antigen is a polymer made up of oligosaccharide repeating units whose chemical 
composition, structure varies widely among Gram-negative bacteria. 
 
 
The LPS layer of the outer membrane represents an effective diffusion barrier toward external stress 
factors. This is due in part to the low fluidity state of the hydrocarbon regions of the Lipid A and to the 
strong lateral interactions between LPS molecules. Furthermore, the negatively charged groups carried 
by Lipid A (as phosphates, pyrophosphates, uronic acids) and often present on the residues of the inner 
Core, participate in ionic interaction with divalent cations, such as Ca2+ or Mg2+ . This contributes to 
create hydrophilic environment that provide a barrier preventing the passage of hydrophobic 
substances such as detergent or antibiotics across the outer membrane. The synergic interactions 
between LPS-LPS, LPS-cations, LPS-OMP play an important role in maintaining the structural 
integrity of the bacterial outer membrane. 
The biosynthesis of LPS is a complex process involving various steps that occur at the plasma 
membrane followed by the translocation of the formed LPS to the bacterial cell surface (figure 1.2.3). 
In general, the Core oligosaccharide is assembled on a preformed Lipid A, while the O-antigen is 
independently assembled and then linked to the Lipid A-Core oligosaccharide (Raetz and Whitfield, 
2002). The enzymology and molecular genetics of the steps of Lipid A biosynthesis are best 
characterized in E. coli (figure 1.2.2). In the first step the UDP-GlcNAc acyltransferase (LpxA) 
promotes the acylation of the sugar nucleotide UDP-GlcNAc. This acyltransferase is selective for 3-
hydroxymyristate, consistent with the composition of E. coli Lipid A and it needs an acyl carrier 
protein (ACP) thioester as donor of substrate. In last steps, two Kdo residues are transferred to not yet 
complete Lipid A backbone, coherent with the structure of LPS of E. coli and lauroyl and myristoyl 
residues are added to the non reducing glucosamine unit, generating acyloxyacyl moieties. LipidA-
Kdo2 is the minimal Lipopolysaccharide that supports growth in most bacteria and is the acceptor on 
which the Core oligosaccharide is assembled via sequential glycosyl transfer from nucleotide sugar 
precursors. 
Figure 1.2.1: General structure of Smooth type LPS (S-LPS) 
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Figure 1.2.2: LpxA catalyzes the first step of Lipid A biosynthesis. It transfers the (R)-3-hydroxyacyl moiety from 
(R)-3-hydroxyacyl-ACP to the 3-position of UDP-	


2-
Lipid A are derived from LpxA. 
 
The assembly occurs at the cytoplasmatic face of the inner membrane, where acceptor and nucleotide 
sugars are available (figure 1.2.3).  
The O-antigen is assembled on undecaprenyl-phosphate (Und-P), a polyisoprenoid lipid to which O-
antigen is linked via phosphodiester bond. 
Different reactions involve the elongation, 
translocation and polymerization of O-repeating 
units leading the polymeric O-antigen linked to 
Und-PP localized to the periplasmatic side of the 
inner membrane. These processes converge in the 
transfer of the O-antigen on the Core domain of the 
preformed Lipid A-Core acceptor, and the 
complete LPS (Lipid A-Core oligosaccharide-O-
antigen) is further translocated to the outer 
membrane, becoming surface exposed (figure 
1.2.3) 
 
 
 
 
 
 
 
 
 
 
Figure 1.2.3: Depiction of LPS biosynthesis 
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1.3 The Core oligosaccharide and O-Specific Side Chain 
 
The Core oligosaccharide is covalently linked to the O-6 of the non reducing unit of glucosamine of 
Lipid A (Holst et al., 1999) and it is characterized by major intra-genus variability compared to the 
Lipid A portion. The Core is conceptually divided into two regions: Inner Core proximal to Lipid A 
and Outer Core that provides an attachment site for O-antigen. The Inner Core is more conservative 
and characterized by the occurrence of peculiar monosaccharides, although there is an high structural 
variability among the same genus. The Kdo performs the linkage between the Core and Lipid A but in 
some cases a derivate, D-glycero-D-talo-oct-ulosonic acid (Ko) is also present as observed in some 
Acinetobacter (Kawahara et al., 1987) or Burkholderia (Silipo et al., 2006) strains. In most cases the 
Core hosts additional Kdo units and other peculiar monosaccharides, the heptoses, tipically L-glycero-
D-manno-heptosepyranoses (L,D-Hep). Some bacteria contain D-glycero-D-manno-heptosepyranoses 
(D,D-Hep), biosynthetic precursor of L,D-Hep, alone or in combination with the more prevalent L,D-
Hep (Ding et al., 1994); while others, like Rhizobium, lack heptoses entirely. The base structure of 
Inner Core is often decorated with non-stoichiometric additions of other sugars, phosphate (P), 
pyrophosphoethanolamine (PEtN) or phosphorylcholine (PCho) residues. The varying extent of these 
modifications contributes to the heterogeneity of LPS molecules. The Outer Core shows more 
structural diversity as might be expected for a region with more exposure to the selective pressures of 
host responses and environmental stresses. It usually contains neutral and acid monosaccharides but 
also amino sugars. It is possible to find phosphate or pyrophosphate groups and occasionally non-
glycidic substituents like aminoacids residues. The O-Chain is present only in the smooth-type LPS. 
This polysaccharide has an high molecular weight (10000-60000 Da) and the O-repeating units may 
comprise varying numbers of monosaccharides (deoxysugars, heptoses, aminosugars, uronic acids), 
which can form homopolymers or, more frequently, heteropolymers. The sugars can bring non 
stoichiometric modifications (N- or O-acetylation or glycosylation) or acyl groups like acetyl, formyl, 
pyruvil groups that may complicate the repeating unit structure. The location of O-polysaccharide at 
the cell surface places it at the interface between the bacterium and its environment; variation of the 
structure can be used to modulate the response of the bacterium to external factors. When the LPSs are 
separated by SDS-PAGE, the extensive heterogeneity in the sizes of the molecules is evident: 
variations in the chain length of the O-polysaccharides give the classical “ladder” patter in SDS-
PAGE, where each band of the ladder represents a Lipid A-Core molecule substituted with an 
increment of additional O- unit.  
The Core of some rough strains and the O-Chains are recognized by the acquired immune system that 
develops specific antibodies against epitopes localized within the oligosaccharide, leading to the rise 
of the immune system.  
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1.4 Structure and biological activity of Lipid A  
 
The Lipid A is the most conservative portion of LPS: its structure is maintained, with few variation, 
among the genus. (Zähringer et al., 1999). The base architecture is made by a disaccharide backbone 
of 2-amino-2-deoxy-D-	

		


-(16) glycosidic linkage. The reducing GlcN 
unit (GlcN I), is phosphorylated at O-1, the non reducing unit (GlcN II) is phosphorylated at O-4 and 
glycosylated at O-6 by Kdo. Both of GlcN units are acylated via ester and amide bonds by long chains 
of 3-hydroxy-fatty acids that constitute the primary fatty acids, 
 	
 	
-hydroxyl groups are 
generally esterified by the secondary fatty acids. A bacterial strain produces a family of Lipid As, 
because this type of molecule has an intrinsic heterogeneity due related to the acylation pattern and to 
the number of phosphate groups, eventually substituted, in non stoichiometric amounts, by other 
groups often as 2-aminoethanol (EtN), 4-deoxy-4-amino-L-arabinopyranose (Ara4N) and 2-
aminoethanolposphate (EtNP). The Lipid A is the real endotoxin principle of the LPS because it is 
recognized by the innate immune system of infected hosts. The innate immune (or non specific) 
system is the first line of defense against invading organisms (Akira et al., 2006), while the adaptive 
immune system is composed of highly specialized cells that process and eliminate the hosts and 
affords protection against re-exposure to the same pathogen.  
The strategy of the innate immune recognition is based on the detection, through pattern recognition 
receptors (PRRs), of constitutive and conserved products of microbial metabolism known as Pathogen 
Associated Molecular Pattern (PAMPs). These include Lipoproteins, Peptidoglycan, Lipoteichoic 
acids and Lipid A of LPS  which represents the invariant pattern in all Gram-negatives. Most of the 
pathogenic phenomena associated with the infection are induced by the interaction of the Lipid A with 
a specific PRR receptor, the Toll-like receptors 4 (TLR4) (Takeda and Akira, 2005). Recognition of 
LPS by TLR-4 is complex and requires several accessory molecules (figure 1.4.1) (Miyake, 2004). 
TLR4 is associated on the cell surface to a the 
glycoprotein MD-2, essential for the formation 
of LPS-TLR4 complex. LPS is first bound to a 
serum protein, LBP (LPS-binding protein) that 
removes the LPS from the outer membrane 
and delivers the LPS to the CD14.  
This is a glycoprotein that mediates the 
interaction LPS-TLR4; in particular the 
mCD14  (membrane bound) is attached to the 
surface of myeloid cells via 
glycosylphosphatidyinositol tail.  
 
Figure 1.4.1: Processing, signalling and clearance of the LPS  
Part I 
7 
 
The sCD14 (soluble form) occurs in the plasma and helps the LPS signalling to the cells, e.g. 
epithelial, endothelial cells, that have not the mCD14 form, allowing  its elimination through the high 
density lipoprotein (HDL) (figure 1.4.1). The LPS bound to mCD14 is transferred to TLR4-MD2 
complex, which undergoes oligomerization and triggers a complex series of events, the so-called 
inflammatory cascade, leading to the production of several effectors molecules as cytokines and 
interleukins. This structural variability of the Lipid A (phosphorylation and acylation pattern) is 
responsible for the three-dimensional changes in overall Lipid A assembly, leading to changes in the 
response of the innate immune system and consequently in the toxicity of Lipid A itself. This 
modulation of Lipid A biological activity can include both the induction and the inhibition of the 
inflammatory process: in the first case Lipid A acts as agonist and it is dose-dependent, in the second 
as antagonist (figure 1.4.3). Low concentrations of an agonistic Lipid A trigger the innate immune 
system to stimulate the adaptive immune system via dendritic cells differentiations; while high 
concentrations cause the massive production of pro-inflammatory factors resulting in septic shock with 
an often fatal outcome of such bacterial infection. In contrast, an antagonistic Lipid A has a low or 
absent toxic activity and it is able to compete with receptor sites of the agonist Lipid A without 
triggering the inflammatory response. 
It was demonstrated that different biological activities of Lipid A are directly correlated to its intrinsic 
conformation (Seydel et al., 2000). Orientation measurements with attenuated total reflectance (ATR) 
infrared spectroscopy were applied on hydrated Lipid A samples, from various sources. Lipid A 
molecules with an asymmetric (4/2) distribution of the acyl chains have a conical molecular shape, a 
large tilt angle of the diglucosamine backbone with respect to the membrane surface, and are 
endotoxically highly active (figure 1.4.2 A); the monophosphoryl hexa-acyl Lipid A has a smaller tilt 
angle, a conical shape deviating only slightly from the cone and it shows a decreased endotoxic 
activity (figure 1.4.2 B). Penta-, tetra-acyl Lipid As or hexaacyl Lipid A with a symmetric acyl chain 
distribution (3/3), present a small tilt angle, a cylindrical shape and result endotoxically inactive or 
antagonistic (figure 1.4.2 C, D, E). Some of the tested Lipid As are reported in figure 1.4.3: the highly 
agonistic Lipid A from E. coli or Salmonella minnesota (type A, figure 1.4.2), the medium 
endotoxically active monophoshoril Lipid A (type B, figure 1.4.2) and the antagonistic Lipid As from 
Rhodobacter capsulatus and spheroides (type C, figure 1.4.2), the LipidVIa, a precursor of enteric 
Lipid A or isolated from Yersinia pestis grown at 37 °C (type D, figure 1.4.2) and Chromobacter 
violaceum (type E, figure 1.4.2).  
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Figure 1.4.2: A: endotoxically highly active E. coli-type Lipid A; B: medium active MPLA; C, D and E inactive 
or antagonistic Lipid As. 
 
Gram negative bacteria have developed mechanisms to modify the biosynthesis and consequently the 
structure of Lipid A in response to environmental stressing conditions (Miller et al., 2005). These 
modifications can promote resistance to host cationic antimicrobial peptides (CAMPs) and alter the 
recognition by TLR4. Yersinia pestis is known as major pathogen due to its ability to be transmitted to 
humans by insect vectors. It is exposed to the innate immune system in humans and rodents at 37°C, in 
fleas at 21°C, and it developed the ability to regulate the Lipid A structure with changes of the 
temperature. At 21°C Lipid A is highly acylated and more resistant to CAMPs, whereas at 37°C is 
largely in LipidIVA form (figure 1.4.3) which does not have a stimulatory effect on human innate 
immune signalling through TLR4. The regulation of Lipid A structure and the differential stimulation 
of human TLR4 might explain in part why insect-based transmission (TLR4 recognition) is much less 
virulent than human-to-human respiratory transmission (TLR4 invisibility), which results in severe 
bacteremia before septic shock (Miller et al., 2005) 
The ability of Lipid A to stimulate the innate immune response that in turn activates the adaptive 
immunity, identifies this molecule as a useful adjuvant for vaccine formulation. Adjuvants are 
combined with vaccine antigens to generate a faster, lasting longer response. Aluminum hydroxide 
(alum) is currently the dominant adjuvant for vaccines and although it is effective at boosting antibody 
response, repeated administration of vaccine are usually required. Monophosphoril Lipid A (figure 
4.2.3) is the first low-toxicity LPS derivate to be approved for widespread human vaccine adjuvant use 
instead of alum, because it generates a useful immune response and has about 0.1 % of the 
inflammatory toxicity of its parent molecule (Mata-Haro et al., 2007). 
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Figure 1.4.3: Agonistic Lipid As from E. coli, N. meningitidis, P. aeruginosa cystic fibrosis form; Antagonistic Lipid As form 
R. spheroides, R. capsulatus, C. violaceum, Lipid VIa (or from Y. pestis grown at 37 °C); Lipid A with reduced toxicity: 
Monophosphoril Lipid A and inactive Lipid As from Helicobacter pylori, P. aeruginosa non-cystic fibrosis form 
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1.5 Capsular polysaccharides (CPSs) and glycoconjugate vaccines 
 
A very broad range of bacterial species present a layer of extracellular polysaccharide: it can consist of 
a slime polysaccharide with little or no cell association (Exopolysaccharide, EPS) or alternatively can 
form an adherent cohesive layer, forming the morphological entity termed capsule (Capsular 
Polysaccharide, CPS). This is anchored to the outer membrane via multiple ionic interactions with 
LPS or covalent bonds to phospholipid or Lipid A molecules. CPS differs from O-antigen with respect 
to the mode of cell surface linkage and size, in fact it tends to be longer and to form a layer on the cell 
surface which often masks the underlying O-antigen. CPSs may themselves be released into the 
growth medium to form the EPS. (Roberts, 1996). Bacterial polysaccharides can be homo- or 
heteropolymers, branched or linear, sometimes decorated by organic or inorganic molecules. This 
results in the multiple serotypes established for many bacterial species. Over 80 different capsular 
polysaccharides (K antigens) have been described for Escherichia coli, and only a small fraction can 
be associated with specific infections (Whitfield and Roberts, 1999). Chemically identical capsular 
polysaccharides may be synthesized by different bacterial species. The CPS of Neisseria meningitidis 
group B is identical to the K1 polymer of E. coli, and the E. coli K18, K22, and K100 antigens have 
the same constituents and a structure similar to the capsule of  Haemophilus influenzae (Jann and Jann, 
1990). The apparent conservation of particular capsular polysaccharide structures between 
taxonomically diverse bacterial genera raises interesting questions concerning the evolution of capsule 
diversity and the acquisition and transmission of capsule biosynthesis genes.  
The primary role of the CPS is to protect the cell from external environment. The presence of hydrated 
layer around the surface may avoid effects of desiccation and may be particularly relevant in aiding 
the transmission of encapsulated pathogens from one host to the next. Furthermore, Capsular 
Polysaccharides promote the formation of a biofilm that assists  the colonization process and the 
adherence of bacteria to several surfaces. These ability can have important consequences: the 
colonization of hospitals can lead to serious nosocomial infections, representing often a permeability 
barrier to antibiotics (such as for Pseudomonas aeruginosa or Acinetobacter baumannii). 
The capsular polysaccharides resulted often immunogenic in humans, so they are a good candidates 
for vaccines development. In addition, they are non-toxic, easily isolated and purified with high yields, 
and have conserved and chemically defined structures. To date, vaccines based on the capsular 
polysaccharides of Neisseria meningitidis groups A, C, W-135, Y, Streptococcus pneumoniae, 
Heamophilus influenzae type b have been already successfully developed (Pon and Jennings, 2008). 
However, the immune response generates by CPS is T-independent (TI) with no immunological 
memory and produce an inadequate response in infants that are the most vulnerable to bacterial 
infections. To overcome this limitation of a new generation of glycoconjugate vaccines were 
developed in which the polysaccharide were conjugated (covalently linked) to a protein carrier, which 
in contrast generates a T-dependent (TD) response (Peeters et al., 2003).  
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The strategy to realize a glycoconjugate compound includes the selection of an appropriate size of the 
saccharide fragment, a protein carrier and the most efficient reaction for the coupling. Bacterial 
antigens can include Capsular Polysaccharide as well as Lipopolysaccharide and Lipooligosaccharide. 
Thus, the antigen may be an oligosaccharide or a polysaccharide, in which case depolymerization if 
needed, can be accomplished by various means: acid or enzymatic hydrolyses, oxidations, alkalin or 
lyase-mediated eliminations or physical methods such as sonication. The purification and the selection 
of a defined range of molecular weight can be obtained by several techniques such as ultrafiltration, 
gel permeation, ion exchange chromatographies. 
Most popular proteins carrier are tetanus toxoid (TTd), diphtheria toxoids (DTd) that are readily 
accessible, and licensed for human and in particular infants use. Toxoids originate from native 
bacterial toxins which are detoxified by the deactivation or modification of some of reactive sites on 
amino acids within the chains. However the use of detoxified bacterial toxins offers some 
disadvantages. Physical and chemical properties of the toxin are modified by the detoxification 
yielding to a lot-to-lot variations, in addition this procedure inactivates some of the readily accessible 
amino groups that could be used in coupling the polysaccharide to the carrier , reducing the 
conjugation efficiency. An alternative has been the use of mutant-derived diphtheria toxin (CRM197) 
and pertussis toxin (CRM3201) which are non toxic and antigenically equivalent to DT.  
Various spacer arms have been used  as a linker (adipic acid dihydrazide, glutaraldehyde, 
diaminobutane, 6-aminohexanoic acid) between the saccharide and the protein. The spacer may avoid 
the shielding of important carbohydrate epitopes by the secondary structure of the carrier protein and 
improve the efficiency of the coupling by increasing the steric accessibility of activated moieties. 
The choice of coupling chemistry is largely driven by the model of conjugate that is needed, namely a 
neoglycoprotein or crosslinked lattice. The first is obtained by the activation of a single end of the 
saccharide that produce the simplest conjugate configuration in which the saccharide chains radiate 
from the individual protein molecules. It is generally more efficient for the coupling of 
oligosaccharides or short polysaccharides. The crosslinked lattice is obtained by random activation at 
several points on the saccharide chain leading to a cross-liked and not defined structure. In general, it 
is the more practical approach for the coupling of polysaccharides.  
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CHAPTER II 
 
GENERAL ASPECTS 
 
2.1 Rhizobium radiobacter RV3 as a source of oligosaccharide with potential use for HIV vaccine 
production 
 
The development of an effective vaccine against HIV remains an unrealized, although still hoped, goal 
in the effort to contain the current pandemic. The humoral immune response to infection by HIV is 
characterized by the production of relative low levels of neutralizing antibodies with a broad activity 
against many different isolates of the virus. The identification and the extensive characterization of 
several monoclonal antibodies (Burton et al., 1994; Corti et al., 2010; Walker et al., 2009; Zwick et 
al., 2001) suggested that the vaccination is possible stimulating the adaptative immune system with an 
appropriate antigen. One broadly neutralizing antibody, 2G12, recognizes a high mannose 
carbohydrate epitope presented on the gp120 glycoprotein of the virus. In particular, it interacts with 
the 
	

 	
-D-Man---D-Man residues, that comprise the D1 arm of the gp120 
glycan shield, although more recent studies have shown that the binding site can also be occupied by 
the D3 arm (figure 2.1.1) (Pantophlet and Burton, 2006).  
 
Figure 2.1.1: Structure of gp120 oligosaccharide target of the 2G12 antibody. All monosaccharides are D configured and in 
the pyranose form. 
 
Furthermore, 2G12 provides an extended surface for multivalent interaction with the conserved cluster 
of oligomannose on the surface of gp120 (Calarese et al.; 2003). The crystal structure of the core of 
gp120 suggests that the carbohydrate attachment sites are clustered together on a part of the gp120 
molecule known as the “silent face” (Kwong et al., 1998; Wyatt et al., 1998; Calarese et al, 2005). 
This face is largely covered by carbohydrate and expected to be relatively weakly immunogenic and, 
hence, is described as immunologically silent. So far, many efforts are focused to the elaboration of a 
proper oligomannose antigen able to stimulate the 2G12, ranging from that present on the gp120 to 
	
 	
 	
 
 
 
 	
 --Man oligosaccharides. These have been 
conjugated on different types of carrier proteins and their affinity for 2G12 analysed together with 
their antigenic potentials (Astronomo et al., 2010).  
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Rhizobium radiobacter RV3 is a Gram negative soil bacterium and produces a Lipooligosaccharides 
structure closely related to the Man9GlcNAc2 glycan shield of the gp120 and for this reason it was 
individuated as a useful source for the development of a potential vaccine for HIV (Chapter III). 
 
2.2 Cupriavidus necator  
 
In order to find a Lipid A with a potential antagonistic activity, structural features of this molecule, 
produced by the non-pathogen Cupriavidus necator DSM 13523, were explored (Chapter IV). This 
choice starts from the assumption that structural moieties of organisms that do not enter in contact 
with humans, may be not or poorly recognized by the immune system; so it is likely that they have 
low, no toxic or antagonistic activity. As reported, the innate immune system is triggered by the 
interaction of differently acylated Lipid A molecules to the TLR4-MD2 complex and the intensity of 
the response depends on the presence of phosphate groups and on the number and size of the fatty 
acids. So, it was established that a diphosphorylated and hexa-acylated specie, as present in 
Escherichia coli LPS, acts as agonist, whereas less acylated specie is inactive or even antagonist 
(section 1.4).  
Cupriavidus necator is a Gram-negative nonobligate predator of different soil Gram-positive and 
negative bacteria (Sillman and Casida, 1986; Zeph and Casida, 1986) including Agromyces ramosus, 
Arthrobacter globiformis, Azotobacter vinelandii, Bacillus subtilis, Bacillus thuringiensis, Ensifer 
adhaerens, Escherichia coli, Micrococcus luteus, Staphylococcus aureus (Germida and Casida, 1983). 
Cupriavidus necator does not require to prey cells to grow, but if the level of available nutrients in soil 
decreases, it attacks other bacteria. The encounter with prey is stimulated by chemotaxis phenomenon 
that it is followed by the attachment and penetration of the prey outer membrane. During 
interperiplasmatic growth phase, there is the cells differentiation and finally the prey envelope lysis. 
Bacteria of genus Cupriavidus are highly resistant to copper (Casida, 1988). They produce a peptide 
growth initiation factor (GIF) which, chelating copper, helps the bacterium to provide the necessary 
copper for its initial growth. It was observed that the growth following the initial is not influenced or 
inhibited by addition of extra copper and the rate of GIF production depend on which amino acid or 
other carbon compounds are available to the bacterium. Furthermore, Cupriavidus seems to use 
copper-GIF for delivering toxic levels of copper to its prey cells (Casida, 1988). Some of the bacteria 
attached are them self predators and in this cases an attack-counter attack phenomenon was described 
(Byrd and et al., 1985).  
 
2.3 Acinetobacter baumannii  
 
Acinetobacter baumannii is an opportunistic Gram-negative bacterium considered the most 
common human pathogen species within its genus, followed by A. lwoffii and A. haemolyticus. 
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This bacterium is widely distributed in nature and is extraordinarily adaptable to a variety of 
environmental conditions, e.g., it may colonize a variety of hospital surfaces such as surgical 
drains and catheters (Peleg et al., 2008). It is generally considered an opportunistic pathogen in 
immuno-compromised patients causing severe nosocomial, bloodstream, pneumonia, or urinary 
tract infections, and septicemia (Van Looveren and Goossens, 2004). 
The propensity of this organism to develop drug-resistance (Fournier et al. , 2006) (against 
carbapenem, beta-lactam, and tetracycline antibiotics) and the lack of development of new drugs to 
treat infections have resulted in a significant increase in Acinetobacter-related studies (Bergogne-
Berezin and Towner, 1996). The most common pathogens belong to the so-called A. calcoaceticus - A. 
baumannii complex (Joly-Guìllou, 2005). The mechanism by which Acinetobacter is able to express 
its pathogenicity is not yet completely elucidated but a crucial role is played by components of the cell 
envelope outer membrane, namely the Lipopolysaccharides and Capsular Polysaccharides. These 
molecules act in synergy by blocking the access of human complement factors to the bacterial cell 
wall, thus preventing bacterial killing and lysis (Goel and Kapil, 2001). So, the establishment of the 
CPS and LPS structures is of importance to understand the physical assemblage of the external 
membrane and its properties, like adhesion to surfaces (i.e. hospital’s furniture or human skin), 
permeability to hazardous compounds (e.g., detergents used to clean surfaces) but also can contribute 
to the development of new pharmacological and immunostimulatory strategies for the prevention or 
the therapy of the diseases (Chapters V and IV).  
 
2.4 Virulence factors of Escherichia coli  and the Enterobacterial common antigen  
 
Escherichia coli is part of the normal micro flora of the gastrointestinal tract of mammals and birds, 
but certain strains have been associated with gastrointestinal diseases in both humans and animals. E. 
coli is serotyped on the basis of their O (somatic), H (flagellar), and K (capsular) surface antigen 
profiles (Nataro and Kaper, 1998; Lior, 1994). A specific combination of O, K and H antigens defines 
the serotype of an isolate. E. coli of specific serotype can be associated reproducibly with certain 
clinical syndromes, but in general the serologic antigens themselves do not confer virulence. In fact, 
some E. coli strains have been categorized into pathogenic groups, based on their virulence properties 
(Nataro and Kaper, 1998). One of these groups is characterized by the production of potent cytotoxins 
that inhibit protein synthesis within eukaryotic cells. These toxins are either termed verocytotoxins 
(VT), because of their activity on Vero cells, or Shiga toxins (Stx), because of their similarity with the 
toxin produced by Shigella dysenteriae (Melton-Celsa and O'Brien, 1998). Therefore, these strains are 
either termed Stx-producing E. coli (STEC) or VT-producing E. coli (VTEC). Enterohaemorrhagic E. 
coli (EHEC) constitutes a subset of serotypes of STEC that has been firmly associated with bloody 
diarrhoea and haemolytic uraemic syndrome (HUS) in industrialized countries (Griffin and Tauxe; 
1991). The majority of disease worldwide is caused by strains of serotype O157:H7, but also by O26, 
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O111, O103, and O145 (Tozzi et al., 2003).  The production of Stx appears to be essential but not the 
only responsible for the pathogenic effects, hence many efforts in recent years have been focused on 
the possible involvement of other virulence factors and on the understanding of their mechanisms. 
Outer membrane components as OM proteins, capsules, LPSs have been extensively considered, in 
particular because they are subjected to the phase variation (Lukácôvá et al., 2008). This phenomenon 
is associated with reversible changes within repeated simple DNA sequence motifs that exhibit high 
mutation rates by loss or gain of repeating units during DNA replication. The switch can be influenced 
by the extracellular conditions. Such reversible changes are heritable and reversible between 
generations, and the switching frequency is characteristic for the gene, the bacterial species and the 
regulatory mechanism. Consequently, the high-frequency variation in the expression of the outer 
membrane components is valid strategy to overcome the immune system.  
The cell surface of enteric bacteria contains an additional antigenic polysaccharide known as the 
Enterobacterial common antigen (ECA) (Kuhn et al., 1988; Männel and Mayer, 1978). It is a 
heteropolysaccharide made up of a trisaccharide repeat unit: 3)--D-FucNAc---D-ManNAcA-
--D-GlcNAc-. The ubiquitous form is represented by the glycolipid ECAPG 
(phoshoglyceride-linked) where polysaccharide ECA chains are covalently linked to 
diacylglycerolphoshate via glycosidic linkage between the reducing terminal GlcN unit and the 
phosphate residue of the phosphoglyceride aglycone, which anchors the ECA to the outer membrane 
(Rick et al; 1998; Rinno et al.; 1980). The two related forms are the ECALPS and the ECACYC isolated 
in certain Enterobacteriaceae. About the first, the linear ECA polysaccharide chains are covalently 
linked to the Core region of the LPS instead of the phosphoglyceride aglycone. In contrast, the 
ECACYC is a cyclic water soluble polysaccharide that contains only the trisaccharide repeating units 
with different degree of O-acetylation (Dell et al., 1984; Staaf et al., 2001). Furthermore, its 
occurrence is quite restricted, in fact it was isolated and characterized in Yersinia pestis (from 3 to 5 
repeating units) (Vinogradov et al., 1994), Shigella sonnei (from 4 to 6 repeating units), Plesiomonas 
shigelloides (4 repeating units), and E. coli K12 ( 4 repeating units) (Erbel et al., 2003; Kajimura et 
al., 2005). Although the structure of these molecule has been characterized, there are few information 
about their biological role or if it is the same in all enteric bacteria. Recent studies suggested that 
ECAPG may be involved in the resistance of Shiga toxin production of E. coli O157:H7 to organic 
acids (Barua et al., 2002). In Salmonella enterica serovar Typhimurium, the ECAPG acts as a virulence 
factor for oral infection in mice by rendering the organism more resistant to bile salts (Ramos-Morales 
et al., 2003). In contrast, there are no information about the biological function of ECACYC. It seems 
that the periplasmic location and cyclic structure of this molecule are similar to those of the 
osmoregulated periplasmic glucans synthetized by many Gram negative Proteobacteria (Bohin; 
2000). 
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PART II: RESULTS AND DISCUSSION 
 
CHAPTER III  
 
SYNTHESIS OF NEW NEOGLYCOPROTEIN USING MANNAN OLIGOSACCHARIDE 
FROM Rhizobium radiobacter RV3  
 
In the following investigation, the Lipoolisaccharide structure produced by Rhyzobium radiobacter 
Rv3 was determined through spectroscopic studies. It shows the occurrence of a mannose 
oligosaccharide (D1’) analogue to the D1 arm of the gp120 Man9GlcAc2 oligosaccharide recognized 
by the broadly neutralizing human anti-HIV antibody 2G12 (section 2.1).  
 
This discovery opened the attractive way to the use of this bacterium for potential HIV vaccine 
development, in particular because this is a natural and available source of antigen .  
Purified LOS of Rhizobium radiobacter Rv3 was tested, but it showed low affinity versus  2G12 
antibody. On the basis of this information, a new neoglycoprotein was realized (figure 3.3.1), 
possessing as antigen portion the modified LOS linked, through a spacer, to the commercial Bovine 
Serum Albumin (BSA) as protein carrier. The molar ratio OS/BSA was determined with two 
independent approaches: colorimetric phenol-H2SO4 test and quantitative GC-MS estimation.  
 
3.1 LOS chemical analyses  
 
Pure LOS was extracted by PCP procedure (section 8.1) from the dry cells of Rhizobium radiobacter 
RV3. LOS SDS-PAGE profile showed the mobility typical of low molecular weight molecules, 
characteristic of lipooligosaccharide species. Combining the information from monosaccharide 
composition, methylation analysis, the LOS fraction contained mainly terminal, 2- and 3,6 substituted 
D-mannose , terminal D-galactose and minor amounts of 3-substituted D-mannose; acidic residues, as 
3-deoxy-manno-oct-2-ulosonic acid (Kdo) and phosphorylated glucosamine were not detected with the 
methylation protocol used. Fatty acids analysis showed the presence of C14:0 (3-OH), C16:0 (3-OH), 
C18:1 (3-OH) and C28:0 (27-OH): the lipids distinctive of this bacterial family (Silipo et al. 2004). 
LOS produced from R. radiobacter Rv3 was totally delipidated and the oligosaccharide mixture was 
analysed via strong anion exchange chromatography (HPAEC) (section 9.3), leading to the separation 
of two different oligosaccharides, OS1 and OS2, whose structure was defined via NMR analysis. 
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3.2 NMR analysis of Core oligosaccharide 
 
The complete assignment of 1H and 13C resonances of each OS1 and OS2 was achieved (1H-NMR 
spectra in figure 3.2.1), combining the information obtained from 2D homo- and heteronuclear 
spectra.  
Figure 3.2.1: (600 MHz, 303 K), 1H-NMR spectra of OS1 (bottom, NaOD 10 mM in D2O) and OS2 (up, D2O) 
 
With regard to OS1 spectra attribution (table 3.2.1, figure 3.2.2), the eight anomeric protons were 
labelled with a capital letter in decreasing order of chemical shifts, whereas two couples of the 
diastereotopic methylene signals were observed in the high field region of the proton spectrum, due to 
the presence of two Kdo residues, Kint and Kext. Thus, a decasaccharide structure was identified in the 
deacylated LOS. With regard to residues A and H, their anomeric protons showed six different 
correlations, and on the basis of their ring proton and carbon resonances, these residues were 
recognized as the two conserved glucosamine moieties constructing the lipid A moiety of the 
oligosaccharide. With regard to residues B-F, the TOCSY and gHSQCTOCSY (this last in figure 
3.2.2) spectra of the anomeric region (figure 3.2.2) could not establish any connectivity after the H-2 
proton, due to the small 3JH1,H2 and 3JH2,H3 coupling constants values; on the other hands, magnetization 
was propagated from H-2 proton up to H-6s, therefore these residues were recognized as mannose, all 
 configured at the anomeric centre due to the value displayed from their C-5.  
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Figure 3.2.2: (600 MHz, 303 K, 10 mM NaOD in D2O) Attribution of anomeric region of the gHSQCTOCSY (black) and 
gHMBC (gray) spectra measured for OS1. Differently from TOCSY spectrum, magnetization propagation was not observed 
for GlcN1P residue A. 
 
Determination of the ring carbon chemical shifts disclosed their substitution pattern, being B and C 
both glycosylated at O-2, D doubly substituted at O-3 and O-6, while E and F the terminal non 
reducing part of the molecule.The galactose unit G was -configured on the basis of its anomeric 
carbon chemical shift at 104.6 ppm and its coupling constant 3JH1,H2 7.8 Hz. TOCSY spectrum related 
the anomeric proton up to H-4, while H-5 position was established analysing TROESY spectrum, due 
to the spatial proximity of these two protons. Ring carbon values suggested the terminal location of 
this residue. As far as the two Kdo residues were concerned, their characteristic diastereotopic H-3ax 
and H-3eq proton signals resident in the high field area of the proton spectrum were used as basis for 
spectroscopical attributions. Exploring scalar connectivities, for each Kdo residue it was possible to 
assign the sequence only from H-3 through H-5. The H-5/H-6 cross peak was not present due to the 
small value of the coupling constant 3JH5,H6. Therefore identification of proton H-6 was made possible 
by the presence of the two intra-residue NOE contacts H-4/H-6 (medium) and H-5/H-6 (strong). 
Scalar connectivities between the other exocyclic Kdo protons were also clearly present and carbon 
chemical shifts identified Kext as an O-8 glycosylated Kdo whereas Kint was substituted at both O-4 
and O-5. Residue sequence was established exploiting scalar gHMBC connectivities (figure 3.2.2, 
structure in figure 3.2.3) and analysis started from the terminal non reducing residues according to 
which E was linked at O-2 of C, which was linked at O-2 of B in turn linked at O-3 of D which was 
the substituent at O-5 of Kint. The other terminal mannose unit, F, was linked at O-6 of D, while 
galactose G was the substituent at O-8 of Kext.  
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The two Kdo residues were  configured on the basis of the chemical shift values of their H-3eq 
protons (Birnbaum et al., 1987) and Kext was located at O-4 of Kint on the basis of the characteristic 
NOE between H-3eq of Kint and H-6 of Kext, observed in the TROESY spectrum (Holst et al., 1995). 
OS1 sequence was completed placing Kint at O-6 of glucosamine H, the distal unit of the Lipid A 
segment of the molecule. With regard to OS2, spectra interpretation followed the same approach 
shown above, and analysis was simplified due to the lower number of residues constituting the 
molecule. Complete spectra attribution (table 3.3.2), identified a structure differing from that of OS1 
for the absence of both F and G units, namely the terminal mannose and galactose residues. 
Figure 3.2.3: Oligosaccharides structure from Rhizobium radiobacter Rv3. All residues are D configured and in pyranose 
form. Residues are labelled according to the NMR attribution in tables 3.2.1 and 3.2.1. OS1 is the major fraction, OS2 
differs from OS1 for the lack of residues F and G. 
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  1 2 3 4 5 6-6' 
A  5.41 2.7 3.62 3.49 4.09 3.78-4.28 
6)--GlcN1P 95.8 56.8 74.7 71.1 72.8 70.6 
B  5.36 4.08 3.99 3.69 3.8 3.88-3.66 
2)--Man 102.1 79.8 71.6 68.3 74.8 62.3 
C  5.29 4.12 3.98 3.67 3.76 3.89 x 2 
2)--Man 101.9 79.7 71.3 68.3 74.6 62.3 
D  5.18 4.28 3.99 3.98 4.2 4.12-3.66 
3,6)--Man 102.3 71.1 80.4 66.5 72.9 66.4 
E  5.05 4.07 3.86 3.63 3.76 3.75 x 2 
t--Man 103.4 71.3 71.6 68.1 74.5 62.4 
F  4.93 4.03 3.88 3.66 3.67 3.77 x 2 
t--Man 101 71.2 71.9 68.1 74 62.4 
G  4.5 3.54 3.72 3.95 3.76 3.80 x 2 
t--Gal 104.6 72.2 73.9 69.9 76.4 62.2 
H  4.41 2.67 3.57 3.64 3.64 3.78-3.46 
6)--GlcN4P 104.2 57.5 77.3 74.5* 75.6* 70.5 
  3eq-3ax 4 5 6 7 8 
Kext  2.13-1.83 4 4.01 3.86 4.3 4.19-3.93 
8)--Kdo 36 67.4 68.5 73 70.8 72.1 
Kint  2.10-2.00 4.05 4.22 3.73 3.74 3.86-3.76 
4,5)--Kdo 35.8 72.6 75.4 73 70.9 64.4 
*These signals can be interchanged 
Table 3.2.1: 1H (regular) and 13C (italic) chemical shifts at 303 K in 10 mM NaOD in D20, measured for OS1 (figure 3.2.3). 
For Kext and Kint C-2 were identified in the HMBC spectrum at 103.5 and 100.8 ppm respectively; while C-1 were not 
detected. All residues are D configured and in pyranose form. 
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  1 2 3 4 5 6-6’ 
A’ 5.49 2.92 3.71 3.54 4.12 4.29-3.81 
6)--GlcN1P 94.85 56.51 73.9† 71.2 72.3* 70.7 
B’ 5.38 4.09 4.00 3.69 3.8 3.88 x 2 
2)--Man 102.2 80.1 71.6 68.5 74.9 62.4 
C’ 5.3 4.12 3.97 3.68 3.76 3.88 x 2 
2)--Man 102.1 79.9 71.5 68.5 74.6 62.4 
D’ 5.18 4.28 4.01 3.9 4.09 3.86 x 2 
3)--Man 102.1 71.3 80.2 66.9 74.3 61.8 
E’ 5.06 4.07 3.86 3.64 3.78 3.65-3.56 
t--Man 103.7 71.5 71.8 68.3 74.7 63.9 
H’ 4.57 2.79 3.67 3.7 3.66 3.52-3.76 
6)--GlcN4P 103.5 57.4 75.6‡ 74.6† 76.4‡ 64.2 
  3eq-3ax 4 5 6 7 8 
K’ext  2.17-1.83 4.02 4.02 3.84 4.11 3.79-3.92 
8)--Kdo 35.9 67.3 68.3 73.4 73.2* 63.8 
K’int  2.12-1.88 4.12 4.26 3.75 3.75 3.87-3.77 
4,5)--Kdo 35.8 72.3 75.0 73.4 70.8 64.6 
*, †, ‡,  These signals can be interchanged 
Table 3.2.2. 1H (regular) and 13C (italic) chemical shifts, at 303 K in D2O, measured for OS2 (figure 3.2.3). C-2 for Kext and 
Kint, could not be established because gHMBC was not measured due to the low amount of material available. All residues 
are D configured and in pyranose form. 
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3.3 Characterization of OS-BSA conjugate 
 
Free amino groups present on the deacylated, dephosphorylated and reduced mixture of 
oligosaccharides (section 9.4) were linked to the lysines residues of BSA using glutaraldehyde as 
linker (figure 3.3.1).  
 
 
 
 
 
 
 
 
 
Figure 3.3.1: Neoglycopretin obtained by the conjugation of the deacylated, dephosphorylated and reduced OS from R. 
radiobacter RV3 with BSA, mediated by glutaraldehyde. Residues in red represent the carbohydrate moiety analogue to the 
gp120 D1 arm (section 2.1) 
 
Before the addition of OS substrate, the formation of Shiff bases between the BSA lysines and 
glutaraldehyde was estimated with the TNBS test (section 9.5). 
A BSA standard solution (1 mg ml-1) was used to build a calibration curve (figure 3.3.2), measuring 
the UV440 absorbance of known quantities of protein.  
 
 
 
 
 
 
 
 
 
Figure 3.3.2: BSA calibration curve 
 
The linear regression returned an interpoling straight line equation: A440 = 0.006 μgBSA  with a good 
sample correlation coefficient (R2= 0.975). The measures performed on BSA conjugated with 
glutaraldehyde are reported in table 3.3.1 
 
μgBSA A440 
25 0.137 
50 0.338 
75 0.485
100 0.644 
150 0.848 
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Table 3.3.1: Estimation of free BSA aminogroups  
Where: 
μgBSA-glut from TNBS test = (A440 / 0.006)  
%NH2-BSA = [(μgBSA-glut) from TNBS test / (μgBSA-glut)] ·100 = 49.7 % in average value represents the 
!

"-amino groups of BSA lysines free after reaction with glutaraldehyde.  
 
The OS-BSA conjugate was chromatographed on Sephacryl HR-100 and, on the basis of the 
chromatographic profile, fractions proximal to the void volume were divided in three groups: OS-
BSAA, OS-BSAB, OS-BSAC, further visualized through SDS-PAGE (figure 3.3.3). 
 
 
Figure 3.3.3: Sephacryl HR-100 chromatogram of the OS-BSA conjugate purification. The unreacted oligosaccharides (OS) 
eluted after an almost one column volume. The mixture of OS-BSA conjugate was divided into three fractions A, B, C and 
further analyzed via SDS-PAGE (8% separating gel, 16 μg) using BSA as standard. 
 
An estimation of molecular weight of the OS-BSA conjugates was determined through GPC on 
TSKG5000PWXLwith respect to commercial protein standards (section 9.5, table 3.3.2) 
 
 
 
 
 
Table 3.3.2: Calibration with standard proteins 
μgBSA-glut A440 μgBSA-glut 
from TNBS test 
% NH2-BSA 
15 0.058 9.72 64.78 
25 0.062 10.28 41.13 
50 0.112 19.98 39.97 
75 0.218 36.33 48.44 
100 0.326 54.32 54.32 
   49.7 
Protein MW(Da) LogMW Time (min) 
Tyroglobulin 669000 5.82 7.95 
Apoferritin 443000 5.65 8.04 
BSA 66000 4.82 9.14 
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The equation of the interpoling straight line: LogMW = -0.8057min + 12.18 was used to calculate the 
molecular weight (MW) of the OS-BSA conjugates through the introduction of measured elution times 
(table 3.3.3, figure 3.3.4). 
 
 
 
 
 
Table 3.3.3: Estimation of OS-BSA conjugates molecular weights 
 
 
Figure 3.3.4: TSK G5000PWXL gel permeation chromatography of OS-BSAA-C fractions and BSA. Calibration was performed 
using protein standards (table 3.3.2) 
 
The molecular weight of the OS-BSAA-C conjugates was major than that of BSA (66000 Da), as 
expected (figure 3.3.4).  
The determination of the carbohydrate load of the protein was performed on the most abundant 
fraction OS-BSAB using the colorimetric phenol-H2SO4 method and a quantitative GC-MS estimation 
(section 9.5).  
 
Phenol-H2SO4 method: 
 
The exact concentration of the BSA component of the neoglycoprotein (0.68 mg ml-1) was estimated 
measuring the UV280 absorbance of the solution and using the #$*
	<
		
"
>
?@\^?. 
The estimation of the carbohydrate content of the synthetic glycoprotein, was performed through the 
phenol - sulfuric acid test, calibrated with an OS solution (1.9 mg ml-1). The interpoling straight line 
obtained by linear regression resulted: A490nm= 0.021μgOS (figure 3.3.5).  
Time (min) LogPM MW (Da) 
OS-BSAA 8.50 5.33 216000 
OS-BSAB 8.98 4.95 88300 
OS-BSAC 9.02 4.91 81500
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Figure 3.3.5: Oligosaccharide calibration curve 
 
The values relative to the sample are reported in table 3.3.4: 
 
 
 
 
 
 
Table 3.3.4: Quantification of the ratio OS/BSA  
Where: 
mgBSA= (μlOS-BSA· CBSA )/1· 10-3; where CBSA = 0.68 μg μL -1 
μgOS-BSA = A490/ 0.021 
 
It is possible to estimate: 
μgOS /mgBSA = 32.62 in average value 
 
From these calculations: 
μmolOS/mgBSA = (μgOS /mgBSA)average /MWOS = 0.018 μmol/mgBSA 
μmolBSA = 1000 μg/MWBSA = 0.015 μmol 
Where: MW BSA= 66 000 Da and MWOS = 1770 Da 
 
It was concluded that: 
μmolOS/μmolBSA = 1.2 
 
 
 
 
μgOS A490 
6 0.099 
10 0.185 
14 0.279 
18 0.416 
mgBSA A490 μgOS-BSA  μgOS/ mgBSA 
0.072 0.052 2.48 34.44 
0.096 0.063 3.00 31.25 
0.120 0.081 3.86 32.17 
   32.62 
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Quantitative GC-MS estimation: 
 
Mannose monosaccharide was detected as acetylated O-methyl glycoside and its response factor was 
calculated with respect to inositol as internal standard (table 3.3.5): 
 
Mannose (μg) Inositol (μg) Mannose/Inositol 
10 50 0.2 
30 50 0.6 
50 50 1 
100 50 2 
 
Table 3.3.5: Quantities of mannose monosaccharide with respect to inositol standard 
 
A known amount of OS-BSAB (13.5 μg) was treated as the mannose monosaccharide standard and its 
content estimated with respect to internal inositol (0.5 μg), as well. The areas relative to the content of 
mannose and inositol were estimated through GC-MS (table 3.3.6) and used for the construction of the 
calibration curve (figure 3.3.6). 
 
 
 
 
 
Table 3.3.6: Areas of the mannose and inositol relative to  the sample and standards 
 
 
Figure 3.3.6: Mannose/inositol calibration curve
 
 
Mannose/Inositol 
 OS-BSAB 0.2 0.6 1 2 
AMan 9457161 116388 278657 1499047 5720929 
AIn 1654527 1829203 1541492 3284902 8416895 
AMan/AIn 0.175 0.064 0.181 0.456 0.680
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The linear regression returned a response factor (AMan/AIn ) = 0.359 (μgMan/μgIn) 
 Hence: 
(μgMan/μgIn)OS-BSA = (AMan/AIn)OS-BSA/0.359 = 0.49  
Where (AMan/AIn)OS-BSA = 0.175 (table 3.3.6) 
 
The quantity of mannose in the sample with respect to the internal inositol (0.5 μg) resulted:  
μgMan = (μgMan /μgIn)OS-BSA · μgIn  = 0.24 μg 
μmolMan = μgMan /MWMan = 1.36 ·10-3 μmol 
 
The quantity of OS, considering the five mannose units in the structure, resulted: 
μmolOS = μmolMan /5 = 2.7 · 10-4 μmol 
μgOS =  μmolOS · MWOS = 0.48 μg 
 
The quantity of BSA of the glycoconjugate with respect to the OS-BSA quantity (13.5 μg) resulted: 
μgBSA = μgOS-BSA - μgOS = 13.02 μg 
μmolBSA = μgBSA /MWBSA = 1.97·10-4 μmol 
 
It was calculated that the molar ratio resulted: 
μmolOS/μmolBSA = 1.37 
 
3.4 Conclusions 
 
The neoglycoprotein synthesized possessed as antigen the LOS produced by the prokaryote Rhizobium 
radiobacter RV3 opportunely derivatized, and the BSA as protein carrier. The approach used for the 
their linkage followed the protocol described by Holst et al., 1991 that suggested a cross reaction of 
the glutaraldehyde linker between the lysines amino groups of the BSA and free amino group of the 
oligosaccharide. About the 50% of the "-amino groups of the BSA available resulted linked to the 
glutaraldehyde. The methods used for the quantification of OS/BSA, the colorimetric phenol-H2SO4 
test and quantitative GC-MS estimation, returned a molar ratio average to 1.3. The independence of 
the approaches was considered a validation of the result. 
However the broadly neutralizing antibody 2G12 resulted not affine to this neoglycoprotein, these 
studies represented a starting point to the further exploration of Rhizobium radiobacter Rv3 for new 
HIV vaccine productions. 
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CHAPTER IV 
 
CHARACTERIZATION OF THE O-CHAIN AND LIPID A PORTIONS OF THE LPS 
FROM Cupriavidus necator DSM 13523 
 
The structure of the glycolipid and O-antigenic portions of the LPS produced by Cupriavidus necator 
DSM 13523 (section 2.2) was elucidated. The O-polysaccharide repeating unit was disclosed through 
spectroscopic analyses, and it was constituted by five deoxy sugars, one of which is the rare 4-deoxy-
-D-arabinohexose. The definition of the Lipid A moiety required the use of mass spectrometry and 
chemical investigations. It presented a conserved biphosphorylated disaccharide backbone peculiarly 
substituted only by 14 carbons fatty acids and the symmetric hexa-acylated specie appeared the most 
abundant. 
 
4.1 Chemical analyses of the Lipopolysaccharide 
 
Cells of Cupriavidus necator DSM 13523 were extracted according to the phenol-water protocol and 
the LPS was recovered only in the water phase, which was purified by enzymatic treatments and 
ultracentrifugation (section 8.2). SDS-PAGE analysis showed the characteristic ladder pattern of the 
LPS (figure 4.1.1, line C). Monosaccharides analysis of the LPS showed the presence of L-rhamnose 
(L-Rha) as main component, D-mannose (D-Man), D-glucose (D-Glc), 2-amino-2-deoxy-D-glucose (D-
GlcN),  L-glycero-D-manno-heptose (L,D-Hep), 3-deoxy-D-manno-oct-2-ulosonic acid (Kdo) and 4-
deoxy-D-arabinohexose (D-ara4dHex) residue. This last residue was identified through NMR analysis 
(section 4.3).  
 
 
 
 
 
 
 
 
 
Methylation analysis detected the presence of 2-, 3- and 3,4- substituted rhamnose units, terminal 4-
deoxy-arabinohexose and 2- and 4- substituted hexoses. The Kdo, heptose, and phosphorylated 
glucosamine were not detected with the methylation protocol used. Fatty acids methyl esters analysis 
showed the presence only of 14 carbons fatty acids: tetradecanoic (14:0), 3- hydroxytetradecanoic 
[14:0(3-OH)] and the 2-hydroxytetradecanoic [14:0(2-OH)] acid. 
Figure 4.1.1: SDS-PAGE (stacking gel 5 %, separating gel 12 %) stained with silver nitrate of water extract (C,6 μg ) from 
Cupriavidus necator DSM 13523. R: standard of E. coli O55:B5 ( 6 μg) 
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4.2 Structural characterization of Lipid A 
 
The Lipid A of Cupriavidus necator was structurally defined trough MALDI-TOF mass spectrometry 
(chapter X). Ion negative spectrum (figure 4.2.1) of intact Lipid A showed two main groups of signals 
A-B and C-D corresponding respectively to hexa- and penta-acyl substitution on biphosphorylated 
glucosamine disaccharide backbone. The base peak B (m/z 1821.7) was composed of four 14:0(3-
OH), two 14:0, while A (m/z 1837.52) presented the replacement of the secondary 14:0 with the 2-
hydroxylated form, since it differed from B of 16 u. The replacement of the 14:0 unit by one 14:0(2-
OH) is only possible for a secondary fatty acid since the primary are always hydroxylated at C-3.The 
same pattern was verified for the penta-acylated species C-D, differing from A and B for the lack of a 
14:0 (3-OH) (figure 4.2.2, table 4.2.1). Less intense A1, B1, C1 and D1 signals were originated by the 
loss of a phosphate group from the parental species A, B, C and D (table 4.2.1).  
 
Figure 4.2.1: Linear ion negative MALDI spectrum of intact Lipid A from C. necator DSM 13523. Peaks attributions are 
reported in table 4.2.1, structures in figure 4.2.2 
 
 
Table 4.2.1: Hexa- and penta-acylated species of Lipid A from C. necator DSM 13523 identified in the ion negative MALDI-
TOF spectrum (figure 4.2.1) The two glucosamine units have been omitted for clarity. 
 
Specie Rel. Int. (%) n. acyl  Phosphate and fatty acids composition Ion (m/z) 
A 73.2 6 4 x 14:0(3-OH), 14:0(2-OH), 14:0, 2 x P 1837.5 
B 100 6 4 x 14:0(3-OH), 2 x 14:0, 2 x P 1821.7 
A1 6.3 6 4 x 14:0(3-OH), 14:0 (2-OH), 14:0, P 1757.7
B1 6.3 6 4 x 14:0(3-OH), 2 x 14:0, P 1742.0 
C 31.7 5 3 x 14:0(3-OH), 14:0 (2-OH), 14:0, 2 x P 1611.9 
D 24.6 5 3 x 14:0(3-OH), 2 x 14:0, 2 x P 1596.0 
C1 13.4 5 3 x 14:0(3-OH), 14:0(2-OH), 14:0, P 1532.2 
D1 10.6 5 3 x 14:0(3-OH), 2 x 14:0, P 1516.2 
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Figure 4.2.2: Structures of the Lipid A molecules from C. necator. Species A and B, C and D were detected in the intact Lipid 
A spectrum, while E, F, G were obtained from ammonia-treated Lipid A. The species A-D yielded the same oxonium ion. The 
broken line in the structures indicates the non stoichiometric presence of hydroxyl group (table 4.2.1) 
 
The first information about the distribution of fatty acids was provided by the ion positive MALDI-
TOF spectrum of intact Lipid A. The ion at m/z 906.81 (figure 4.2.3) was consistent with a 
phosphorylated oxonim ion, substituted by two 14:0(3-OH) and one secondary 14:0 (figure 4.2.2). The 
absence of other species related to the substitution of the secondary 14:0 with the 14:0(2-OH), 
suggested that this heterogeneity is located on the reducing unit of GlcN (GlcN I). In order to favorite 
the ionization in positive mode, Lipid A was dephosphorylated. The oxonium ion signal at m/z 824.15 
in the ion positive MALDI-TOF spectrum (figure 4.2.4) was consistent with the composition of fatty 
acids structure proposed above.  
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Figure 4.2.3: Expansion of the linear ion positive MALDI spectrum of the intact Lipid A. The structure of the oxonium ion 
(m/z 906.81) is reported in figure 4.2.2. 
 
 
Figure 4.2.4: Expansion of the linear ion positive MALDI spectrum of the dephosphorylated Lipid A. The structure of the 
oxonium ion (m/z 824.15) is consistent whit the fatty acids composition reported in figure 4.2.2. 
 
The position of the ester-linked fatty acids was determined analyzing the ion negative MALDI 
spectrum of Lipid A subjected to mild alkaline hydrolysis with ammonium hydroxide (Silipo et al., 
2002). The treatment removes preferentially the ester-linked acyloxyacyl esters leaving the amide-
linked ones together with their acyloxy substituents. The spectrum (figure 4.2.5) showed the 
occurrence of a main tetra-acylated specie F (m/z 1371.7) carrying two 14:0(3-OH), two (14:0). It was 
accompanied by specie E (m/z 1387.75) that differs form F for the replacement of a 14:0 with a 14:0 
(2-OH). Very less intense peaks E1 and F1 corresponded to E and F species missing of a phosphate 
group. The tri-acyl specie G (m/z 1161.73) was also recorded, consistent with the presence of two 
14:0(3-OH) and one 14:0 (table 4.2.2 and structures in figure 4.2.2).  
These information together with that provided by the oxonium ion (figure 4.2.2) led to the conclusion 
that the secondary ester -linked fatty acids were located on the primary amide-linked chains and that 
the reducing unit of the glucosamine (GlcN I) accommodated the microheterogeneity related to the 
presence or not of an hydroxyl group on the secondary 14:0.  
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Figure 4.2.5: Linear ion negative MALDI spectrum of ammonia-treated Lipid A of C. necator DSM 13523 
Composition of species is reported in table 4.2.2, structures in figure 4.2.2 
 
 
Specie Rel. int.(%) n. acyl Phosphate and fatty acids composition Ion (m/z) 
E 53.1 4 2 x 14:0(3-OH), 14:0(2-OH), 14:0, 2 x P 1387.7 
F 100 4 2 x 14:0(3-OH), 2 x 14:0, 2 x P 1371.7 
E1 8.6 4 2 x 14:0(3-OH), 14:0(2-OH), 14:0, 2 x P 1308.5 
F1 19.5 4 2 x 14:0(3-OH), 2 x 14:0, 2 x P 1291.8 
G 51.8 3 2 x 14:0(3-OH), 14:0, 2 x P 1161.7 
 
Table 4.2.2: Molecular species after ammonia treatment of Lipid A of C. necator DSM 13523(figure 4.2.5). The two 
glucosamine units have been omitted. 
 
 
4.3 Spectroscopic analysis of the O-Chain 
 
1H NMR of the purified LPS contained the diagnostic signals relative to the repeating unit of the O-
Chain (figure 4.3.1): five anomeric signals (5.09 - 4.99 ppm), several overlapped douplets at 1.3 ppm 
due to the methyl groups of rhamnose units, and two signals at 1.77 and 1.54 ppm corresponding to 
the axial and equatorial protons respectively of the 4-deoxy sugar. All residues were labelled in order 
of decreasing chemical shift with a letter (A-E), and the analysis of the homo- and heteronuclear 2D 
spectra led to the assignment of all proton and carbon chemical shifts (table 4.3.1) 
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Figure 4.3.1: (600 MHz, 303 K, D2O), 1H NMR of the O-Chain repeating unit of C. necator DSM 13523. 
Letters are referred to the NMR attribution in table 4.3.1 
 
 
  
1 2 3 4 5 6-6' 
A 5.09 4.05 3.95 3.51 3.86 1.32 
2)--L-Rhap 102.6 80.3 71.1 73.4 70.7 17.9 
B 5.05 4.18 3.91 3.57 3.88 1.32 
3)--L-Rhap 103.3 71.2 80.1 72.5 70.6 17.9 
C 5.02 4.14 4.06 3.82 3.97 1.35 
3,4)--L-Rhap 103.6 71.03 81.43 78.4 69.4 18.3 
D 5.00 3.77 4.12 1.77(ax)-1.55(eq) 3.94 3.67-3.65 
t--D-4dAraHexp 100.6 69.9 69.1 29.7 73.1 65.4 
E 4.99 4.19 3.84 3.79 3.79 1.31 
3)--L-Rhap 103.6 71.2 79.1 70.6 70.6 18.2 
 
Table 4.3.1: 1H (regular) and 13C (italic) chemical shifts at 303 K in D20, measured for the O-chain of C. necator DSM 
13523 (proton spectrum in figure 4.3.1, structure in figure 4.3.2). 
 
Residues A, B, C and E were classified as -Rha (6-deoxy-mannopyranose); the manno configuration 
was explained by the weak scalar correlation in the DQ-COSY spectrum relating H-2 to its vicinal 
protons (H-1 and H-3) and one strong between H-3 and H-4. H-1 of the spin system D correlated via 
H-2 and H-3 with high field signals linked to non hydroxylated C-4 and it was identified as a 4-deoxy-
arabinohexose on the base of literature data (Katzenellenbogen et al., 2003; Gamian et al., 1985).  
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The  configuration of all the rhamnose residues was inferred by the H-1 chemical shifts and 
comparing the C-5 chemical shifts with respect to the standard value of methyl deoxypyranoside (69.4 
ppm) (Bock and Pedersen, 1983).  configuration was assigned to the 4-deoxy-arabinohexose on the 
basis of the typical NOE correlation H-1/H-5 of  configured sugars (figure 4.3.4). In the 13C-1H-
HSQC spectrum (figure 4.3.3) the C-2 of A, C-3 of B and E, C-3 and C-4 of C appeared down-field 
shifted indicating the branching position for each residue. The site of attachment of 4-deoxy-
arabinohexose was confirmed by the NOESY spectrum, which showed the correlation between H-1 of 
D and H-4 of C (figure 4.3.4). Further NOE correlations between H-1 of A and H-3 of C, H-1 of C 
and H-3 of B, H-1 of B and H-3 of E, H-1 of E and H-2 of A disclosed the sequence of residues, 
confirmed also by the long range correlations (figure 4.3.2). 
 
Figure 4.3.2: Structure of the O-Chain repeating unit of C. necator DSM 13523.Residues labelling reflects the letters used 
for the NMR attribution in table 4.3.1. 
 
 
 
 
Figure 4.3.3: (600 MHz, 303 K, D2O) Attribution of the HSQC spectrum of the O-Chain from C. necator (table 4.3. 1)  
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Figure 4.3.4: (600 MHz, 303 K, D2O) Attribution of the anomeric region of the NOESY (black) and COSY (blue and red) 
(table 4.3.1)  
 
The presence of the rare sugar 4-deoxy--arabinopyranose, was confirmed by the spectroscopic 
analysis of the monosaccharide isolated from LPS by acid hydrolysis and GPC chromatography 
(section 9.6). The proton spectrum (figure 4.3.5) showed the occurrence of three anomeric signals (A-
C) where B resulted the most intense. The proton and carbon chemical shifts were assigned through 
the use of COSY, TOCSY, TROESY and HSQC bidimensional spectra. 
Residues B and C resulted  and  configured according to the values of 3J1,2 coupling constant of 0.87 
Hz for B, 3.89 Hz for C. Residue A was identified as 1,6-anhydro-4-deoxy-arabinopyranose, because 
of the downfield glycosylation shifts of the C-1 and C-6. 
Figure 4.3.5: (600 MHz, 298 K, D2O), 1H NMR of the mixture of 4-deoxy-arabinopyranose monosaccharides isolated from 
the LPS of C. necator DSM 13523. Letters and numbers on the signals are referred to the NMR attribution in table 4.3.2  
. 
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  1 2 3 4ax-4eq 5 6-6' 
A 5.38 3.46 3.85 2.14-1.76 4.72 3.90-3.77 
1,6-anhydro-4dAraHexp 102.8 76.1 69.2 37.3 74.8 69.3 
B 5.05 3.59 4.12 1.76-1.54 3.97 3.64-3.60 
-D-4dAraHexp 93.2 70.1 69.2 29.2 72.9 65.4 
C 4.99 3.50 3.96 1.95-1.67 4.23 3.68-3.63 
-D-4dAraHexp 95.0 71.9 68.4 30.9 68.6 64.3 
 
Table 4.3.2: 1H (regular) and 13C (italic) chemical shifts at 298 K in D20, measured for the mixture of 4-deoxy-
arabinopyranose monosaccharides 
 
4.4 Conclusions 
 
Cupriavidus necator produces mainly a symmetric hexa-acyl Lipid A made up by the conserved 
biphosphorylated disaccharide glucosamine backbone, substituted by tetradecanoic acid and the 
respective 3- and 2- hydroxylated forms. The amide-linked fatty acids carried the acyloxy substituents 
and the microheterogeneity given by the non stoichiometric substitution of a secondary 14:0 with 14:0 
(2-OH) was on the reducing glucosamine (figure 4.2.2). The fatty acid pattern seems closely related to 
that of the highly agonistic Lipid A of E. coli, which has an asymmetric distribution of the acyl chains 
and a secondary dodecanoinc acid. Different Lipid As from non-pathogenic bacteria as Rhodobacter 
capsulatus, Rhodobacter spheroides and Chromobacter violaceum were described as antagonists 
(Seydel et al., 2000, section 1.4); in particular, the Lipid A from Chromobacter violaceum has an 
hexa-acyl symmetric structure, similary to that found for Cupriavidus necator. These assumptions 
increase the interest to the investigation of the biological activity of Lipid A of Cupriavidus necator. 
NMR analysis allowed the establishment of the O-polysaccharide repeating unit. It is completely 
formed by deoxy sugars, four rhamnose units and one of the 4-deoxy-arabinopyranose as terminal unit 
of the chain. This last sugar is rare and identified only in certain Citrobacter strains (Katzenellenbogen 
et al., 2003; Romanowska et al., 1987, Gamian et al., 1985; Romanowska et al., 1981). The neutral 
and lipophilic feature of the O-polysaccharide is shared by the Lipopolysaccharides and Capsular 
polysaccharides of many other soil bacteria, most of the members of the Rhizobiaceae family (De 
Castro et al., 2008; De Castro, Fregolino et al., 2008), or other genera as Azospirillum (Fedonenko et 
al., 2008) and Kaistella (Gargiulo, De Castro et al., 2008). Next studies will address the Core 
oligosaccharide structure, and the understanding of LPS involvement in the environmental adaptation 
process of this bacterium or in its predatory activity.  
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CHAPTER V 
 
LIPOOLIGOSACCHARIDE STRUCTURAL CHARACTERIZATION OF A CLINICAL 
ISOLATE OF Acinetobacter baumannii, STRAIN SMAL 
 
The complete structural characterization of the Lipooligosaccharide produced by a clinical isolate of 
Acinetobater baumannii strain SMAL was determined to gain valuable information that will provide 
an understanding of the mechanism activity adopted by this emerging pathogen (section 2.3). In 
particular, the characterization of the Lipid A moiety of the LPS is important since it plays a crucial 
role in the pathogenesis of this bacterium and give rise to the innate immune response of the patient. 
The sequence of the Core oligosaccharide was achieved through the combined use of the chemical and 
spectroscopic techniques, and it was found to be similar to that of Acinetobacter baumannii ATCC 
19606 (Vinogradov et al., 2002), although the LOS from the strain SMAL presented an enhanced 
zwitterionic character. Regarding the Lipid A structure, mass spectrometry experiments revealed that 
it is composed of a heterogeneous mixture of molecules differing for type and degree of acylation. The 
proportion among the differently acylated species changed in response to the growth conditions: 
predominance of the hepta-acylated species was observed when the bacterium was grown in Fetal 
Bovine Serum (FBS) at 37°C, whereas the hexa-acylated molecular species resulted more abundant 
using Luria Broth (LB) as growth medium. The results would suggest that hepta-acylation of Lipid A 
is a mechanism of adaptation to the mammalian host by A. baumannii. 
 
5.1 Chemical analyses of the Lipooligosaccharide  
 
Freeze-dried bacterial cells were grown in LB at 28 °C and extracted according to PCP method 
(section 8.3). The LOS was found to be composed of D-glucose (D-Glc), 2-amino-2-deoxy-D-galactose 
(D-GalN) , 3-deoxy-manno-oct-2-ulosonic acid (Kdo) and 2-amino-2-deoxy-D-glucuronic acid (D-
GlcNA). Fatty acids were analysed via GC-MS as methyl ester derivatives. The combined information 
from total and O-linked composition identified the following ester-linked fatty acids: dodecanoic 
(12:0), 2-hydroxydodecanoic [12:0(2-OH)], and 3-hydroxydodecanoic [12:0(3-OH)] acid; 3-
hydroxytetradecanoic acid [14:0(3-OH)] appeared as an amide-linked residue. The 3-hydroxy fatty 
acids possessed the (R)- and the 2-hydroxy fatty acid the (S)-configuration (Rietschel, 1976). Location 
of acyl substituent was determined via ESI MS spectrometry, analysing the intact and ammonia-
treated Lipid A. Finally,  in order to verify the influence of the environment on the bacterial Lipid A 
structure, Acinetobacter baumannii strain SMAL was grown in LB and in FBS media at 37°C 
(sections 8.3 and 5.3). 
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5.2 Mass spectrometry analysis of the intact and ammonia-deacylated Lipid A from the growth in 
Luria Broth at 28 °C 
 
The intact and ammonia deacylated Lipids A were analysed by the Electrospray Ionization Fourier-
Transform Ion Cyclotron Resonance Mass Spectrometry (ESI-FT-ICR MS) (Chapter X). The charge-
deconvoluted negative ion mass spectrum of native Lipid A (figure 5.2.1) showed five groups of 
pseudomolecular ions, that originate from intrinsic heterogeneity caused by the type and the number of 
fatty acids linked to the disaccharide backbone. Each set of signals was labelled with a letter, and 
within each set, the different peaks were distinguished by numbers. Accordingly, group A was 
composed from hepta-acylated species, B from hexa-acylated, C from penta-acylated, D from tetra-
acylated and E from tri-acylated species (table 5.2.1).  
 
 
 
Figure 5.2.1: Pseudomolecular peaks measured by ESI-FT-ICR MS of Lipid A family produced by Acinetobacter baumannii 
strain SMAL (structures in figure 5.2.2). The peaks at m/z = 1447.5 and 1236.4 and other minor peaks are impurities not 
related to Lipid A. 
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Ion (m/z) Rel. Int. (%) Species n-Acyl Proposed fatty acid/phosphate composition 
1911.3 51.8 A1 7 2 x 14:0(3-OH), 2 x 12:0(3-OH), 12:0(2-OH), 2 x 12:0, 2 x P 
1895.3 17.0 A2 7 2 x 14:0(3-OH), 2 x 12:0(3-OH), 3 x 12:0, 2 x P 
1883.3 28.0 A3 7 14:0(3-OH), 3 x 12:0(3-OH), 12:0(2-OH), 2 x 12:0, 2 x P 
1867.3 8.0 A4 7 14:0(3-OH), 3 x 12:0(3-OH), 3 x 12:0, 2 x P 
1831.3 4.8 A5 7 2 x 14:0(3-OH), 2 x 12:0(3-OH), 12:0(2-OH), 2 x 12:0, P 
1803.3 3.2 A6 7 14:0(3-OH), 3 x 12:0(3-OH), 12:0(2-OH), 2 x 12:0, P 
1729.1 100 B1 6 2 x 14:0(3-OH), 2 x 12:0(3-OH), 12:0(2-OH), 12:0, 2 x P 
1712.1 46.2 B2 6 2 x 14:0(3-OH), 2x 12:0(3-OH), 2 x 12:0, 2 x P 
1700.1 17.5 B3 6 14:0(3-OH), 3x 12:0(3-OH), 12:0(2-OH), 12:0, 2 x P 
1684.1 14.3 B4 6 14:0(3-OH), 3x 12:0(3-OH), 2 x 12:0, 2 x P 
1649.2 11.4 B5 6 2 x 14:0(3-OH), 2 x 12:0(3-OH), 12:0(2-OH), 12:0, P 
1633.2 8.5 B6 6 2 x 14:0(3-OH), 2x 12:0(3-OH), 2 x 12:0, P 
1605.1 3.6 B7 6 14:0(3-OH), 3x 12:0(3-OH), 2 x 12:0, P 
1530.0 86.9 C1 5 2 x 14:0(3-OH), 12:0(3-OH), 12:0(2-OH), 12:0, 2 x P 
1514.0 24.6 C2 5 2 x 14:0(3-OH), 12:0(3-OH), 2 x 12:0, 2 x P 
1501.9 24.1 C3 5 14:0(3-OH), 2 x 12:0(3-OH), 12:0(2-OH), 1 x 12:0, 2 x P 
1485.9 7.2 C4 5 14:0(3-OH), 2 x 12:0(3-OH), 2 x 12:0, 2 x P 
1451.0 18.3 C5 5 2 x 14:0(3-OH), 12:0(3-OH), 1 x 12:0(2-OH), 12:0, P 
1434.0 7.0 C6 5 2 x 14:0(3-OH), 12:0(3-OH), 2 x 12:0, P 
1347.8 55.8 D1 4 2 x 14:0(3-OH), 12:0(3-OH), 12:0(2-OH), 2 x P 
1331.8 15.5 D2 4 2 x 14:0(3-OH), 12:0(3-OH), 12:0, 2 x P 
1319.8 7.5 D3 4 14:0(3-OH), 2 x 12:0(3-OH), 12:0(2-OH), 2 x P 
1303.8 7.0 D4 4 14:0(3-OH), 2 x 12:0(3-OH), 12:0, 2 x P 
1149.6 18.0 E1 3 2 x 14:0(3-OH), 12:0(2-OH), 2 x P 
1133.6 1.2 E2 3 2 x 14:0(3-OH), 12:0, 2 x P 
 
Table 5.2.1: Molecular species of intact Lipid A from A. baumannii strain SMAL indentified by ESI-FT-ICR MS (spectrum in 
figure 5.2.1, structures in figure 5.2.2). The two glucosamine units have been omitted. 
 
In particular, the composition of the predominant species B1 (figure and table 5.2.1), was consistent 
with the occurrence of two 14:0(3-OH), two 12:0(3-OH), one 12:0(2-OH), one 12:0 and two 
phosphate units; B2 was related to B1 since 12:0(2-OH) was replaced by 12:0, B3 differed from B1 
since one 14:0(3-OH) was replaced by one 12:0(3-OH), and B4 differed from B3 by the replacement of 
12:0(2-OH) with 12:0. The presence of one 12:0(2-OH), as identified in chemical analysis, was 
confirmed by the difference of 16 u between different couples of a pseudomolecular ions, like B1 – B2 
or B3 – B4. This difference indicated the replacement of the 12:0(2-OH) unit by one 12:0, a 
substitution that is only possible for a secondary fatty acid and not for a primary which is always 
hydroxylated at C-3. The species from B5 to B7 had the same lipid composition of shown for B1,B2,B4, 
respectively, except that one phosphate was missing. 
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A similar pattern similar was identified in almost all the other peak clusters, although some peaks were 
missing probably due to their low abundance. Considering B1 as reference, the homolog species in the 
other clusters were identified as follows (figure and table 5.2.1): A1 contained one additional 12:0, C1 
was missing one 12:0(3-OH), D1 lacked one 12:0(3-OH) and one 12:0 whereas E1 conserved the two 
units of 14:0(3-OH) and that of 12:0(2-OH). The occurrence in every cluster of the 12:0(2-OH) was 
indicated by the presence of peaks differing for 16 u, as discussed above. Therefore, considering the 
B1 composition, the location of the four primary fatty acids was straightforward: the two amide-linked 
14:0(3-OH) units were amide-linked, whereas the other two 3-hydroxyl-bearing fatty acids were ester-
bound substituents at O-3 of each glucosamine residue (figure 5.2.2). 
 
 
Figure 5.2.2: Structures of the Lipid A from A. baumannii strain SMAL, species from A1 to E1 were detected in the intact 
Lipid A spectrum  and molecules F1 and G1 were obtained from ammonia-treated Lipid A. A1, B1 and C1 yielded the same 
oxonium ion 
The location of the two secondary fatty acids was inferred analysing the infrared multi-photon 
dissociation (IRMPD) MS/MS data recorded in positive mode or the molecular ions complexed with 
with triethylamine (Kondakova and Lindner, 2005) .Under such conditions, [B1 + TEA] at m/z = 
1830.4 u produced an abundant oxonium fragment ion at m/z = 1046.8 u (structure in figure 5.2.2), 
representative of the non-reducing glucosamine moiety of the Lipid A with its substituents, one 
phosphate, one 14:0(3-OH), one 12:0(2-OH), one 12:0(3-OH) and one 12:0. On the basis of this 
information, the two secondary fatty acids identified in B1, were located on the non-reducing 
glucosamine moiety, and their exact position was inferred analysing the ammonia treated LA (see 
below). The same oxonium ion was observed for A1 and C1 species. 
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The exact position of the ester-linked fatty acids was inferred by analysis of the ammonia-treated LA 
(Silipo et al., 2002). Accordingly, analysis of the negative ESI spectrum (figure 5.2.3) of the 
ammonia-treated Lipid A identified the secondary fatty acids on the corresponding primary amide-
linked residues: it contained three different clusters, named F, G and H, related to tetra-, tri- and di-
acylated species, respectively (table 5.2.2).  
 
 
Figure 5.2.3: Pseudomolecular peaks identified by ESI-FT-ICR MS (structures in figure 5.2.2) of ammonia-treated Lipid A 
from A. baumannii strain SMAL. 
 
The more informative clusters were F and G, whereas the diacylated species, H1-3, were identified as 
side-products of the chemical treatment: namely from the ammonia removal of the secondary fatty 
acid located on the amide-linked acyl residue of both F and G clusters. 
The composition of the predominant species, G1 (figure 5.2.3, table 5.2.2), disclosed the occurrence of 
two 14:0(3-OH), one 12:0(2-OH), and two phosphates. The distribution pattern within each cluster 
was similar to that of the native Lipid A, i.e., the substitution of 12:0(2-OH) with 12:0, the 
replacement of one 14:0(3-OH) by one 12:0(3-OH), and the lack of one phosphate unit. Information 
from G1 ion were combined with the indication contained in the oxonium ion (1046.8 u, structure in 
figure 5.2.2) descending from B1 peak of the native Lipid A: actually, according to the oxonium ion 
composition, the hexa-acylated B1 species possessed two secondary fatty acids on the non-reducing 
glucosamine, one 12:0(2-OH) and one 12:0. The finding that only the 12:0(2-OH) unit was left after 
ammonia treatment led to position this fatty acid on the amide linked 14:0(3-OH), whereas the other, 
12:0, lost during the chemical treatment, was considered ester bound on the 12:0(3-OH) unit. On the 
basis of the above consideration, the location of the secondary fatty acids composing the penta-, tetra- 
and tri-acylated species in the native Lipid A, was determined (figure 5.2.2). Finally, cluster F mass 
distribution indicated the occurrence of tetra-acylated Lipids A with a fatty acid composition different 
from that described for the tetra-acylated Lipids A in the native sample (cluster D). 
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Ion (m/z) Rel. Int. (%) Species n-Acyl Proposed fatty acid/phosphate composition 
1332.8 40.9 F1 4 2 x 14:0(3-OH), 12:0(2-OH), 12:0, 2 x P 
1316.8 20.1 F2 4 2 x 14:0(3-OH), 2 x 12:0, 2 x P 
1304.8 22.0 F3 4 14:0(3-OH), 12:0(3-OH), 12:0(2-OH), 12:0, 2 x P 
1288.8 11.6 F4 4 14:0(3-OH), 12:0(3-OH), 2 x 12:0, 2 x P 
1252.8 11.6 F5 4 2 x 14:0(3-OH), 12:0(2-OH), 12:0, P 
1236.8 5.1 F6 4 2 x 14:0(3-OH), 2 x 12:0, P 
1224.8 4.6 F7 4 14:0(3-OH), 12:0(3-OH), 12:0(2-OH), 12:0, P 
1150.6 100 G1 3 2 x 14:0(3-OH), 12:0(2-OH), 2 x P 
1134.6 95.8 G2 3 2 x 14:0(3-OH), 12:0, 2 x P 
1122.6 15.6 G3 3 14:0(3-OH), 12:0(3-OH), 12:0(2-OH), 2 x P 
1106.6 30.1 G4 3 14:0(3-OH), 12:0(3-OH), 12:0, 2 x P 
1070.6 11.6 G5 3 2 x 14:0(3-OH), 12:0(2-OH), P 
1054.7 14.8 G6 3 2 x 14:0(3-OH), 12:0, P 
1026.6 6.2 G7 3 14:0(3-OH), 12:0(3-OH), 12:0, P 
952.5 69.8 H1 2 2 x 14:0(3-OH), 2 x P 
934.5 18.5 H2 2 14:0(3-OH), 12:0(3-OH), 2 x P 
872.5 14.9 H3 2 2 x 14:0(3-OH), P 
 
Table 5.2.2: Molecular species of ammonia- treated Lipid A from A. baumannii strain SMAL identified by ESI-FT-ICR MS 
(spectrum in figure 5.2.3, structures in figure 5.2.2). The two glucosamine units have been omitted. 
 
This discrepancy was only apparent and witnessed the effectiveness of the ammonia treatment; 
actually, lipid composition of cluster F was not related to that of the cluster D, but reflected the 
distribution of the ester bound acyls on the primary amide linked fatty acids of the originally hepta-
acylated Lipid A family (cluster A). The above information led to assign the structure of the hepta-
acylated species; actually, F1 composition reflected the presence of two 14:0(3-OH), one 12:0(2-OH), 
one 12:0 and two phosphates, therefore when compared to G1, F1 contained one additional 12:0 unit. 
Consequently, the only position compatible with the chemical treatment adopted and still available on 
the disaccharide backbone, was the 14:0(3-OH) unit on the GlcN-I residue yielding to both F1 and A1 
structures reported in figure 5.2.2.  
 
5.3 Structural variation of Lipid A under different growth conditions  
 
The influence of the environment on the bacterial Lipid A structure of A. baumannii strain SMAL  was 
tested growing cells in FBS (Fetal Bovine Serum) medium at 37°C, since this condition is closer, to 
that experienced from the bacterium during the infection process in humans. Growth in Luria Broth 
(LB) at the same temperature was performed as control experiment (section 8.3).  
Lipid A from FBS growth was analysed via MALDI-TOF (figure 5.3.1) because it did not produce any 
result with ESI MS. The failure to produce data on ESI MS might be related to the low purity grade of 
the sample, since the extraction procedure employed (hot phenol-water) did not remove efficiently the 
components of the complex medium used. 
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Figure 5.3.1: Linear ion negative MALDI-TOF spectrum of Lipid A from A. baumannii strain SMAL grown in FBS at 37 °C. 
Peaks labels are referred to the species indicated in table 5.2.1 
 
Since the instrument used (MALDI or ESI) could modify the proportion between the pseudomolecular 
ions, MALDI of the intact Lipid A was recorded and it was found comparable to the ESI spectrum of 
the same sample (figure 5.3.2). 
 
 
Figure 5.3.2: Linear ion negative MALDI-TOF spectrum of intact Lipid A from A. baumannii strain SMAL grown in LB at 28 
°C. The proportions among species are comparable to that found in ESI spectrum (figure 5.2.1). Peaks labels are referred to 
the species indicated in table 5.2.1 
 
The ion negative MALDI-TOF spectrum of Lipid A from FBS at 37°C (figure 5.3.1) identified two 
main clusters A1 and B1, related to hepta- and hexa-acylated species, respectively. The composition of 
each cluster was analogous to that reported for the Lipid A from LB at 28 °C (figure 5.2.1, table 
5.2.1), but the proportion among the hepta- and the hexa-acylated species was reversed, being the 
hepta-acylated species the most abundant. 
In order to determine which growth parameter, medium and/or temperature, induced this effect, Lipid 
A obtained from the cultivation in LB at 37°C, was analysed through ESI MS and the spectrum (figure 
5.3.3) showed the occurrence of hexa- and hepta-acylated species in proportions similar to those found 
for the Lipid A obtained from LB at 28°C (figure 5.2.1).  
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These results suggest that the acylation pattern changes with growth conditions, and that the higher 
amounts of the hepta-acylated Lipid A is not related to growth temperature but to the different 
environment created from the growth medium. 
 
 
 
Figure 5.3.3: Pseudomolecular peaks of Lipid A from A. baumannii strain SMAL grown in LB at 37°C measured by ESI-FT-
ICR MS as control experiment. Peaks labels are referred to the species indicated in table 5.2.1 
 
 
5.4 Spectroscopic characterization of Core oligosaccharide from the growth in Luria Broth at 28 °C 
 
The complete structure of Core oligosaccharide 1 (figure 5.4.1) was deduced by combining the NMR 
spectroscopic data of the products isolated by alkaline degradation and acid hydrolysis (section 9.7). 
The first approach provided the structure of the incomplete Core oligosaccharide 2 (figure 5.4.1) 
caused by the lost of unit(s) during the alkaline treatment. This information was recovered by 
analyzing the product 3 obtained by mild acid hydrolysis (figure 5.4.1). 
The truncated Core oligosaccharide (Figure 5.4.1, 2) comprising the lipid A sugar backbone and a 2-
amino-2-deoxyuronic acid derivative possessing a double bond conjugated to the carboxy group 
_`	<*{
|
	

-elimination of the 4-substituted GlcNA. 
The 1H NMR spectrum of 2 (Figure 5.4.2 a) contains eight anomeric signals and three sets of 
diastereotopic methylene signals due to the presence of three Kdo residues. A detailed analysis of both 
the homo- and heteronuclear NMR spectra of the product 2 led to the complete assignment of its 
proton and carbon chemical shifts (table 5.4.1), which revealed its structure. Because the substituent at 
O-

_`	<*
|
 

 	
}	
 		t of the LPS, the product obtained from mild 
acid hydrolysis (figure 5.4.1, 3) was analyzed by NMR spectroscopy, which revealed an additional 
monosaccharide residue, unit I (Figure 5.4.2 b, table 5.4.2), but lacked the lipid A moiety (residues A 
and E) and the two Kdo units (Kb and Kc) as expected.  
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Combining the information from both 2 and 3, the complete structure of the core oligosaccharide was 
determined as oligosaccharide 1 (figure 5.4.1). Surprisingly, this structure  is equivalent to that 
previously described for A. baumannii strain ATCC 19606 (Vinogradov et al., 2002). 
 
 
Figure 5.4.1: 1:Complete structure of the Core oligosaccharide of LOS produced by A. baumannii strain SMAL. All sugars 
are D configured and in pyranose form. 2: Oligosaccharide structure isolated after alkaline hydrolysis of LOS. 
an hex-4-en-2-aminuronic resi

-elimination. 3: Oligosaccharide structure obtained from LOS after 
mild acid hydrolysis. The structure of Lipid A family is reported in figure 5.2.2 
 
 
Figure 5.4.2: a: !"##$&'+<>'?2O) 1$@Z
2 derived from the alkaline degradation  of A. 
baumanni LOS (table 5.4.1). b[!>##$&'##'?2O) of oligosaccharide 3 derived from LOS after mild hydrolysis (table 
5.4.2). Residue A and E are non reducing and reducing glucosamine units of Lipid A, respectively. The residues close to the 
free reducing end of the oligosaccharide give rise to different signals in the spectrum, as B and B’, D and D’, because their 
Z\]
Z
Z^]
'Z
labelled according to figure 5.4.1. 
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  1 2 3ax 3eq 4 5 6 6’ 7 8 8’ 
A 5.66 3.41 3.89 - 3.65 4.16 4.29 3.77 - - 
6)--GlcN1P <_< ""< 70.8 - 70.8 73.7 70.8 - - 
B 5.49 3.75 4.67 - 6.01 - - - - 
3)--HexAN <`> "_< 72.4 - 105.0 146.3 168.8 - - 
C 5.37 3.54 3.75 - 3.45 4.07 3.80 3.80 - - 
t--Glc <`q 72.4 q< - q#< q+< 61.6 - - 
D 5.00 3.13 3.68 - 3.48 3.55 3.75 3.94 - - 
t--GlcN <`q 57.1 73.5 - 71.2 77.1 >_< - - 
E 4.89 3.05 3.85 - 3.73 3.75 3.71 3.45 - - 
6)--GlcN4P _##< ">< 73.5 - 75.2 75.2 63.7 - - 
F 4.75 3.36 3.67 - 3.68 3.66 4.00 3.83 - - 
4)--Glc 102.7 74.0 75.2 - q<" 76.2 61.1 - - 
G 4.66 3.52 3.59 - 3.44 3.46 3.74 3.92 - - 
2)--Glc 102.6 77.1 75.7 - 70.1 77.1 61.8 - - 
H 4.53 3.36 3.67 - 3.78 3.63 3.99 3.87 - - 
4)--Glc 103.6 74.3 q{< - q<< 76.2 61.2 - - 
Ka - - 2.94 2.33 4.88 4.45 4.32 4.17 3.96 3.96 
4,7)--Kdo 176.0 101.8 35.6 72.4 63.7 71.4 77.6 >#< 
Kb - - 1.94 2.37 3.98 4.51 3.71 3.89 3.66 3.89 
4,5)--Kdo 176.1 100.8 35.6 73.8 70.4 73.8 70.8 65.0 
Kc - - 2.11 1.74 4.05 3.99 3.74 3.99 3.74 3.95 
t--Kdo 176.0 103.4 35.6 67.0 68.1 73.2 72.2 64.1 
 
Table 5.4.1: 1!Z|13C (italic) chemical shifts at "##$&'+<>?20, measured for oligosaccharide 2 obtained 
after alkaline hydrolysis (figure 5.4.2 a).  ( residue B )-elimination of the 4-] All 
sugars are D configured and in pyranose form 
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*Overlapped signals 
 
Table 5.4.2: 1!Z|13C (italic) chemical shifts at >##$&'## ?20, measured for oligosaccharide 3 obtained 
after acid hydrolysis (figure 5.4.2 b). Residues A and E (non reducing and reducing GlcN units of Lipid A) and Kb and Kc 
(two Kdo units) are missing, but residue I is present. All sugars are D configured and in pyranose form 
 
5.5 Conclusions 
The complete sequence of the Core oligosaccharide of LOS of Acinetobacter baumanni strain SMAL 
was achieved through  the combined use of chemical and spectroscopic procedures. The backbone is 
formed of 12 sugar residues, which are organized as a highly branched inner core  moiety and is 
equivalent to one of the structures reported for A. baumannii ATCC 19606 (Vinogradov et al., 2002). 
This region contains a motif that could be present within the A. baumannii LPS (Vinogradov et al., 
2002; Vinogradov et al., 1998); however, it is also present in the Core region of LPS from A. 
radioresistens (Leone et al., 2007).  
  1 2 3 3' 4 5 6 6’ 7 8/8' 
B 5.06 4.27 4.34 3.98 4.11 - - - 
3,4)--GlcNAcA <"< 54.3 78.2 75.3 74.4 176.1 - - 
B' 5.00 4.26 4.38 3.98 4.11 - - - 
3,4)--GlcNAcA <q+ 54.3 78.0 75.3 74.4 176.1 - - 
C 5.37 3.52 3.75 3.45 4.06 3.80 3.75 - - 
t--Glc <`> 72.6 74.0 70.7 q+< 61.4 - - 
D 4.95 3.12 3.68 3.47? 3.53? 3.93* - - 
t--GlcN <<+ 57.1 73.5 71.2 77.5 61.8* - - 
D' 4.90 3.09 3.66 3.43 3.47 3.93* - - 
t--GlcN <`< 57.2 73.5 70.7 77.3 61.8* - - 
F 4.67 3.36 3.62 3.57 3.74 3.95* - - 
4)--Glc 104.2 73.8 75.2 76.1 74.0 61.8* - - 
G 4.66 3.51 3.59 3.46 3.75 3.92 3.70 - - 
2)--Glc 102.7 77.3 75.5 70.8 74.0 >_< - - 
H 4.54 3.35 3.66 3.76 3.66 4.00 3.87 - - 
4)--Glc 103.6 74.4 76.2 q<{ 75.0 61.8 - - 
I 5.74 3.54 4.00 4.02 3.96 3.70 3.90 - - 
t--GalN <>> 52.2 67.5 >`< 72.3 61.7 - - 
Kap - - 1.95 2.16 4.13 4.32 3.92 4.12 ~3.80 
4,7)--Kdop 178.8 <q" 34.0 72.1 64.0 71.2 77.8 61.5 
Kaf - - 2.21 2.67 4.48 4.62 3.66 3.97 - 
4,7)--Kdof 178.7 106.2 44.3 q<< 85.4 71.0 80.1 - 
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In contrast to the Core region of LPS from A. baumannii ATCC 19606, the galactosamine linked to 
GlcNAcA is not -acetylated, and the Core oligosaccharide is not truncated. These features might 
reflect the adaptation of the bacterium to the host environment, in particular, the cationic amino sugars 
decrease the net negative charge of the Core region and thus might shield the bacterial membrane from 
the effect of host defense agents, like the cationic antimicrobial peptides. 
The structure of the Lipid A family was disclosed through mass spectrometry analyses and it varies 
both with the growing medium composition and the temperature. Analysis of the intact and ammonia-
treated Lipid A, showed a heterogeneous blend of molecules, differing for both degree and type of 
acylation pattern (figure 5.2.2). In particular, when the bacterium was grown in LB at 28°C (or 37°C) 
it produced a complex family of glycolipids, containing the diphosphorylated glucosamine 
disaccharide backbone variously substituted, ranging from tri- to hepta-acylated molecules. Within 
each cluster, the different species either were due to the non-stoichiometric replacement of (S)-12:0(2-
OH) with 12:0 or one (R)-14:0(3-OH) with (R)-12:0(3-OH), or to the lack of one phosphate unit. At 
this regard, it must be noted that concerning the genus Acinetobacter, (S)-12:0(2-OH) was reported so 
far only for the LPS of A. radioresistant (Leone et al., 2007) where it was present in small amounts. 
The hexa-acylated lipid A displays those features usually considered important for an agonistic 
endotoxin, as that of E. coli, namely six fatty acids with a chain length of fourteen and/or twelve 
carbons, distributed in an asymmetric fashion on the glucosamine disaccharide backbone (Alexander 
and Rietschel, 2001). Another feature emerging from the present study is the modulation of the Lipid 
A family composition upon the growth medium used. The growth of A. baumannii in FBS at 37°C, 
promoted the biosynthesis of hepta-acylated Lipid A, a species usually considered as a weak 
immunostimulant of TLR4-MD2, and also able to confer antibiotic resistance to the bacterium. FBS 
medium was chosen as a mimic of the host environment, the results obtained open the way to new 
experiments finalized to the analyse the modulation of the Lipid A structure in response to other, and 
possibly more host-like, stimuli. In summary, A. baumannii strain SMAL , was able to modulate its 
lipid A structures in response to the growth medium, passing from a mixture with putative agonistic 
activity to one for which less inflammatory properties are expected. This data contribute to a better 
understanding of the virulence of this emerging successful pathogen. 
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CHAPTER VI 
 
IDENTIFICATION AND STRUCTURAL DETERMINATION OF THE CAPSULAR 
POLYSACCHARIDES FROM TWO CLINICAL ISOLATES OF Acinetobacter 
baumannii, STRAINS SMAL AND MG1 
 
Lipopolysaccharides from many Acinetobacter species have been described, and the occurrence of 
both R- (Fregolino et al., 2010; Vinogradov et al., 2002 ) and S-forms of LPS was disclosed (Haeseley 
et al., 1998; Vinogradov et al., 2001). More than 10 surface polysaccharides were isolated from 
different A. baumanni strains (Pantophlet, 2008), but in most cases it is not clear if they originate from 
CPSs or OPSs. To date, only two CPSs from Acinetobacter species were defined, and belonged to A. 
calcoaceticus BD4 (Kaplan et al., 1985) and to A. lwoffii F78 (Hanuszkiewicz et al., 2008). The 
structure of capsular polysaccharides by two clinical isolates of A. baumannii strains SMAL and 
MG1was elucidated. Hot phenol/water extractions of the dry biomasses, followed by enzymatic 
digestions and repeated ultracentrifugations led to the isolation of capsular material: these 
polysaccharides were negative to Western Blot analysis with anti-lipid A antibodies, and their 
structures were established on the basis of NMR spectroscopy and GC-MS analyses. The A. 
baumannii MG1 CPS consisted of a linear aminopolysaccharide with acyl substitution heterogeneity at 
the -4 amino group of the bacillosamine residue; NMR analysis disclosed the occurrence of 3-
hydroxy-butyrric acid on 19% of the bacillosamine residue, as shown in figure 6.3.3. The repeating 
unit of the CPS produced by strain SMAL comprised a pentasaccharide backbone, as depicted in 
figure 6.4.2-2, which was previously described as the O-antigen of another Acinetobacter baumannii 
species (strain ATCC 17961) (MacLean et al., 2009) while here it occurs as a capsule. Together with 
the peculiarity of the structures found for these two A. baumannii strains, these data are of importance 
to put on molecular basis serological tools. In addition to this, these results highline that care must be 
taken in the development of these diagnostic devices, because similar if not identical polysaccharides 
might be constituents of the lipopolysaccharides O-antigen or of the bacterial envelope capsule, as 
here reported for A. baumannii SMAL. 
 
6.1 Isolation and chemical analyses of ultracentrifuge supernatants and sediment  
 
Freeze-dried cells of A. baumannii MG1 and SMAL were treated with aqueous 90% phenol-
chloroform-light petroleum (PCP) to extract R-form LPS, and the remaining pellets were successively 
extracted according to the hot phenol/water method. The water phases were further purified, i.e. 
nucleic acid and protein contaminants were removed by enzymatic digestion and the resulting 
solutions were dialyzed and subjected to several cycles of ultrcentrifugation (UC) (section 8.3). Sugar 
analysis of the UC sediments gave the same compositions as identified for the LOSs from the two A. 
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baumannii strains, namely D-Glc, D-GalN, D-GlcN, and 3-deoxy-D-manno-oct-2-ulosonic acid (Kdo). 
The monosaccharide composition of the UC supernatant from A. baumannii MG1 comprised L-
GalNA, D-QuiN4N (bacillosamine), and D-GlcN. The absolute configuration of QuiN4N was assigned 
using the same sugar obtained from the CPS produced by A. lwoffii F78 (Hanuszkiewicz et al., 2008) 
as standard, and similarly the GalNA butylglycoside was compared to the analogue derivative 
obtained from the LPS of  (Corsaro et al., 2006). Furthermore, after weak 
methanolysis and acetylation, GC-MS analysis showed the presence of QuinN4N substituted at -4 by 
(S)-3-hydroxybutyric acid. The substituted position was assigned on the basis of the retention time and 
mass spectrum analogies with the same residue identified in the CPS of A. lwoffii F78. The sugar 
composition of the UC supernatant from A. baumannii SMAL revealed the presence of D-Gal, D-Glc, 
D-GlcN, D-GalN, and 2,3-diacetoamido-2,3-dideoxy-glucuronic acid (DAGA). 
 
6.2 Electrophoretic and Western blot analysis of ultracentrifuge supernatant and sediment 
 
The sediments and supernatants from UC were analyzed by SDS-PAGE. The gel was first fixed with 
Alcian blue then with silver nitrate, and disclosed the occurrence of LOS molecules in the sediment 
(figure 6.2.1), whereas the supernatants contained high molecular mass material which was sensible to 
Alcian blue (figure 6.2.2, lines 1-4) (section 9.2). Here, the presence of LOS was negligible and was 
detected only after having overloaded the gel (figure 6.2.2, lines 5 and 6). 
 
 
 
 
 
 
 
 
 
 
 
 
 
In order to exclude that the isolated polysaccharides might originate from LPS, the CPS preparation 
was subjected to Western blot analysis developed after mild acid hydrolysis of the membrane with the 
monoclonal antibody (mAb) A6 (Kuhn et al., 1992), which specifically recognizes the free 
bisphosphorylated diglucosamine backbone of lipid A (section 9.2).  
Figure 6.2.1: SDS-PAGE (stacking gel 5%, 
separating gel 15 %), stained with Alcian 
blue and silver nitrate procedure of UC 
sediments; 1: A. b }$~ !+ Z| 2: A. b. 
$_!+Z|3: E. coli _>~}!+Z| 
Figure 6.2.2: SDS-PAGE (Stacking gel 5%, 
separating gel 8 and 15 %) of the UC supernatants; 
lines 1 and 2 are stained only with Alcian blue; lines 
3-6 are silver stained applying Alcian blue as 
fixative first. 1: A. b}$~!_Z|2: A. b MG1 (1 
Z|3 and 5: A. b }$~!_Z|4 and 6: A. b 
$_!_Z| 
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This antibody had been used earlier for the identification of non-stainable S-form LPS in various 
Acinetobacter strains and LOS in A. lwoffii F78 (Hanuszkiewicz et al., 2008). The CPS isolated from 
A. baumannii MG1 and SMAL did not bind mAb A6 (figure 6.2.3, lines 2 and 3). Only when applied 
in high amounts (figure 6.2.3., lines 4 and 5), a very faint smear appeared at the bottom of the 
membrane, with a migration similar to that observed for the purified LOS (figure 6.2.3, lines 6 and 7), 
confirming its occurrence in trace amounts. The lack of reaction of mAb A6 with the material in the 
upper part of the gel pointed at the presence of a CPS in both, A. baumannii MG1 and SMAL. 
 
 
Figure 6.2.3: Western blot of the UC supernatants (lines 2-5) and sediments (lines 6-7) from A. baumannii SMAL and MG1, 
detected with mAb A6. 1: LPS E. coli _>!`Z|2 and 4: UC supernatant of A. baumannii }$~!"+"Z|3 and 5: 
UC supernatant of A. baumannii $_!"+"Z|6 and 7: UC sediments from A. baumannii SMAL and MG1, 
\!Z
| 
 
6.3 Spectroscopic characterization of the CPS from A. baumannii strain MG1 
 
In order to establish the structure of the repeating unit of the CPS of A. baumannii MG1, the UC 
supernatant was analyzed. 
The 1H NMR spectrum (figure 6.3.1) contained several diagnostic signals: three anomeric ones  (5.30-
4.50 ppm), and those of four -acetyl methyl protons (approx. 2.00 ppm) and two methyl signals 
(approx. 1.2 ppm). Of the latter, the most intense signal originated from H-6 of the bacillosamine, and 
the other one was related to 3-hydroxybutyric acid (HBA) present in non-stoichiometric amounts. The 
sugar residues were labelled with a letter (A-C) in order of their decreasing anomeric chemical shifts, 
and D corresponded to HBA. By analysis of the 2D NMR spectra of the polysaccharide all proton and 
carbon chemical shifts could be assigned (table 6.3.1). 
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Z>_[!"##$&'+<`, D2O) 1$@
repeating unit of the CPS from A. baumannii MG1 (table 
6.3.1). Area1 
Z

!D, Area1); Area2 accounts for all the 

Z
-{!D |-6s from bacillosamine (C residue) regardless the type of 
-substitution at C-{
!|1 and Area2 according to formula 1, suggested a 
]Z
-{
]_< 
 
 1 2 3 4 5 6-6’ 
A 5.21 4.16 3.91 4.34 4.10 - 
4)--L-GalpNAcA <`" 50.4 68.1 q<q 72.7 175.1 
B 4.93 3.91 3.90 3.67 4.09 3.72-3.63 
4)--D-GlcpNAc <<" 54.6 70.4 q<q 71.6 60.7 
C 4.60 3.80 3.87 3.80 3.52 1.17
3)--D-QuipNAc4NR* 101.8 "q< 76.8 "q< 72.5 17.6 
D - 2.33 x 2 4.19 1.24 - - 
HBA 175.3 46.2 66.0 23.8 - - 
* R is Acetyl (81%) or HBA (19%) 
 
Table 6.3.1: 1!Z|13!|

!+<`' D2O, in ppm) of the repeating unit of the CPS from A. 
baumannii MG1 (proton spectrum in figure 6.3.1) 
 
Residue A was classified as a O-4 substituted -GalpNAcA. The galacto stereochemistry was 
identified by the weak scalar correlations in both the COSY and TOCSY spectra of H-4 to its vicinal 
protons (H-3 and H-5), the -configuration was established on the basis of the chemical shift (5.21 
ppm) and on the broad singlet shape of the H-1 signal.  
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The chemical shifts of the ring carbons identified one nitrogen-bearing carbon, namely C-2 (50.4 
ppm), which was -acetylated as proven by the H-2 deshielded chemical shift and by the presence of 
-acetyl signals in the proton spectrum. The C-4 signal appeared in the low field region of the HSQC 
spectrum (79.7 ppm) proving glycosylation at this position, and H-5 displayed a long-range correlation 
with a carbon at 175.1 ppm, confirming the uronic acid feature of this residue. Similar considerations 
identified B as a O-4 substituted 2-acetamido-2-deoxy--glucopyranose. With regard to unit C 
(bacillosamine), the multiplicity of the anomeric proton could not be assigned since it appeared as a 
very broad singlet at 4.60 ppm. Therefore, the -configuration was suggested from both the 1H and 13C 
anomeric chemical shifts and confirmed by the NOE contacts (figure 6.3.2) of H-1 to both, H-3 and H-
5, due to the axial orientation of these three protons. The examination of the carbon chemical shifts of 
this residue identified two nitrogen bearing carbons, i.e. C-2 and C-4 (both at 57.9 ppm), and C-3 
which was glycosylated (76.8 ppm). Using the same approach, the HBA residue was completely 
assigned and, based on the GC-MS data, placed at the amino group at C-4 of residue C.  
Information regarding the substitution degree at -4 of C was deduced from the integration of two 
groups of signals in the high field region of the proton spectrum (figure 6.3.1), namely the broad 
peak at 2.33 ppm, which accounted for the two methylene protons of HBA (Area1), and the two 
methyl groups (Area2) at 1.24 (H-4 protons of HBA) and 1.17 ppm (H-6 protons of C). 
At this regard, methyl signal at 1.17 ppm comprehended the methyl protons from all the 
bacillosamine residues present in the polymer, regardless their acylation state on the nitrogen at 
C-4, that could be either acetylated or substituted with the HBA unit. This methyl signal could not 
be integrated directly, but its contribute to Area2 was deduced as follows: both Area1 and Area2 
were normalized with respect to the number of protons they represented (two and three, 
respectively), so that (Area2)/3 represented the number of HBA residues plus those of 
bacillosamine, while (Area1)/2 reflected the total number of HBA moieties. In this way, the 
bacillosamine amount was deduced subtracting Area1 from Area2, this difference together with 
Area1, was elaborated according to formula 1, disclosing an overall substitution degree with HBA 
at C-4 of this unit equal to 19%. 
 
 
Formula 1 
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Figure 6.3.2: 	

}!"##$&'+<`, D2O) of the CPS from A. baumannii MG1 
(table 6.3.1). T


C. The broad anomeric signal of C induced the 

'

Z
]
ZZ&
by amplifying the area of interest, as indicated in the inset. The intra-1,3 maybe overestimated due to the 
coinc
Z-3 of C 
-3 of B (table 6.3.1). 
  
 
 
The analysis of the NOESY spectrum (figure 6.3.2) showed a spatial proximity between H-1 of A 
and H-3 of C, H-1 of B and H-4 of A, and H-1 of C and H-4 of B, and thus, disclosed the 
sequence between the three residues as reported in figure 6.3.3 
 
Figure 6.3.3: Structure of the repeating unit of the CPS from A. baumannii $_@!_<|. Residues are 
labelled according to the $@Z table 6.3.1 
 
Finally, CPS proton and HSQC spectra were recorded in 10 mM deuterated HCl (data not shown). 
Under this condition a large low field shift was found for H-5 and (less) H-1 signals of the 
GalpNAcA residue suggesting that the carboxylic group of this residue was in the free acid form. 
The structure of the of CPS (figure 6.3.3) was further confirmed by the NMR analysis of the di- and 
trisaccharide obtained after solvolysis with triflic acid and purification of the crude water extract 
(section 9.8). 1H-NMR of the trisaccharide is showed in figure 6.3.4 and all proton and carbon 
chemical shifts were assigned using 2D NMR (table 6.3.2). 
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Z>{[!>##$&'+``, D2O) 1$@

of the CPS from A. baumanni strain MG1 
obtained after solvolysis with triflic acid. The bacillosamine is present as reducing unit (B 'B’ Z, table 
6.3.2) 
 
 
 
 1 2 3 4 5 6-6’ 
A 5.2 4.19 3.89 4.33 4.1 - 
4)--L-GalpNAcA <`> 50.3 67.8 71 73.2 175.1 
B 5.10 4.01 3.99 3.78 3.96 1.14 
3)--D-QuinpNAc4NR* <+_ 54.3 74.8 58.3 68 _q< 
C 4.93 3.89 3.77 3.54 4.01 3.80-3.70 
t--D-GlcpNAc 100.2 "{< 72.2 70.6 73.5 61.2 
B’ 4.68 3.74 3.83 3.78 3.53 1.17 
3)--D-QuinpNAc4NR* <"` 57.1 76.8 58.2 72.4 _q< 
E - 2.32 4.19 1.23 - - 
S-3-HBA 174.8 46.4 >"< +< - - 
* R is Acetyl or HBA  
 
Table 6.3.2: 1!Z|13!|

!+``'D2O, in ppm) of the trisaccharide of the CPS from A. 
baumannii MG (proton spectrum in figure 6.3.4) 
 
6.4 Spectroscopic characterization of the CPS from A. baumannii Strain SMAL 
 
The proton NMR spectrum of the CPS produced by strain SMAL showed five anomeric signals and a 
crowded carbinolic area, together with the occurrence of four -acetyl methyl signals. The analysis of 
the 2D NMR spectra was impaired by the high number of signals, many of which overlapped, and 
from their broad shape which resulted in poor quality spectra. These problems were circumvented by 
studying the deacetylated CPS and recording the sample under alkaline conditions (proton spectrum in 
figure 6.4.1), due to which the amino-geminal protons were shifted to high field.  
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The five anomeric signals were labelled A-E in decreasing order of their chemical shifts, and the 
attribution of the 2D homo- and heteronuclear spectra (table 6.4.1) followed the strategy described 
above for the MG1 CPS and characterized the structure of the repeating unit (figure 6.4.2-1).  
Residue A |
 		
 
 -Galp branched at O-3, O-4 and O-\@
 	
 -configuration was 
established from both, anomeric proton and carbon chemical shifts. The analysis of the proton and 
carbon signals identified B as terminal 2,3-diamino-dideoxy--glucopyranosuronic acid (DAGA), as 
indicated by the trans diaxial disposition of all the ring protons together with the occurrence of two 
nitrogen-bearing carbons (C-2 and C-3, 56.5 and 57.8 ppm, respectively), and from the 1H,13C long-
range correlation between H-5 and C-6 at 175.9 ppm. 
 
 
Z>{_[!>##$&'+<_'#$? in D2O) 1$@
}A. baumannii SMAL. Signals are 
labelled according 
$@] in table 6.4.1 
 
Residue C |
		

-Glcp, substituted at position 6, due to the low-field displacement of the 
corresponding carbon signal in comparison to the standard value (61.8 ppm) (Bock and Pedersen, 
1983) Monosaccharides D and E |		
		

-galacto 
-gluco configured, respectively. 
The complete carbon chemical shift attribution identified D as an O-
 	
-GalpN residue, 
while E |

 	
-GlcpN. The sequence of the monosaccharides was determined from NOE 
connectivities between H-1 of A and H-6 of C, H-1 of B and H-4 of A, H-1 of C and H-3 of D, H-1 of 
D and H-3 of A, H-1 of E and H-6 of A (figure 6.4.3), which was confirmed by the observed inter-
residual HMBC correlations. 
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Figure 6.4.2: 1 and 2: Structures of the repeating unit of the CPS isolated from A. baumannii SMAL. Residues are labelled 
according to the $@attribution in table 6.4.1 
 
 
 
 
 
 
 1 2 3 4 5 6-6’ 
A 5.03 4.06 4.06 4.47 4.16 4.11-3.88 
3,4,6)--D-Galp <q` 67.6 q<> 78.0 >< 70.3 
B 4.76 2.52 2.67 3.36 3.69 - 
t--DAGA _#< 56.5 57.8 72.2 77.8 _q"< 
C 4.64 3.38 3.49 3.60 3.64 4.04-3.77 
6)--D-Glcp 104.6 73.2 75.7 68.8 q< 65.1 
D 4.53 3.06 3.69 4.16 3.67 3.76-3.79 
3)--D-GalpNAc 105.5 52.2 83.3 67.4 74.8 61.2 
E 4.37 2.61 3.36 3.36 3.44 3.92-3.75 
t--D-GlcpNAc 103.5 56.4 75.5 ><q q"< 60.8 
 
Table 6.4.1: 1!Z|13!|

!+<_'#$? in D2O, in ppm) of the repeating unit of the 
CPS from A. baumannii SMAL (proton spectrum in figure 6.4.1) 
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Figure 6.4.3: !>##$&'+<_'#$? in D2O) Attribution of the Z}
}
from A. baumannii SMAL. Inter- and intra-residue contacts are labelled ( table 6.4.1). 
 
 
On the basis of the above information and considering that the alkaline treatment removed the pre-
existing acetyl groups, the structure of the repeating unit of the O-deacylated CPS produced from A. 
baumannii SMAL was as shown in figure 6.4.2- 2. It was further confirmed by the analysis of the 
oligosaccharide (figures 6.4.4, table 6.4.2) obtained after periodate degradation of the purified CPS 
(section 9.8). 
 
 
 
Figure 6.4.4[!>##$&'#"'?2O) 1$@and structure of the periodate degradation product from A. 
baumannii SMAL. All monosaccharides are in pyranose form, signals and residues labelling reflects 
$@Z in 
table 6.4.2 
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 1 2 3 4 5 6-6’ 
A’ 4.89 3.71 3.92 4.40 3.90 3.79-3.64 
3,4,6)--D-Galp <<> 68.5 q#< 76.5 71.1 61.3 
B’ 5.05 3.81 4.04 5.59 3.79 - 
t--DAGA 102.1 54.7 55.7 71.4 77.4 _q>< 
C’ - - - 3.63-3.67 3.94 3.56-3.73 
Glycerol - - - 63.6 71.5 ><q 
D’ 4.57 4.00 3.72 3.97 3.69 3.83-3.69 
3)--D-GalpNAc 105.1 "< 72.2 >`< 76.1 62.2 
 
Table 6.4.2: 1!Z|13C (italic) chemical shifts !#"', D2O) of the periodate degradation product from A. 
baumannii SMAL CPS. Labels are in analogy to those used for the parent polysaccharide, similarly glycerol numbering 
reflects that of the protons in the parent Glcp C 
 
6.5 Conclusions 
 
The carbohydrate material produced from two A. baumannii clinical isolates, MG1 and SMAL, was 
studied with the purpose to establish their location in the cell envelope together with their 
structures.Western blot analysis classified these materials as CPSs and the extensive use of NMR 
spectroscopy determined the carbohydrate sequence of each repeating unit. With regard to A. 
baumannii MG1, the repeating unit of the capsular structure is constituted from three different amino 
sugars (figure 6.3.3) and is quite similar to the O-antigen of the LPS from another strain of A. 
baumannii (figure 6.5.1) (Vinogradov et al., 2003)
 
 
Figure 6.5.1. Structure of the O-antigen of the LPS from A. baumannii strain 24. 
 
Indeed, both polymers possess a -bacillosamine residue acylated non-stoichiometrically with HBA at 
-4, but they differ in the absolute configuration of the GalpNA residue and the acetylation at O-6 of 
the GlcpN unit, which is absent in the MG1 CPS. As far as A. baumannii SMAL is concerned, its CPS 
is constituted of a pentasaccharide repeating unit (figure 6.4.2-2), rich in amino sugars, as was often 
found in CPS or O-antigens from this bacterial species. The structure of this polysaccharide is not 
new, and it was recently reported for the O-antigen of another A. baumannii strain, ATCC 17961 
(MacLean et al., 2009). The structures of the CPSs from A. baumannii MG1 and SMAL may 
contribute to the establishment of  a serotyping scheme for this bacterium. 
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CHAPTER VII 
 
LPS ANALYSIS AND ISOLATION OF TWO FORMS OF CYCLIC Enterobacterial 
common antigen (ECA) FROM THE ENTEROHAEMORRHAGIC Escherichia coli 
O157:H- 
 
The following discussion is the results of a collaboration regarding the study of the LPS produced by 
the enterohaemorrhagic E. coli O157:H-. Preliminary data reported the experimental observation of 
phase variation (section 2.4) of the bacteria colonies growth at 37°C and 20 °C on solid Nutrient-Agar. 
The target of project was to investigate if this phenomenon was affecting LPS structure or other 
carbohydrate components. Chemical and spectroscopic analyses evidenced that LPS structure was not 
affected, but also that E. coli O157:H- produced two forms of ECACYC: the tetrameric ECACYC and the 
pentameric ECBCYC.  
 
7.1 Screening of phenol and water extracts of E. coli O157:H-at 37°C and 20°C 
 
The O-polysaccharide of E. coli O157:H- was obtained after mild hydrolysis of the LPS in the phenol 
phase and subsequent fractionation of the oligosaccharides by GPC (section 9.9). 1H-NMR spectrum 
(figure 7.1.1) showed four anomeric signals (A-D) corresponding to the tetrasaccharide repeating unit 
already characterized for the LPS of E. coli O157 (Wang and Reeves, 1998). 1H and 13C chemical 
shifts were completely assigned by the use of COSY, TOCSY, NOESY and HSQC bidimensional 
spectra (table 7.1.1). Analyses conducted on the sugars composition and on the Lipid A structure of 
phenolic LPS were a further confirmation of the known structure.  
 
 2)--D-Rhap4NAc---L-Fucp---D-Glcp---D-GalpNAc- 
A                               C                           D                     B 
 
7.1.1: (600 MHz, 300 K, D2O) 1H-NMR and structure of the O-Chain repeating unit of E. coli O157:H-. Residues and 
anomeric signals are labelled according to the NMR attribution in table 7.1.1. 
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 1 2 3 4 5 6-6’ 
A 5.27 4.06 4.07 3.99 3.92 1.22 
2)--D-Rhap4NAc 102.1 79.2 69.2 54.3 69.4 18.0 
B 5.13 4.32 4.12 4.27 4.10 3.77 
3)--D-GalpNAc 101.5 50.2 78.1 69.7 72.4 62.4 
C 4.97 3.88 3.88 3.88 4.39 1.17 
3)--L-Fucp 100.4 68.3 79.6 72.9 68.2 16.4 
D 4.59 3.31 3.60 3.54 3.55 3.95-3.86 
4)--D-Glcp 105.1 74.6 75.5 77.7 76.2 60.9 
 
Table 7.1.1: 1H (regular) and 13C (italic) chemical shifts at 300 K in D20 measured for the O-chain from E. coli O157:H-
(proton spectrum in figure 7.1.1). 
 
 
Water extracts at 20°C and 37 °C were purified by enzymatic treatments, dialysis and repeated 
ultracentrifugations (section 8.4). UC sediments and supernatants were screened by SDS-PAGE 
stained with silver nitrate only (figure 7.1.2 gels A) and with Alcian blue fixative prior the silver 
nitrate (figure 7.1.2 gels B). The UC sediments stained with silver (figure 7.1.2 gels A, lines 3) 
showed a migration pattern equal to the phenolic LPS (figure 7.1.2 gels A, lines 2); other materials 
was revealed by double staining and appeared as a smear in the high molecular weight region (figure 
7.1.2 gels B, lines 3). UC supernatants resulted totally negative to the presence of LPS or others 
species with the silver staining (figure 7.1.2 gels A, lines 4-7), but very positive to the double staining 
(figure 7.1.2 gels B, lines 4-7). The presence of L-Gal in the chemical analyses and the positivity to the 
Sulfate test (Silvestri et al., 1982) suggested the occurrence of agarose in the samples. Its presence, 
originating from the growth on solid medium, explained the positivity to Alcian blue stain able to fix 
on the gel this polymer. Sugars compositional analyses showed in first two UC supernatants the 
presence of D-Fuc4NAc (4-acetamido-4,6-dideoxy-D-galactose), D-GlcNAc (N-acetyl-D-
glucosamine), D-ManNAcA (N-acetyl-D-mannosaminuronic acid) characteristics of the 
Enterobacterial common antigen repeating unit. Further analyses were focused on the purification and 
isolation of this polysaccharide. 
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7.1.2: SDS-PAGE (stacking gel 5%, separating gel 12 %) of UC sediments and supernatants from water extracts of E. coli 
O157:H - grown at 37 °C and 20°C . Gels A are stained with silver nitrate, B with Alcian blue first and then silver nitrate. 1: 
LPS of E. coli O55:B5 as standard; 2: LPS from phenol phases of E. coli O157:H -; 3: UC sediments from water phases of E. 
coli O157:H - ; 4-7: UC supernatants from water extracts of E. coli O157:H -. Sample were loaded in quantity of 6μg. 
 
7.2 Purification and immunodetection analysis of LPS in water extracts 
 
In order to remove the contamination, UC sediment from water extract at 20 °C was chromatographed 
on Q-Sepharose resin with a NaCl gradient (section 9.9, table 7.2.1). The fractions were monitored 
using the phenol-H2SO4 test (table and figure 7.2.1; section 9.5).
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Table 7.2.1: Q-Sepharose fractions of the UC sediment from water extract of E. coli O157:H- grown at 20 °C. They were 
eluted with NaCl gradient and monitored through the phenol-H2SO4 test 
Fraction A490 NaCl (M) Fraction A490 NaCl (M)
1 0.05 0.01 12 0.06 0.4 
2 0.88 0.01 13 0.02 0.7 
3 0.69 0.01 14 0.11 0.7 
4 0.21 0.01 15 0.07 0.7 
5 0.11 0.2 16 0.07 0.7 
6 0.18 0.2 17 0.09 1 
7 0.37 0.2 18 0.04 1 
8 0.07 0.2 19 0.05 1 
9 0.04 0.4 20 0.09 1 
10 0.18 0.4 21 0.11 1 
11 0.07 0.4 22 0.02 1 
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Figure 7.2.1: Profile of the Q-sepharose chromatography (table 7.2.1) 
 
On the basis of chromatographic profile (figure 7.2.1), new fractions were obtained: 
A (fractions 1-4), B (fractions 5-8) and C (fractions 9-13). The SDS-PAGE of the 
fractions A, B, C (figure 7.2.2) revealed a more abundant presence of LPS with a 
minor amount of high molecular weight bands (related to the presence of agarose), 
in the fractions eluted with low ionic strength. 
 
 
Figure 7.2.2: SDS-PAGE (stacking gel 5 %, separating gel 12 %) of A, B, C fractions obtained from Q-Sepharose 
chromatography. R: LPS of E. coli O55:B5 as standard; 1: A (fractions 1-4); 2: B (fractions 5-8);3: C (fractions 9-13). 
Sample were loaded in quantity of 4μg. 
 
Chemical analyses confirmed this evidence because of the reduction of the galactose amount in the 
fraction A respect to the UC-sediment (figures 7.2.3 and 7.2.5).  
 
 
Figure 7.2.3: GC-MS chromatogram of the acetylated O-methyl glycosides relative to the UC sediment from water extract of 
E. coli O157:H -grown at 20 °C. 
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Figure 7.2.4: Zoom of the GC-MS chromatogram of the acetylated O-methyl glycosides relative to the UC sediment from 
water extract of E. coli O157:H- grown at 20 °C. Characteristics sugars of the LPS of E. coli 0157 are appreciable. 
 
 
Figure 7.2.5: GC-MS chromatogram of the acetylated O-methyl glycosides relative to the fraction A from Q-Sepharose 
purification 
 
 
 
Figure 7.2.6: Zoom of the GC-MS chromatogram of the acetylated O-methyl glycosides relative to the fraction A from Q-
Sepharose purification. The relative abundances of the sugars are increased respect to those found in UC-sediment analysis 
(figure 7.2.4); the Fucose (Fuc) resulted absent.  
 
Finally, the fraction A obtained from Q-Sepharose containing the LPS of E. coli grown at 20 °C, was 
subjected to a Western Blot analysis with a polyclonal antibody for the LPS of E. coli O157 (figure 
7.2.7 A and SDS-PAGE B, lines 1, section 9.2). Not purified LPS from water extract at 37 °C was also 
analyzed (figure 7.2.7 A and B, lines 3) and both LPSs were recognized by antibody as the phenolic 
LPS (figure 7.2.7 A, line 4).  
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These data, together with that obtained by chemical and spectroscopic analyses, suggested the analogy 
of the structure among the LPSs extracted from the water and phenol phases. In conclusion, the water-
LPS is not subject to structural variability caused by phase variation but it is a result of a non complete 
repartition of the LPS in the phenol phase. 
 
 
Figure 7.2.7: A: Western blot with primary Ab for LPS of E. coli O157. B: SDS-PAGE (5% stacking gel, 12 % separating 
gel) stained with silver nitrate. 1: Fraction A of Q-Sepharose containing the LPS of E. coli O157:H - grown at 20 °C;2: First 
UC supernatant containing ECACYC and ECBCYC from water extract at 20 °C; 3: LPS of E. coli O157:H - from water extract 
at 37 °C; 4: LPS of E. coli O157:H - from phenol extract at 37 °C; 5: LPS of Rhizobium rhizogenes as negative check; 6: 
LPS of E. coli O55:B5. Samples were loaded in quantity of 6μg. 
 
 
7.3 Characterization of the two cyclic forms of the Enterobacterial common antigen 
 
The first UC supernatant from water extract at 20 °C was purified by an enzymatic hydrolysis with -
agarase, dialysis and different gel permeation chromatographies (section 9.9). In particular GPC 
Biogel-P100 allowed the separation of the two cyclic forms of Enterobacterial common antigen 
(ECA) that were completely characterized by mono and bidimensional NMR. Proton NMR showed, 
for both polysaccharides, the occurrence of the three anomeric signals (A-C, or A’-C’) corresponding 
to the trisaccharide repeating unit of the Enterobacterial common antigen (figure 7.3.1). The form 
indicated with ECACYC corresponded to that characterized elsewhere (Erbel et al., 2003), the other 
form indicated with ECBCYC  presented only small variations of chemical shifts  with respect to 
ECACYC (table 7.3.1 and 7.3.2). The absence of reducing sugars signals and the high solubility in water 
of the samples was a further confirmation of the presence of ECACYC and excluded the other possible 
forms of ECA like ECAPG and ECALPS.  
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 3)--D-Fucp4NAc---D-ManpNAcA---D-GlcpNAc- 
                                     A (A’)                            C (C’)                            B (B’) 
 
 
 
Figure 7.3.1: (600 MHz, 308 K, D2O). Proton spectra and structure of cyclic ECA and ECB repeating unit isolated form 
water extract at 20°C. Residues and signals are labelled according to the NMR attribution in tables 7.3.1 and 7.3.2. 
 
The signals labeled with A(A’), B(B’) and C(C’
 		
 
 -*{
 -*{
 -
ManNAcA residues, respectively. The C-4 of A(A’), C-2 of B (B’) and C-2 of C(C’) were assigned to 
upfield-shifted amino substituted carbon signals. Inter-residual NOE signals observed in the NOESY 
spectra showed the connectivity between protons B(B’)1 and A(A’)3, C(C’)1 and B(B’)4, confirmed by 
HMBC experiment that in addition showed the A(A’)1 and C(C’)4 long range inter-residual correlation 
(figure 7.3.2). These data were supported from the downfield shifts of the corresponding carbons and 
confirmed the same repeat unit for the two forms of Enterobacterial common antigen (figure 7.3.1). 
 
ECACYC 
 1 2 3 4 5 6 NHAc C(O) 
A 5.12 3.80 4.07 4.32 4.25 1.04 2.07 - 
 
3)--D-Fucp4NAc 102.0 68.8 72.7 50.8 67.7 16.6 23.2 175.4 
B 4.97 3.98 3.82 3.77 4.03 3.84-3.76 2.01 - 
4)--D-GlcpNAc 94.2 54.3 70.5 78.9 71.4 61.2 23.3 175.2 
C 4.86 4.53 4.06 3.76 3.82 - 2.07 - 
4)--D-ManpNAcA 99.6 54.2 73.4 79.3 78.7 175.9 23.3 176.6 
 
Table 7.3.1: 1H (regular) and 13C(italic)  chemical shifts at 303 K in D20 (600 μl), measured for ECACYC  (figure 
7.3.1) 
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ECBCYC
A’ 5.19 3.77 4.00 4.31 4.23 1.06 2.07 - 
3)--D-Fucp4NAc 101.4 68.4 74.9 51.7 67.3 16.6 23.2 175.8 
B’ 4.95 3.96 3.79 3.75 3.97 3.83-3.75 2.03 - 
4)--D-GlcpNAc 95.7 54.3 70.5 78.3 71.6 61.2 23.3 175.3 
C’ 4.80 4.51 4.07 3.77 3.80 - 2.07 - 
4)--D-ManpNAcA 99.6 54.4 73.5 78.4 78.5 175.2 23.2 176.6 
 
Table 7.3.2: 1H (regular) and 13C(italic)  chemical shifts at 303 K in D20 (600 μl), measured for ECBCYC (figure 7.3.1) 
 
 
 
Figure 7.3.2: (600 MHz, 303K, D2O), Attributions of the HSQC (red and blue) and HMBC (green) spectra of ECACYC 
(table 7.3.1) 
 
The ring dimension of these molecules was determined through MALDI-TOF experiments (figures 
7.3.3 and 7.3.4). The mass of the ECACYC (m/z 2428.43) (figure 7.3.3) corresponded to a tetrameric 
molecule, while ECBCYC (m/z 3035.69) (figure 7.3.4) differed from the ECACYC only for the addition 
of one repeating unit (m/z 607.26 ), therefore it is the pentameric form. 
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Figure 7.3.3: Ion negative MALDI-TOF spectrum of ECACYC 
 
 
 
Figure 7.3.4: Ion negative MALDI-TOF spectrum of the mixture of ECACYC and ECBCYC 
 
7.4 Conclusions 
 
These studies conducted on the LPS  in the water cellular extracts of the pathogenic E. coli O157:H- 
proved that it is not involved in the phase variation, since no structural difference was found respect to 
phenolic LPS. The chemical identity of the LPSs in the water phase of cellular extracts was 
demonstrated by chemical analyses and through an immunodetection analysis with an antibody raised 
from the LPS of E. coli O157. Furthermore, the investigation of water extracts led to the identification, 
purification and characterization of two cyclic forms of the Enterobacterial common antigen. 
Literature data report the production of ECACYC from different Enterobacteriaceae, in particular that 
of E. coli K12 is constituted by 4 repeating units and each molecule contains from 0 to 4 O-acetyl 
groups (Erbel et al., 2003; Kajimura et al., 2005).  
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The presence of the tetrameric ECACYC for a pathogenic strain of E. coli and together with the  
pentameric form, ECBCYC, represents a new datum. Further studies will be focused on the study of 
biological functions of these molecules and eventually on their implication as a virulence factor . 
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PART III: MATERIALS AND METHODS 
 
CHAPTER VIII 
 
ISOLATIONS OF LIPOPOLYSACCHARIDES AND CAPSULAR POLYSACCHARIDES 
 
8.1 Rhizobium radiobacter RV3 
 
Rhizobium radiobacter Rv3 strain DSM 30207 was grown in liquid shake culture in Nutrient Broth 
(NB, Fluca, cod. 03856, 24 l) medium at 27 °C for 40 h (early stationary phase). Cells were collected 
by centrifugation (3500 g, 4 °C, 15 min), washed sequentially with ethanol, acetone and diethyl ether 
and finally freeze-dried (yield 0.3 g/l). Isolation of LOS was performed on dry cells by aqueous 90 % 
phenol-chloroform-light petroleum (PCP) (2 : 8 : 5 v/v/v) extraction (Galanos et al., 1969). After 
removal of the light solvents under vacuum, LOS was precipitated from the phenol with water, washed 
with aqueous 80 % phenol and acetone, finally the solid was suspended in water and lyophilized (2% 
wLOS/wcells). The remaining cell pellet was extracted according to the hot phenol-water protocol 
(Westphal and Jann, 1965): cells were treated with 30 ml of water and an equal volume of 90 % 
phenol, solution was incubated at 68 °C for 20 minutes. Phenol-water phases separation was 
performed by spinning at 4 °C. Dialysis (cut-off 10000 Da) was used for phenol removal from the 
extractions phases which were finally freeze-dried. LOS was recovered only in water extract (7.4 % 
wLOS/wcells) together with high quantity of cyclic -glucans and for this reason not further  considered.  
 
8.2 Cupriavidus necator DSM 13513 
 
Cells of Cupriavidus necator DSM 13513 were cultivated in Nutrient Broth (8 l) medium at 26 °C, 
collected by centrifugation (9800 g, 4 °C, 15 min), washed with distilled water and extracted 
according water-phenol protocol (section 8.1) and LPS was found in water extract only (160 mg). This 
latter (50 mg) was purified from protein and nucleic contaminants by enzymatic treatment and 
ultracentrifugation. It was solved in the digestion buffer (100 mM TRIS, 50 mM NaCl, 10 mM MgCl2, 
buffer at pH 7.5) at a concentration of 5 mg ml-1, and treated with DNAse (Sigma, cod. DN25) at 37 
°C overnight, successively Proteinase K (Sigma, cod. P5147) was added and the solution left at 56 °C 
for 4 h. The sample, after dialysis (cut-off 10000 Da), was ultracentrifugated (440000 g, 4 °C, 16 h) 
and LPS was recovered both in the supernatant (7 mg) and sediment (15 mg), but this last was used for 
further analyses. 
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8.3 Acinetobacter baumannii clinical isolates SMAL and MG1 
 
Acinetobacter baumanni SMAL and MG1 strains were multidrug-resistant (MDR) clinical isolates 
representative of a clonal lineage causing nosocomial infections, including sepsis, in different Italian 
settings and recovered since 2002. The isolates were identified by using the Vitek 2® automated 
instrument ID system (BioMérieux, Marcy l'Etoile, France), and sequencing of blaOXA-51-like gene 
(Turton et al., 2006) species identification was also confirmed by using gyrB PCR method previously 
described (Higgins et al., 2007). Genomic relatedness among A. baumanni isolates was investigated 
by pulsed-field gel electrophoresis (PFGE) (Endimiani et al., 2007). 
Strains SMAL and MG1 were grown in liquid shake culture in Luria Broth (LB, Sigma, cod. 3022, 24 
l) medium at 28 °C and cells were collected by centrifugation (9800 g, 4 °C, 20 min), washed 
sequentially with distilled water, ethanol, acetone, ethyl ether, suspended in water and freeze-dried 
(yield 0.3 g/l for both strain). Isolation of LOS was performed on dry cells by PCP extraction (section 
8.1) (strain SMAL yield 0.8 % wLOS/wcells; strain MG1 yield 0.7 % wLOS/wcells). The remaining cell 
pellet was extracted according to the hot phenol-water protocol (section 8.1) and in both cases 
preliminary chemical and electrophoretic analysis revealed the presence of polysaccharide material in 
the water phases (strain SMAL yield 22 % w/wcells, strain MG1 yield 20 % w/wcells), hence phenol 
phases were not investigated. 
CPSs were purified from nucleic acid, proteins and LOS by enzymatic treatment (section 8.2) 
(DNAse, Roche Germany 04716728001; Proteinase K, Roche Germany 03115836001) and repeated 
ultracentrifugations. After dialysis and freeze-drying, enzyme-treated water phase (30 mg for each 
strain) was solved in distilled water and ultracentrifugated (105 000 g, 4 °C for 12 h). The LOS-
containing sediment was suspended in water and ultracentrifugated again in the same conditions. This 
sediment was lyophilized and used for further analysis (strain SMAL yield 9 mg , strain MG1 13 mg ). 
The CPS-containing supernatants were pooled and ultracentrifugated (500 000 g, 4 °C, 48 h), the 
supernatant, namely the purified CPS, was freeze-dried and finally used for the chemical analyses 
(strain SMAL yield 18 mg , stain MG1 yield 15 mg). Furthermore, A. baumannii strain SMAL was 
cultivated in 50 ml of LB and 50 ml of FBS (Fetal Bovine Serum, EuroClone, cod. ECS0180D) at 37 
°C. In order to verify the variation of Lipid A structure, dry cells were extracted according to the hot 
phenol-water method and LOS was recovered in the water layer, after dialysis and freeze drying. 
Yields were similar to that reported above. 
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8.4 Escherichia coli O157:H- 
 
Cells were cultivated on solid Nutrient-Agar at 37 °C and 20 °C and extracted according to the phenol-
water protocol (section 8.1). Water extracts were treated with DNAse, Proteinase K (section 8.2), 
dialysed and freeze-dried (96 mg for 37 °C and 171 mg for 20 °C). LPSs were further purified by four 
ultracentrifugation steps (440 000 g, 4 °C, 16h), resuspending in distilled water the UC sediments 
obtained each time. Finally, the UC sediments were freeze-dried (7 mg for 37 °C and 15 mg for 20 
°C).  
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CHAPTER IX 
 
GENERAL AND ANALYTICAL METHODS 
 
9.1 Electrophoretic and chemical analyses  
 
Discontinuous SDS-PAGE (Sodium Dodecyl Sulphate Polyacrylamide Electrophoresis) (Laemmli, 
1970) of samples were performed on Mini Protean III Bio-Rad system run at 150 constant voltage. 
Gels were realized as reported: 5 % stacking gel, 12 % separating gel for LOS of R. radiobacter, LPS 
of E. coli O157: H- , LPS of C. necator and 8% for neoglycoprotein analysis. Gels were stained 
according to the silver stain procedure for Lipopolysaccharide (Kittelberger and Hilbink, 1993), with 
coomassie procedure for proteins (Zehr et al., 1989) and Alcian blue fixative for negative charged 
polysaccharides (Min et al., 1986).  
Total fatty acid content and monosaccharide composition were determined by treating the LPS (1 mg) 
with methanolic HCl 1 M at 80 °C for 16 h. The solution was extracted three times with an equal 
volume of n-hexane, the top layers (n-exane) were combined and dried. Fatty acids methyl esters 
(FAME) were analyzed directly by GC-MS. The bottom layer (methanol) was dried and the O-methyl 
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mixture of acetylated O-methyl glycosides was analysed by GC-MS.  
The absolute configuration was determined by GC-MS analysis of the chiral 2-octyl (Leontein et al., 
1978) or 2-butyl (Gerwig et al., 1978) derivatives. The ester-linked fatty acids were selectively 
released from LPS by base-catalysed hydrolysis (0.5 M NaOH, 37 °C, 2 h). The solution was acidified 
to pH 4.0 by addition of 1 M HCl drops and extracted twice with an equal volume of CHCl3. Fatty 
acids were recovered in the organic layer, esterified with diazomethane and analysed by GC-MS.  
Glycosyl-linkage analysis of LPS was performed derivatizing monosaccharides as partially methylated 
alditol acetates (PMAA) and analysed by GC-MS (Ciucanu and Kerek, 1984) 1-2 mg of sample were 
solubilized in dry DMSO (1 ml) and then powered NaOH (100 mg) was added to promot the sugars 
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of iodomethane (from 0°C to 25 °C, 16 h) 
and per-O-methylated lipopolysaccharide was extracted by adding water and chloroform to the 
reaction mixture. The organic layer was washed with 50 ml of water, dried under vacuum, dissolved in 
2 M TFA. After 1 h at 120 °C, it was dried and acid traces were removed by isopropanol washing and 
drying. Partially methylated monosaccharides were converted in alditols by reduction with NaBD4 in 
ethanol (1 h, 25 °C), followed by borates treatment with methanol and AcOH. Methylated alditols 
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*2O, 80 °C, 30 min.) and salts removed with water-
chloroform extraction.  
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All GC-MS analyses were performed with an Hewelett–Packard 5890 instrument, equipped with a 
SPB-5 capillary column (Supelco, 30 m x i.d. flow rate, 0.8 ml/min, He as a carrier gas). EI mass 
spectra were recorded with an ionization energy of 70 eV and an ionizing current of 0.2 m A. The 
temperature program used for the analyses was the following: ?

 

{
??




°C/min, 300 °C for 5 min.  
Exceptions regarded: 
Monosaccharides and fatty acids of LOS from A. baumannii strain SMAL: 150 °C for 3 min, 
???
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Monosaccharides of CPSs from A. baumannii strains SMAL and MG1: ?
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°C at 10 °C/min, 300 °C for 12 min. 
 
9.2 Immunodetection analyses 
 
The ultracentrifuge sediments and supernatants of A. baumannii water extract were subjected to SDS-
PAGE and Western Blot using an antilipid A monoclonal antibody (mAb) A6 (Kuhn et al., 1992). 
SDS-PAGE was performed with 5 % stacking gel; separating gel composition was optimized for the 
type of molecule screened, and it was 15 % for LOS or, in the case of CPS molecules, it was 
polymerized using two different acrylamide percentages: 8 % (top half) and 15 % (bottom half). LPSs 
of E. coli O157: H- were analysed with 12 % separating gel and Western Blot using a non commercial 
polyclonal antibody for LPS of E. coli O157.  
Western blot analysis was accomplished on Biorad Trans Blot Cell System and a PVDF membrane 
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g/l, 15 % methanol) for 16 h, at 10 °C, 26 V for Acinetobacter baumannii samples and for 2 h at 4 °C, 
100 V for LPS of E. coli.  The membrane was incubated with 1 % AcOH (100 °C, 2 h) to cleave the 
Kdo glycosidic linkage; this step is necessary because the primary antibody A6 is specific for the 
Lipid A in its free form, namely without the core region.  
Western blot detection of samples was performed as follows: membrane was washed with Tris-Tween 
buffer (3 x 30 min; Tris 1.21 g/l, Tween 20 0.5 ml/l, pH 8.0); blocked for 1 h in Tris-Tween buffer 
with evaporated defatted milk (5 %); incubated for 16 h with the primary antibody A6 or in that for 
LPS of E. coli O157 (dilution 1:200) in dilution buffer (Na2HPO4 1.78 g/l, NaCl 8.77 g/l, Tween 20 
0.5 ml/l, pH 7.4) and 2 % of evaporated defatted milk. Membrane was then washed with Tris-Tween 
buffer (3 x 15 min) and Acinetobacter baumannii samples were incubated for 2 h with secondary 
antibody alkaline phosphatase (AP) conjugated goat anti-mouse IgG (Jackson ImmunoResearch, cod 
115-055-003, 1:1000) while E. coli O157:H- samples with goat anti-rabbit AP-IgG (Sigma, cod. 
A3687) antibody. 
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Finally, membrane was rinsed with Tris-Tween buffer (2 x 15 min) first and with PBS after; 
membrane was then wash with AP-buffer (10 min; 0.1 M NaHCO3, 1 mM MgCl2  6 H2O, pH 9.0) and 
treated with a solution containing AP-buffer, NBT (Biomol, cod. 06428, 50 mg/ml in 70 % DMF) and 
BCIP (Biomol, cod. 02291, 50 mg ml-1 in DMF) in ratio 2:1 v/v respectively or in alternative with the 
premixed NBT-BCIP solution (Sigma, cod. B6404) until color development.  
 
9.3 Isolation of oligosaccharides from LOS of Rhizobium radiobacter RV3 
 
The de-O-acylation of LOS (60 mg) was performed dissolving the sample in anhydrous hydrazine (25 
mg ml-1), stirred at 37°C for 30 min, cooled, poured into ice-cold acetone (15 ml), and allowed to 
precipitate. The precipitate was centrifuged (6000 g, 30 min), washed twice with ice-cold acetone, 
dried, and then dissolved in water and lyophilized (50 mg). The sample was de-N-acylated with 4 M 
KOH (10 mg ml-1) for 16 h at 120 °C (Gargiulo et al., 2008), and after neutralization it was desalted 
by gel permeation chromatography on Sephadex G-10 (Pharmacia, 1.5  50 cm, eluent water, flow 0.5 
ml min-1) column. The resulting oligosaccharide fraction (9 mg) eluted in the void volume and was 
further purified by HPAEC on a Carbopack PA-100 column (9 x 250 mm) eluted with a linear gradient 
of 30-37% of 1 M sodium acetate in 0.1 M NaOH at 2.0 ml min-1 over 100 min. In this condition OS1 
and OS2 retention time was 41 and 62 min., respectively. Finally, OS1 and OS2 were desalted as 
mentioned above, yielding to 1.2 and 0.7 mg, respectively. 
 
9.4 Preparation of the carbohydrate component of the neoglycoprotein 
 
LOS (100 mg) was de-O-acylated as described in the section 9.3 and dephosphorilated with 48 % 
aqueous HF (20 mg ml-1) for 48 h at 4 °C. Solution was diluted and HF removed by dialysis (cut-off 
3500 Da). De-O-acylated and dephosphorilated mixture of oligosaccharides were reduced by treatment 
with NaBH4 (20 mg) overnight at 4 °C. The reducing agent was destroyed with few drops of glacial 
AcOH, salts were removed by dialysis (cut-off 3500 Da) and finally sample was freeze-dried (60 mg). 
Complete delipidation was afforded with 4 M KOH treatment (section 9.3), yielding to the complete 
deacylated, dephosphorylated and reduced oligosaccharide mixture (OS, 40 mg). 
 
9.5 Synthesis and characterization of OS-BSA conjugate 
 
The oligosaccharides (section 9.4) were conjugated to the protein carrier, commercial BSA, using 
glutaraldehyde as linker by the formation of Schiff bases with BSA lysines residues and with free 
amino groups of the oligosaccharides (Holst et al., 1991).  
BSA (10 mg, Sigma, cod. A7906) was activated with glutaraldehyde (5% final concentration; Sigma, 
cod. 40855) in Argon saturated buffer (2 ml, Na2CO3 50 mM pH 9.2).  
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The reaction was left under stirring overnight at 25 °C in the dark. Formation of the Schiff base 
between BSA lysines and glutaraldehyde was monitored with the TNBS test (Habeeb, 1966) (section 
3.3). Known volumes of BSA-glutaraldehyde and BSA standard solution (1 mg ml-1), used for 
calibration, were diluted with Na2CO3 50 mM pH 9.2 buffer to a volume of 300 μl. The solutions were 
treated with 300 μl of 0.1% 2,4,6-trinitrobenzensulphonic acid (TNBS) or picrylsulfonic acid (Sigma, 
cod. P2297), mixed and  incubated at 40 °C for 2 h. Then, 300 μl of 10 % SDS were added to 
solubilise the protein, and finally 150 μl of 1 M HCl were added, before the UV440 measures.  
BSA-linker adduct was extensively dialyzed at 4°C, in the dark, versus degassed Na2CO3 50 mM 
buffer at pH 9.2; finally OS (4 mg) was added and the solution was stirred overnight at 25 °C. Schiff 
bases cross-linking glutaraldehyde with OS and BSA were then reduced adding NaBH4 (50 mg, 6h, 
r.t.), the excess of the reducing agent was destroyed upon addition of few drops of glacial AcOH and 
the solution was dyalised and directly desalted on Biogel P-2 (Bio-Rad, 1.5 x 116 cm, eluent 
NH4HCO3 50 mM, flow 0.2 ml min-1 ). OS-BSA conjugate was further chromatographed on Sephacryl 
HR-100 (GE-Healthcare, 1.5 x 116 cm, eluent NH4HCO3 50 mM, flow 0.25 ml min-1). The eluates 
were monitored with an in-line refraction index detector (Knauer, K-2310). The conjugate was eluted 
in proximity of void volume as a broad peak, whereas unreacted OS was highly retained from the gel 
and recovered after almost one column volume. On the basis of the chromatographic profile, fractions 
proximal to the void volume were pooled in three groups, OS-BSAA, OS-BSAB and OS-BSAC (2, 7, 
and 2 mg, respectively), and analyzed on SDS-PAGE, using BSA as reference. Molecular weight of 
the three conjugates was evaluated via gel permeation chromatography on TSK G5000PWXL, run on 
Agilent 1100 system, using NH4HCO3 50 mM at 1.0 ml min-1 and monitoring the eluate with the UV 
detector at 210 nm ; calibration curve was calculated using commercial protein standards (section 3.3). 
The quantity of the carbohydrate component of the glycoconjugate were determined through the 
phenol-H2SO4 test (Dubois et al., 1956) and the quantitative GC-MS estimation (section 3.3) on OS-
BSAB, the most abundant fraction. Accordingly to the first method, precise volumes of the OS-BSAB 
sample and of the OS standard solution (1.9 mg ml-1) were diluted with water until a final volume of 
200 μl and equal volumes of a 5% phenol solution were added. Finally, 1 ml of concentrate H2SO4 was 
added to the solutions and, after vigorous mixing, carbohydrate containing samples appeared orange-
yellow and the UV measures were performed at 490 nm.  With regard to the GC-MS quantification, 
mannose monosaccharide (calibration standard) and OS-BSAB were converted in acetylated O-methyl 
glycosides and analyzed according to the procedure and parameters described in the section 9.1. 
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9.6 Isolation of the 4-deoxy--D-arabinohexose  
 
LPS was hydrolyzed with AcOH 1% (100 °C, 2 h), the precipitate (Lipid A) was collected for 
centrifugation (9800 g, 4 °C, 15 min) and the supernatant (30 mg) was fractionated on Biogel-P2  
(Biorad, 1.5 x 98 cm, eluent NH4HCO3 50 mM, flow 0.2 ml min-1). On the basis of 1H-NMR, the 
fraction (6 mg) eluted in the void volume of the column was the O-antigen still derivatized with the  
4dAraHex. Therefore, the O-antigen, was hydrolyzed with TFA 10 mM (10 mg ml-1) at 100 °C for 3 h. 
The reaction was monitored by TLC (CHCl3: CH3OH: H2O 14:6:1, L-Rha as reference). After 
neutralization with NH4HCO3, the solution was chromatographed on Biogel-P2 (Biorad, 1 x 47 cm, 
eluent water, flow rate 0.1 ml min-1) and fractions were combined on the basis of TLC (isopropanol: 
water 8:2, L-Rha as reference) migration. Monosaccharide isolated was directly used spectroscopic 
studies.  
 
9.7 Isolation of oligosaccharides from LOS of A. baumannii strain SMAL 
 
LOS (20 mg) obtained from PCP extraction was totally deesterified by hydrazinolysis and deamidated 
by strong alkaline hydrolysis as described in the section 9.3. Oligosaccharides were desalted on a 
Sephadex G-10 column (GE-Healthcare , 96.5 x 1.5 cm, eluent water, flow 0.2 ml min-1) and purified 
by HPLC (Agilent 1100) on a TOSOH TSK3000 PWXL size exclusion column (87. 6mm x 30 cm, 
7μm; TOSOH precolumn 6.00 mm x 4 cm) eluted with water at 0.8 ml min-1  (OS2  product , 3 mg). 
Another LOS portion (15 mg) was hydrolysed with AcOH 1% (100 °C, 2h); the precipitate (Lipid A,  
5 mg) was collected for centrifugation ( 9800 g, 4 °C, 15 min) and washed with water. The 
supernatants were combined, freeze-dried and chromatographed on TSKHW-40 size exclusion 
column. The OS3 (8 mg) was the first product eluted and was used directly for NMR studies. 
 
9.8 Chemical treatments on CPSs from A. baumannii strains SMAL and MG1  
 
Deacetylation of SMAL CPS was performed treating the purified water extract (10 mg) according to 
the strong alkaline hydrolysis protocol (section 9.3). The sample was desalted by size exclusion 
chromatography on Biogel-P2 (Biorad, 1.5 x 120 cm, eluent NH4HCO3 50 mM, flow 0.2 ml min-1) 
where it was recovered in the void volume of the column (4 mg).  
Smith degradation (Defaye and Wong, 1986) was accomplished on the UC purified CPS (15 mg) of A. 
baumannii SMAL. The sample was solved in 1 ml of water and treated with an equal volume of 0.1 M 
NaIO4  for 72 h at 4 °C. Sample was reduced (NaBH4, 10 mg), neutralized with AcOH and dialyzed 
(cut-off 3500 Da). Finally, it was hydrolyzed (1 % AcOH, 2 h, 100 °C), centrifugated and the 
supernatant was purified on Biogel P2 (as above). 
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Solvolysis procedure with triflic acid (0.5 ml, -20 °C for 3 h ) was performed on the water extract of A. 
baumannii MG1 (20 mg) under anhydrous conditions. The solution was neutralized with NH4OH 28% 
(Perepelov et al., 2000) and was fractioned on Biogel P2 (as above). The product was further purified 
on by HPLC (Agilent 1100) on a RP-C8 (Supelco Supelcosil, 15 mm x 4.6 cm) column, eluted with 
water at 0.8 ml min-1  in isocratic condition  monitoring the eluate with the RI and UV detector at 210 
nm. 
 
9.9 LPS purification and isolation of the Enterobacterial common antigen from E. coli O157:H- 
 
UC sediment of the water extract (10 mg) at 20 °C, were partially delipidated with NaOH 10 mM at 37 
°C for 2 h. After neutralization the solution was chromatographed on Q-Sepharose Fast flow (GE-
Healthcare, 1 x 3.5 cm, 0.2 ml min-1) ion exchange column, eluted with a NaCl gradient (10 mM, 200 
mM, 400 mM, 700 mM, 1 M). The fractions were monitored using phenol-H2SO4 test (section 9.5) 
and combined accordingly Chemical and electrophoretic screening of the pooled fractions revealed 
that the LPS was eluted with NaCl 10 mM and 200 mM (3 mg and 2 mg, respectively). 
The first UC supernatant of the water 	<
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 -agarase 
(Sigma, cod. A6306) in a 50 mM potassium buffer pH 6.0 at 43 °C. The hydrolysis was monitored 
with the Nelson-Somogyi reducing sugar test (Somogyi, 1952), using Gal (1 mg ml-1) for calibration. 
The sample, after agarase treatment, was dialysed, freeze-dried (60 mg) and fractionated on size 
exclusion column Sephacryl HR-100 (GE-Healthcare, 1.5 x 100 cm, eluent NH4HCO3 50 mM, flow 
0.2 ml min-1). The fraction containing ECACYC (15 mg) was retained from the gel and recovered after 
about one column volume. This fraction was further chromatographed on Biogel-P30 (Biorad, 1.5 x 74 
cm, eluent NH4HCO3 50 mM, flow 0.2 ml min-1) and ECACYC was recovered in the void volume of the 
column. The last fractionation was performed on Biogel P-100 (Biorad, 1.5 x 74 cm, eluent NH4HCO3 
50 mM). The proton NMR of the single fractions allowed to isolate pure ECACYC (2 mg) and ECBCYC 
(1 mg).  
The O-antigen used for spectroscopic analyses was obtained from the LPS after acid hydrolysis as 
described in the section 9.7.  
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CHAPTER X 
 
MASS SPECTROMETRY 
 
10.1 Preparations of Lipid As 
 
Free lipid A was obtained by hydrolysis of LPS with 1% acetic acid at 100 °C for 2 h.  After 
centrifugation (9800 g, 4 °C, 20 min), Lipid A was collected as a precipitate, washed two or three 
times with water and finally freeze-dried. 1-5 mg of Acinetobacter baumannii SMAL LOS returned 
0.3 -1 mg of Lipid A. The purified Lipid A. from Cupriavidus necator was obtained first washing 
crude water extract (50 mg) with 15 ml of a CHCl3: CH3OH: H2O (16: 8: 1 v/v/v) mixture for 
phospholipids removal. Then, the dry water extract was further purified by ultracentrifugation 
(440000g, 4°C, 16 h) and UC solid (40 mg) was treated with AcOH 6 %. However, the sample was 
not completely soluble in the acid solution, so it was centrifugated and the clear supernatant was 
treated for 3 h at 100 °C. The Lipid A was collected by centrifugation and freeze dried (0.8 mg).  
The selective ester-bound acyloxyacyl deacylation was promoted by NH4`
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25 °C, 16 h) directly on Lipid A (0.2-0.6 mg) of Cupravidus necator and Acinetobacter baumanni 
strain SMAL at 28 °C (Silipo et al., 2002). Furthermore, Lipid A (0.2 mg) of Cupriavidus necator was 
dephosp	

		
|
??


`







@ 
 
10.2 Electrospray Ionization Fourier-Transform Ion Cyclotron Resonance Mass Spectrometry  
 
ESI-FT-ICR-MS  analysis was performed in negative and positive ion mode using a hybrid Apex Qe 
FT-ICR-MS (Bruker Daltonics, Billerica, MA, USA), equipped with a 7 T superconducting magnet 
and the Apollo dual ion source. The instrument was controlled by Bruker’s ApexControl software, 
version 2.0.0.36, and data was recorded in broadband mode with 512 k data sampling rate. Mass scale 
was calibrated externally, using compounds of known structure. For the negative ion mode samples (~ 
10 ngμl-1) were dissolved in a 50:50:0.001 (v/v/v) mixture of 2-propanol, water, and triethylamine 
(pH ~ 8.5). For the positive ion mode  a 30:10:0.4 (v/v/v) mixture of water, acetonitryl, and acetic acid 
(pH ~ 3) was used. The samples were sprayed at a flow rate of 2 μlmin-1. Capillary entrance voltage 
was set to 3.8 kV, and drying gas temperature to 150°C. The spectra, which showed several charge 
states for each component, were charge deconvoluted, using the DataAnalysis Software (Bruker 
Daltonics) and mass numbers given refer to monoisotopic molecular masses. For unspecific 
fragmentation the voltage in the external collision cell was increased from 3V to 30V. Infrared multi-
photon dissociation (IRMPD) of isolated parent ions was performed with a 25 W, 10.6 μm CO2 laser 
(Synrad, USA).  
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The unfocused laser beam was directed through the centre of the trap. Duration of laser irradiation was 
adapted to generate optimal fragmentation and varied between 10 - 80 ms. Fragment ions were 
detected after a delay of 0.5 ms. Details on the structural characterization of LPS by FT ICR-MS are 
given elsewhere (Kondakova and Lindner, 2005). 
 
10.3 MALDI-TOF mass spectrometry  
 
The analyses were conducted using a Applied BioSystems (Framingham, MA) Voyager STR 
instrument equipped with delayed extraction technology. The matrix solution was prepared by 
dissolving 2,5-dihydroxybenzoic acid in TFA 0.1 M : CH3CN (30:70 by volume) at a concentration of 
20 mg ml-1. Freeze-dried Lipid As were dissolved in CHCl3:CH3OH:H2O (2:3:1 by volume), while the 
ECACYC and ECBCYC in water. The sample matrix solution mixture (1:1 v/v, 1 μl) was deposited into a 
stainless steel gold-plate 100 sample MALDI probe tip and dried at 25 °C. Ions formed by a pulsed 
UV laser beam (nitrogen laser, = 337 nm) were accelerated through 25 KV. Mass spectra were 
recorded in negative linear ion mode, using a delay time of 150 ms, grid voltage of 0.5% and 1000 
shots/spectrum and laser intensity of about 2000. 
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CHAPTER XI 
 
NMR SPECTROSCOPY 
 
11.1 Oligosaccharides from Rhizobium radiobacter Rv3 
 
NMR experiments were carried out on a Bruker DRX-600 spectrometer equipped with a CryoProbe 
operating at 303 K. Chemical shift of spectra recorded in D2O are expressed in  relative to internal 
acetone (1H at 2.225 ppm, 13C at 31.45 ppm). Two-dimensional spectra (DQ-COSY, TOCSY, 
TROESY, gHSQC, gHMBC and gHSQCTOCSY) were measured using standard Bruker software. For 
the homonuclear experiment, 512 FIDs of 2048 complex data points were collected, with 40 scans per 
FID, mixing times of 120 ms for TOCSY and gHSQCTOCSY, and 250 ms for TROESY spectra 
acquisition. The spectral width was set to 10 ppm and the frequency carrier was placed at the residual 
HOD peak. For the HSQC spectrum, 512 FIDS of 2048 complex points were acquired with 50 scans 
per FID, the GARP sequence was used for 13C decoupling during acquisition. gHSQCTOCSY and 
gHMBC were not measured for OS2 due to the low amount of compound available. Data processing 
was performed with standard Bruker Topspin 3 program, the spectra were assigned using the computer 
program Pronto (Kjaer et al., 1994). 
 
11.2 O-Chain from Cupriadivus necator 
 
Spectra of LPS were recorded at 303 K in D2O con a Bruker DRX-600 spectrometer equipped with a 
CryoProbe and were calibrated on internal acetone. Two dimensional homonuclear spectra (DQ-
COSY, TOCSY, NOESY) were recorded with 1024 FIDs of 2048 data points and 16 scans per FID. 
For heteronuclear HSQC and HMBC spectra, 512 FIDS of 2048 complex points were acquired with 
24 and 240 scans per FID, respectively. Spectra of 4-deossi--D-arabinohexose were recorded at 298 
K. For Two-dimensional experiments (DQ-COSY, TOCSY, TROESY, HSQC),  512 FIDs of 2048 
complex data points were collected with 8 scans per FID for COSY and 24 for the others. Data were 
transformed, processed and analysed with Bruker Topspin 2.1 software.  
 
11.3 Oligosaccharides from Acinetobacter baumannii SMAL and MG1 
 
1H and 1H-13C NMR experiments on OS2 were carried out with a Varian Inova 500 spectrometer form 
Consortium INCA (L488/92, Cluster 11) equipped with a reverse probe operating at 296 K. The 
spectra of OS3 were recorded at 300 K with a Bruker DRX-600 spectrometer equipped with a 
cryogenic probe. All spectra were calibrated with respect to internal acetone. For all homonuclear 
experiments were measured with data sets of 2048 x 512 points, 32 scans were acquired, and mixing 
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times of 200 and 120 ms were employed for ROESY and TOCSY experiments, respectively. Each 
data matrix was zero-filled in both dimensions to give a matrix 
of 4096 x 2048 points and was resolution-enhanced in both 391 dimensions by a shifted sine-bell 
function before Fourier transformation. The HSQC experiment was performed by using a data set of 
2048 x 512 points, whereas for the HMBC experiment a data set of 2048 x 256 points was used. For 
each t1 value, 64 scans were acquired, and the HMBC sequence was optimized for a 6 Hz long- 396 
range coupling constant. All NMR spectra were acquired and transformed by using the Topspin 3.0a 
program and studied with Pronto software. 
 
11.4 Capsular polysaccharides from Acinetobacter baumannii SMAL and MG1 
 
A. baumannii MG1 homo- and heteronuclear spectra were recorded using Varian Inova 500 MHz 
spectrometer equipped with a inverse z-gradient probe (Consortium INCA, L488/92, Cluster 11) 
operating at 298 K. With regard to A. baumannii SMAL, spectra were acquired on a Bruker 600 MHz 
equipped with a CryoProbe, operating at 291 K for the fully deacetylated capsule, or at 305 K for the 
periodate degraded product. Chemical shifts are expressed in ppm relative to internal acetone (1H at 
2.225 ppm, 13C at 31.45 ppm). Two-dimensional spectra (DQ-COSY, TOCSY, NOESY, gHSQC and 
gHMBC) were measured using the standard Varian or Bruker software. 
For the homonuclear experiment, 512 FIDs of 2048 complex data points were collected, with 40 scans 
per FID, a mixing time of 120 or 200 ms was applied for the TOCSY and NOESY spectra, 
respectively. For the HSQC and HMBC spectra, 256 FIDS of 2048 complex points were acquired with 
50 scans per FID. Processing of the Varian and Bruker data and analysis was performed with Bruker 
TopSpin 2.1 program. 
 
11.5 O-Chain and the Enterobacterial common antigen from E. coli O157: H- 
 
The two forms of the Enterobacterial common antigen (ECA and ECB) were analysed at 308 K in 
D2O on a Bruker DRX-600 spectrometer equipped with a CryoProbe; O-Chain from phenolic LPS at 
300 K (calibrated on internal acetone). ECA and ECB two-dimensional experiments 512 FIDS of 2048 
complex data points were collected; DQ-COSY with 24 scans, NOESY and TOCSY 32 scans, HSQC 
40 scans, HMBC 64 scans and HSQCTOCSY 110 scans per FID. COSY, NOESY, TOCSY and 
HSQC relative to the O-Chain were recorded with  40, 48, 40, 140 scans per FID. Processing and 
analyses of spectra were performed with Bruker Topsin 2.1 software.  
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PART IV: STRUCTURAL CHARACTERIZATION OF MENB OMVS MEMBRANE CONSTITUENTS 
 
This part of the thesis regards a project developed in collaboration with the Novartis Vaccines 
Diagnostic of Siena and it is reported as accepted by a clearance process. 
  
1: Introduction 
 
1.1 Neisseria meningitidis and the new vaccine approach against group B based on Outer 
Membrane Vesicles (OMVs) 
 
Neisseria meningitidis is an encapsuled diplococcal Gram-negative bacterium. Commonly it colonizes 
the mucosal membranes of the human nasopharynx but when it enters in the bloodstream can cause 
meningitis and sepsis. Most infection cases are acquired by person-to-person contact through aerosol 
droplets or contacts with respiratory secretions from asymptomatic carriers. Neisseria has been 
isolated only in humans because cannot get iron other than from human sources (transferrin and 
lactoferrin). Meningococcal meningitis remains a worldwide problem and occurs in both endemic and 
epidemic forms. 
12 distinct N. meningitidis serogroups have been defined on the basis of the immunochemistry of their 
CPSs (table 1); groups A, B, C, WI35 and Y are the foremost responsible of severe meningitis and 
septicemia especially in infants and young children. 
 
Serogroups Structure of CPS repeating unit 
A 6)--D-ManpNAc(3OAc)-(1PO4 
B 8)--D-Neup5NAc-(2 
C 9)--D-Neup5NAc(7/8OAc)-(2 
H 4)--D-Galp-(12)-glycerol-PO4-(1 
I 4)--L-GulpNAcA-(13)--D-ManpNAcA(4OAc)-(1 
K 3)--D-ManpNAcA-(14)--D-ManpNAcA(4OAc)-(1 
L 3)--D-GlcpNAc-(13)--D-GlcpNAc-(13)--D-GlcpNAc-PO4-(1 
X 4)- -D-GlcpNAc-PO4-(1 
Y 6)--D-Glcp-(14)--D-NeupAc-(2 
W135 6)--D-Galp-(14)--D-NeupAc-(2 
Z 4)--D-GalpNAc-(11)-glycerol-(3PO4-(1 
29E 7)--D-Kdo-(23)--D-GalpNAc-(1 
 
Table 1: Neisseria meningitidis serogroups classification on the base of CPSs structures 
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Group A is characterized by its propensity to cause large-scale epidemics in developing countries, as 
Africa and Asia (Wang et al., 1992). Meningococcus B (MenB) is the most important cause of 
endemic meningitis in industrialized countries, accounting for 30%–40% of cases in North America 
and for up to 80% in certain European countries, and most of the remaining cases are caused by group 
C. MenB is especially diffused in Norway, Netherlands, Germany and Denmark, while increasing 
proportions of group C strains have been reported from Slovak and Czech Republics, Greece, 
Republic of Ireland, Spain (Berron et al., 1998), Canada and the United Kingdom (Ramsay et al., 
1997). Group B also can cause severe persistent epidemics, such as that occurred in Latin American 
countries or in Norway and New Zealand (Martin et al., 1998). Approximately 10%-15% of the 
disease in the United States is caused by groups Y and W135, however since 2000 group W135 has 
caused outbreaks in Saudi Arabia, Burkina Faso, making complex the epidemiological situation in this 
region (Mayer et al., 2002).  
Groups A, C, Y and W135 infections are prevented by vaccines based on high molecular weight CPS. 
Groups A and C were licensed in 1976 in the USA and Europe, tetravalent ACYW135 in USA in 1982 
(Brandt et al., 1978; Vodopija et al., 1983) These vaccines unfortunately failed in induce an 
immunological memory and were poorly effective in young children and infants. Consequently, 
efficacious CPS-protein conjugate vaccines (table 2) have been developed, these are safe, 
immunogenic in young infants and induce long-term immune memory (Pon and Jennings, 2008).  
 
Table 2: Glycoconjugate commercial vaccines against serogroups A, C, W135, Y. 
 
Group B is the only serogroup whose infection cannot be prevented by CPS-based vaccines. Its CPS is 
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on gangliosides of human cell surfaces including the neural cellular adhesion molecule involved in 
cell-to-cell adhesion, so that the immune system does not produce antibodies against an antigen having 
similarity to self-structures.  
 
 
Commercial Vaccine Serogroup Protein Carrier Producer 
Manjugate C CRM197 DTd Chiron (1999) 
Menivact C CRM197 DTd Aventis-Pasteur(2002) 
Meningitech C CRM197 DTd Wyeth (2002) 
NeisVac-C C TTd Baxter Vaccini (2002) 
MCV4 Tetravalent ACYW135 TTd Sanofi-Pasteur (2005) 
Pnc9-MenC 9 valent MenC/S.pneumoniae CRM 197 Wyeth (2000) 
MenAfriVac A TTd Serum Institute of India 
for Meningitis vaccine 
project (2010) 
Part IV 
85 
 
Another possible explanation is that CPS is easily degraded by neuraminidase or the acidic pH 
promotes the formation of internal esters with resulting loss of 
antigenicity. An attempt was made to develop a conjugated 
vaccine using group B capsular PS in which the N-acetyl 
group of the sialic acid residues were replaced with N-
propionyl group (Sanofi-Pasteur), (Bruge et al., 2004). The 
vaccine was tested in a Phase I trial on adult volunteers and 
found to be safe, but the antibodies induced were devoid of 
functional activity. New vaccine approaches against serogroup B 
meningococcus have been explored, such as the reverse vaccinology (Rappuoli and Covacci, 2003), 
and the preparation of Outer-Membrane Vesicles (OMVs) (Fischer et al., 1999). OMVs are small 
membranous spherical vesicles containing capsular polysaccharide, outer membrane proteins (OMPs) 
and lipooligosaccharides (LOSs). 
The OMV antigen is produced by fermentation of an appropriate Neisseria meningitidis strain, 
followed by concentration and bacterial inactivation, lysis and elaboration of OMV through iterated 
steps of centrifugation and sonication; OMVs are separated, than characterized according size and 
morphology. 
A vaccine based of OMVs is already available (MeNZB, Novartis), it is effective against homologous 
strains but it fails against heterologous bacteria because of antigenic variability. One of the outer 
meningococcal OMPs, PorA, was identified as a major inducer of bactericidal antibodies and is 
expressed by almost all meningococci. However, there is a large number of PorA proteins with 
different antigenic specificities so that the elicitation of an immune response against one PorA antigen 
does not confer protection against strains with heterologous PorA antigens. OMVs vaccines are thus 
strain-specific vaccines that can only be used against clonal disease outbreaks but not for prevention of 
sporadic disease caused by heterologue strains. PorB and FetA, two other OMPs, may be interesting 
vaccine candidates and probably only a limited number of combinations of these proteins needs to be 
used for an effective vaccine (Urwin et al., 2004). 
 
2: Results and discussions 
 
2.1 Structural characterization of the polysaccharide components on Outer Membrane Vesicles 
(OMVs) of Neisseria meningitidis serogroup B (MenB) 
 
The following discussion regards the analyses performed on the polysaccharide components 
constituting the MenB OMVs produced by Novartis Vaccines Diagnostic of Siena.  
In the frame of this work, different points were defined as targets and analyzed: preliminary 
spectroscopic analysis on intact OMVs were performed in order to try an identification of the 
Figure 1: Depiction of  OMV 
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contribution of LOS and CPS to the sialic acid content on the vesicles. Further analyses were focused 
on the isolation and structural characterization of LOS. In particular chemical analyses of 
monosaccharides were accomplished to determine LOS immunotypes of the strain used for vaccine 
production. Lipid A family were structurally defined through MALDI mass spectrometry. Finally, the 
content of LOS and CPS outside vesicles was determined, as well. Novartis vaccine lots are named in 
the text with capital letters, for simplicity. 
 
2.1.1 NMR analyses of native capsular polysaccharide and of intact OMVs 
 

 	
 
 	#{
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	
 
 -(28)-N-acetyl-sialic acid, was used as 
reference and it was characterized through mono (figure 2) and bidimentional NMR experiments. The 
assignment of chemical shifts (table 3) was in agreement with literature data (Bhattacharjee et al., 
1975). 
 
 
 
 
 
 
 
 
 
 
 
Figure 2: 1H NMR spectrum of MenB CPS in D2O, 600 MHz, 298 K, acetone as internal standard 
 
 
Table 3: Chemical shift (ppm) of MenB CPS in D2O, 600 MHz, 298 K, acetone with internal standard 
* Determined through 1H-13C-HMBC spectrum. 
 
Spectroscopic analysis on intact vesicles was performed after D2O exchange through vivaspin system, 
and 1H NMR spectrum (figure 3) showed only signals of soluble components, whereas the insoluble 
material conferred to the base line an arched shape. In these conditions, neither signals of CPS or LOS 
were observed; it was concluded that spectroscopic approach did not allow their direct estimation on 
the vesicle. 
Nucleus 
3-3’ 4 5 6 7 8 9-9’ C=O (NHCOCH3) 
1H 1.75-2.67 3.72 3.80 3.72 3.91 4.12 3.77-4.12 1.98 
13C 41.7 69.6 53.8 74.5 70.7 78.6 62.7 176.3* 
1.82.02.22.42.62.83.03.23.43.63.84.0 ppm
O
COO-
O
H
H
H
HO
H
AcHN
HOH2C
H
H
OH
H
O
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Figure 3: 1H NMR spectrum of intact vesicle exchanged with D2O, 600 MHz, 298 K 
 
2.1.2 Electrophoretic and Spectroscopic analyses of LOS and CPS extracted from OMVs 
 
OMVs were treated according to the hot phenol/water method (Westphal et al., 1965). Silver nitrate 
staining (figure 4, lanes 1 and 2) showed the presence of LOS both in water and in phenol phases, 
however this latter contained proteins and only minor amount of LOS (figure 4 lane 2’). This behavior 
of repartition was reproducible for all samples tested, and figure 4  shows the results for sample A3. 
Further analyses were focused on water extracts. 
 
 
 
Figure 4: SDS-PAGE of A3 sample. R: E.coli O55:B5 LPS standard (8 g); 
__[
!`Z|\
\++[

!`Z|
respectively with silver and coomassie. 
 
1H NMR analysis of water extracts did not give information on LOS because of the low mobility in 
solution of this molecule, but it was possible to detect the capsular polysaccharide signals (1H NMR 
figure 5). Although the spectra contained other dialysis impurities, the CPS signals were recognized in 
the gHSQC spectrum (figure 6) on the basis of the values reported in table 3. 
 
1.01.52.02.53.03.54.04.55.0 ppm
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Figure 5: 1H NMR of water extracts of A2 (bottom) and A3 (top )samples. D2O, 600 MHZ, 298 K, calibrated on N-acetyl sialic 
acid signal (2.08 ppm). Blue semi-squared indicated impurities, red arrows CPS signals.  
 
 
Figure 6: 1H-13C-gHSQC of A3 water phase, D2O 600 MHz, 298K.. calibrated on N-acelyl sialic acid signal (2.08 ppm). 13C 
signals were underlined with blue circles. 
 
DOSY experiment on A3 sample was measured to estimate the mobility in solution of CPS. The 
mobility of the CPS from OMV was higher (figure 7-a ) with respect to that of the intact CPS (figure 
7-b) this could be attributable to a depolymerization process promoted by the phenol/water extraction. 
To prove this hypothesis, intact CPS was submitted to the same extraction and DOSY spectrum was 
recorded (figure 7-c).  
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The mobility of the sample was intermediate between that of the intact sample and that extracted from 
the OMV; this experiment proved that the hot treatment induced a depolymerization of the sample but 
also that the entity of this depolymerization was different from that observed for the sample extracted 
from the OMV. In conclusion, the loss of molecular weight of CPS contained in water phase was 
related only in part to the hot extraction treatment and the contribute from the sonication treatments 
used for vesicles assembling seems possible. 
 
Figure 7: DOSY spectra, D2O, 600 MHz, 298 K, acetone as internal standard. a: A3 water phase, b: intact CPS of MenB, c: 
CPS of MenB after water/phenol extraction. 
 
 
2.1.3 GC-MS quantification of LOS immunotypes 
 
Neisseria meningitidis is classified in immunotypes on the basis of LOSs structures.  
Among the 12 LOSs structures only 9 are known in detail and indicated with L, the different 
immunotypes share a conserved core oligosaccharide (figure 8), and distinct R1, R2, R3, R4 
substituents.  
 
Figure 8: Conserved Core oligosaccharide of Neisseria meningitidis 
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The relationship among the R substituents and the immunotypes classification is showed in table 4.   
 
 
Table 4: Neisseria meningitidis immunotypes 
 
-chain (R2
 
 
 -D-Glucose residue diagnostic of L2 and L5 immunotypes or it is a 
phosphoethanolamine (PEA) in L1, L3, L7 and L8 LOS species. 
The structures of L8, L10, L11, L12 are not defined, however L8 has an immunochemical behavior 
similar to L1. This differs from L3, L7, L9 for the nature of the R1 	

	
-chain, whereas 
the difference between L1 and sL1 (sialilated), L3 and L7, L2 and L4 regards the presence of sialic 
acid. R3 and R4 are not relevant for L1, sL1, L3, L7, L9 immunotypes classification.  
	
 		
 
 	
 
 	
 		
 
 	
 -chain allows the individuation of 
different immunotypes (or combination of them). 
Indeed, GC-MS branching point analysis was used to establish the relative ratio of specific 
immunotypes. Immunotype of the strain of MenB used for OMVs preparations was unknown, so the 
following discussion started from the assumption that only the most probable immunotypes for group 
B, L1, sL1, L3, L7 were present, L9 was considered equivalent to L7 because it possesses the same R1 
group.  
The speciation of L1, sL1, L3, L7 immunotypes took into account the following characteristic residues 
	

	
-chain: 
	 4-linked-galactose (4-gal) was representative of L1 and sL1 
	 6-linked-galactose (6-gal) was representative of sL1 
	 4-linked-2-amino-hexose (4-hexN), considered gluco-configured, was representative of L7 
and L3 
Another important residue was 3-linked-galactose (3-gal): this PMAA derivative is representative of 
L7 and L3 LOS immunotypes; in this last species, 3-gal is contained twice so that the following 
formula can be associated to the area of 3-gal: L7 + 2 * L3. 
 R1 
 -chain) 
R2  
	
 
R3 
	
 
R4  
	
 
L1 -D-Gal-(14)--D-Gal 3-PEA H H 
sL1 -Neu-(26)--D-Gal-(14)--D-Gal 3-PEA H H 
L2 -D-Gal-(14)--D-GlcNAc-(13)--D-Gal -D-Glc 6-7 PEA Ac 40% 
L3 -Neu-(23)--D-Gal-(14)--D-GlcNAc-(13)--D-Gal 3-PEA H H 
L4 -Neu-(23)--D-Gal-(14)--D-GlcNAc-(13)--D-Gal H 6-PEA 3-Ac 50% 
L5 -D-Gal-(14)--D-GlcNAc-(13)--D-Gal -D-Glc H Ac 60% 
L6 -D-GlcNAc-(13)--D-Gal H 7-PEA H 
L7 -D-Gal-(14)--D-GlcNAc-(13)--D-Gal 3-PEA H H 
L9 -D-Gal-(14)--D-GlcNAc-(13)--D-Gal 6-PEA H H 
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On the basis of the consideration above, LOS immunotyping of OMV samples was performed 
considering the area of the PMAA reported in table 5, so that quantification of sL1, L1 and the sum of 
L3 plus L7 was achieved. 
The use of formulas 3-gal = (L7 + 2 * L3) and 4-hexN = (L7 + L3) to determine the amount of the 
single L3 and L7 components, returned for some samples negative values, for this reason these LOS 
species were not calculated  but only their sum (L3 + L7) was considered (see table 5). A possible 
explanation for the occurrence of negative values could be that the 4-hexN area was computed without 
any corrective factor, or also that the sample contained other immunotypes different from those 
considered in our assumption; in fact 4-
 

		
 
 	
-chain of L2, L4, L5; if so, the 
formulas associated to the 3-gal and 4-hexN areas are not valid and yield to an erroneous result. 
 
 
 
 
 
 
 
 
 
 
 
Table 5: Areas of diagnostic residues relative to A3, B2, B4, C3, D1 samples 
 
On the basis of these premises, immunotypes composition was estimated for five different samples 
(table 6, figures 9 - 13) 
 
Immunotype Calculated as 
A3 
area % 
B2 
area % 
B4 
area % 
C3 
area % 
D1 
area % 
L1 4-gal - 6-gal 63,7 63,7 54,9 66,7 67,4 
sL1 6-gal 17,9 14,8 19,9 18,8 20,2 
L3 +L7 4-hexN 18,4 21,5 25,3 14,5 32,6 
 
Table 6: Immunotypes quantification  
 
These other derivatives were not considered:  
	 Neuraminic acid for sL1 and L3 because its detection requires different chemical treatments 
(carboxyl reduction) and generally it is not quantitative.  
	 The terminal galactose (t-gal) for L7 and L1 because its detector response is different from 
mono substituted residues. 
 
 
Residue Immunotype A3 area B2 area B4 area C3 area D1 area 
4-gal L1 + sL1 661172 1167363 374876 1207864 1483381 
6-gal sL1 145310 220656 99677 265378 341871 
4-hexN L7 + L3 149066 319877 147535 197648 196414 
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Intense peaks of t-glc and 4-glc were also present, but their abundance was not clear on the basis of the 
structure of the known immunotyes. 6-hexN (comparable to 4-hexN) residue could belong to unkown 
immunotypes structure or to Lipid A. 
The presence of 2-hex, 4,6-hex, 2,4-hex, 3,4-gal, residues was unclear, whereas some important 
residues such as heptoses of Core, and terminal glucosamine were absent. Phosphorylation of these 
residues can avoid the derivatization process consequently explain of their absence. 
 
 
Figure 9: A3 PMAA chromatogram. A, B, C were complex mixture of glycidic derivates. 
A and B: t-ketof +4-pent; C: 6-ketof + undefined derivate. “Hex” indicated an hexose with not attributed configuration. 
 
 
 
Figure 10: PMAA chromatogram of sample B2. A, B, C were complex mixture of glycidic derivates.  
A: t-ketof +4-pent, B: 4-pent, C: 6-ketof + undefined derivate.“Hex” indicated an hexose with not attributed configuration. 
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Figure 11: PMAA chromatogram of sample B4 .“Hex” indicated an hexose with not attributed configuration. 
 
 
Figure 12: PMAA chromatogram of sample C3.“Hex” indicated an hexose with not attributed configuration. 
 
Figure 13: PMAA chromatogram of sample D1. A and B: t-ketof +4-pent.“Hex” indicated an hexose with not attributed 
configuration. 
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2.1.4 MALDI MS spectrometry characterization of Lipid A  
 
Lipid A was obtained after mild acid hydrolysis of water phase and analyzed by MALDI MS 
spectrometry. 
The ion negative MALDI spectrum (figure 14) recorded on intact Lipid A showed the presence of 5 
groups of pseudomolecular ions [M-H]- labeled with capital letters A, B, C, D, E (table 7). Base peak 
B (m/z 1632.38) corresponded to penta-acylated Lipid A with two 3-hydroxytetradecanoic acids 
(C14:0) 3-OH, one 3-hydroxydodecanoic acid (C12:0) 3-OH, two dodecanoic acids C12:0. It differed 
from specie A for the lacking of one PEA unit on the glucosamine backbone. The less intense peak C 
(m/z 1572.73) was attributed to a tetra-acylated Lipid A with one C12:0 less with respect to A. The 
same composition of fatty acids but one PEA unit was observed for D, another tetra-acylated specie E 
was observed which differed from D for the substitution of (C12:0) 3-OH with a C12:0.  
It is proposed that peaks A1, A2, C1 and C2 were originated by fragmentation of A and C, in particular 
these peaks were attributed to the loss of -CH2-CH2-NH2 (- 44 u.m.a.) or -O-CH2-CH2-NH2 (- 60 
u.m.a.) fragments. Alternatively A1 and C1 might be related to B and E respectively, by addition of a 
phosphate.  
 
Figure 14: Ion negative MALDI spectrum of intact Lipid A from sample A3.(not calibrated) 
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Table 7: Composition of penta- and tetra-acyl Lipid A of MenB 
 
Oxonium ion (m/z 849,10) observed in the spectrum measured in the positive mode (not showed) was 
consistent with the presence of three fatty acids, in particular (C14:0) 3-OH, (C12:0) 3-OH and C12:0, 
on the non-reducing GlcN unit (GlcN II), (figure 15-2).  
The location of fatty acids (figure 15-1) was attributed on the basis of literature data (Kulshin et al., 
1992; John et al., 2009 ). Lipid A of other samples was investigated (figures 16-20) and the relative 
abundances of the species individuated in the MALDI spectra are reported in table 8. For simplicity all 
the values are normalized with respect to the pseudomolecular ion A1. 
 
 
Figure 15: 1: Proposed penta-acyl Lipid A structure. 2: Oxonium ion 
  
Species n. acyl Composition Ion (m/z) 
       A 5 2 x C14:0 3-OH, C12:0 3-OH, 2 x C12:0, 2PEA, 2 x GlcN, 2P 1754.59 
A1 5 B+80 (P) or A-44 1712.85 
A2 5 A- 60 1693.84
B 5 2 x C14:0 3-OH, C12:0 3-OH, 2 x C12:0, PEA, 2 x GlcN, 2P 1632.38. 
C 4 2 x C14:0 3-OH, C12:0 3-OH, C12:0, 2PEA, 2 x GlcN, 2P   1572.73 
C1 4 E + 80 or C-44 1529.36
C2 4 C-60 1512.86 
D 4 2 x C14:0 3-OH, C12:0 3-OH, C12:0, PEA, 2 x GlcN, 2P 1449.69 
E 4 2 x C14:0 3-OH, 2 x C12:0, PEA, 2 x GlcN, 2P 1433.49 
1                                                                       2 
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Table 8: Relative abundances of species identified in MALDI spectra for A3, A2, B3, C4, D3, E4 samples 
 
 
 
Figure 16: Ion negative MALDI spectrum of Lipid A from sample A2. (not calibrated) 
 
Figure 17: Expansion of ion negative MALDI spectrum of Lipid A from sample B3. (not calibrated) 
Sample                 Pseudomolecular ion 
 A A1 B C D E 
A3 1.25 1 2.5 0.5 0.5 0.37 
A2 0.5 1 1.67 - 0 .25 - 
B3 - 1 2.32 -- - 0.77 
C4 0.1 1 0.22 -- 0,1 - 
D3 - 1 1.18 -- 0.09 0.21 
E1 1.38 1 1.53 -- - - 
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Figure 18: Ion negative MALDI spectrum of Lipid A from sample C4. (not calibrated) 
 
Figure 19: Ion negative MALDI spectrum of Lipid A from sample D3. (not calibrated) 
 
 
Figure 20: Expansion of ion negative MALDI spectrum of Lipid A from sample E1. (not calibrated) 
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PEA bi-substituted specie (A) was present in four of six analyzed samples, PEA mono-substituted 
species (B and A1) were always present whereas, tetra-acylated (C, D, E) resulted in unimportant 
amount if not visible at all. 
Concluding, the strain analyzed produced predominantly a penta-acyl Lipid A with phosphate groups 
substituted with PEA units, as well. Structural variations regarded essentially the presence of PEA, 
phosphate, C12:0 or (C12:0) 3-OH that constituted the non stoichiometric substituents of Lipid A 
(Van Der Ley et al., 2001).  
Future studies could be focalized on the relationship between Lipid A and pirogenicity caused by 
bacterium, being Lipid A the immunostimulatory unit of LPS endotoxin.  
 
2.1.5.Chemical and electrophoretic analyses to determine the content of LOS and CPS outside the 
OMVs 
 
OMVs preparations were filtrated on vivaspin system and the permeates, after dyalisis, were extracted 
with hot water/ phenol mixture. SDS-PAGE analysis of water extracts showed clearly low molecular 
weight band of LOS only for sample F (figure 21, lane F), whereas phenol extracts (non showed) 
presented proteins traces.  
 
Figure 21: SDS-PAGE with silver stain. R: standard LPS E.coli O55:B5 (4μg); R’: LOS MenB (8 μg); samples: F, G, H, I, L, 
M, N (16 μg) 
 
Further information about the content of CPS and LOS in water extracts were obtained by GC-MS 
analyses of acetylated O-methyl glycosides. Chromatograms showed peaks of 3-deoxy-D-manno-
octulosonic acid (Kdo), diagnostic of LPS, and glucosamine (GlcN) only for samples F and G (figures 
22, 23). Kdo abundance was very low, and the occurrence of LOS presence cannot be excluded, 
because in the other samples Kdo amount may be under the analyses revelation limit. This 
consideration can be applied to the SDS-PAGE as well, in fact in this case sample G was LOS-
negative, while chemical analyses proved its presence. Differently from LOS, CPS was contained in 
all samples as proved by the presence of the diagnostic residue of Neuraminic acid (NeuA) in the 
chemical analyses (figures 22-27). 
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Figure 22: Expansion of GC-MS chromatogram of acetylated O-methyl glycosides of F 
 
Figure 23: Expansion of GC-MS chromatogram of acetylated O-methyl glycosides of sample G  
 
 
Figure 24: Expansion of GC-MS chromatogram of acetylated O-methyl glycoside of sample I 
 
 
Figure 25: Expansion of GC-MS chromatogram of acetylated O-methyl glycosides of L 
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Figure 26: Expansion of GC-MS chromatogram of acetylated O-methyl glycosides of M 
 
 
Figure 27: Expansion of GC-MS chromatogram of acetylated O-methyl glycosides of N 
 
 
 
3- Materials and Methods 
 
 3.1 Isolations of Lipopolysaccharide and Capsular Polysaccharide 
 
3.1.1 Outer Membrane vesicles of Neisseria meningitidis serogroup B 
 
Outer Membrane Vesicles preparations were dyalised and freeze dried prior extraction procedure. 
Vesicles were disrupted according to the water/phenol method (Westphal and Jann, 1965): dried 
vesicles were treated with 1 ml of water and an equal volume of 90 % phenol, solution was incubated 
at 68 °C for 15 minutes. Phenol-water phases separation was performed by spinning at 4 °C.  
Dialysis (cut-off 3500 Da) was used for phenol removal from the extractions phases which were 
finally freeze-dried.  
Water phases were obtained in yield of 0,3 mg/mg vesicle and phenol phases in yield of 0,7 mg/mg vesicle 
(average values). 
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3.2 General and analytical methods 
 
3.2.1 SDS-PAGE and chemical analyses of LOS and CPS from OMVs 
  
SDS-PAGE (Laemmli, 1970) of samples was performed on Mini Protean III Bio-Rad system run at 
150 constant voltage. Discontinuous gels were realized (5 % stacking gel, 15 % separating gel) and 
stained according to the silver stain procedure for lipopolysaccharide (Kittelberger and Hilbink, 1993) 
or with coomassie procedure for proteins (Zehr et al., 1989). In order to determine the content of LPS 
and CPS outside vesicles, OMVs solutions were filtrated on vivaspin system (cut-off 10000 Da) 
collecting a volume of permeate equal to the half of initial volume. Permeates were dyalised (cut-off 
1000 Da), freeze dried and extracted according to water/phenol protocol (section 3.1.1). Water and 
phenol extracts, after freeze drying (0.9 mg in average values), were screened through SDS-PAGE as 
described above. Water extracts were treated according to the procedure to perform the GC-MS 
analysis of sugars as acetylated O-methyl glycosides: samples were dried over P2O5 for 1 h under 
diminished pressure and treated with methanolic HCl at 80 °C for 16 h. Solvent was dried and the 
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°C for 5 min. 
GC-MS branching point analysis of monosaccharides was performed derivatizing monosaccharides as 
partially methylated alditol acetates (PMAA) (Ciucanu and Kerek, 1984). 
2 mg of water phase was solubilized in dry DMSO (1 ml) and the addition of powered NaOH (100 
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iodomethane (from 0°C to 25 °C, 16 h) and per-O-methylated lipooligosaccharide was extracted by 
adding water and chloroform to the reaction mixture. The organic layer was washed with 50 ml of 
water, dried under vacuum, dissolved in 4 M TFA. After 4 h at 120 °C, it was dried and acid traces 
were removed by isopropanol washing and drying. Partially methylated monosaccharides were 
converted in alditols by reduction with NaBD4 in ethanol (1 h, 25 °C), followed by borates treatment 
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80 °C, 30 min.) and salts removed with water-chloroform extraction. PMAA derivates dissolved in 
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-MS was an Hewelett–Packard 5890 instrument, equipped 
with a SPB-5 capillary column (Supelco, 30 m x i.d. flow rate, 0.8 mL/min, He as a carrier gas). EI 
mass spectra were recorded with an ionization energy of 70 eV and an ionizing current of 0.2 m A.  
 
 
 
Part IV 
102 
 
3.3 Preparations and Mass Spectrometry of Lipid A  
 
3.3.1 MALDI MS spectrometry of intact Lipid A  from N. meningitidis serogroup B 
 
Free lipid A was obtained after treatment of the water extract (2 mg) with 1% acetic acid (100 C, 3 h). 
After centrifugation (8,000 g, 20 min, 4 °C), the lipid A was collected as precipitate, washed twice 
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MALDI-TOF analyses were performed on Applied BioSystems (Framingham, MA) Voyager STR 
instrument equipped with delayed extraction technology. Dried Lipids A were dissolved in a mixture 
of CHCl3:CH3OH:H2O (2:3:1 by volume) and the matrix, 2,5-dihydroxybenzoic acid, was dissolved in 
TFA 0.1 M and CH3CN (30:70 by volume) at a concentration of 20 mg/ml. A sample matrix solution 
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through 25 KV. Mass spectra were recorded in negative and positive linear ion mode, using a delay 
time of 200 ms, grid voltage of 0.5% and 500 shots/spectrum and laser intensity of 2200.  
 
3.4 NMR spectroscopy 
 
3.4.1 Capsular polysaccharide of Neisseria meningitidis serogroup B 
 
All spectra were acquired on a Bruker 600 MHz equipped with a cryo probe at 298 K in D2O. 
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 2O) spectra were calibrated with internal acetone (1H at 
2.225 ppm, 13C at 31.45 ppm). Homonuclear 1H-1H-COSY and heteronuclear 1H-13C-HSQC spectra 
were recorded with 512 FIDs of 2048 complex data points, respectively with 8 and 16 scans per FID. 
1H-13C-HMBC was recorded with 256 FIDs of 2048 data points and 80 scans per FID. 
Spectra of water phases A2 and A3 were calibrated on N-acelyl sialic acid signal (2.08 ppm).  
For 1H-13C-HSQC 256 FIDs of 2048 complex data points were collected with 160 scans per FID. 
DOSY spectra were acquired at 298 K with the Bruker sequence stebpgp1s using data sets of 32K x 64 
points, 8 scans were acquired for each increment, and the two key paramete
_

 (250 and 4.8 
ms, respectively) were optimised on the 1D sequence. 
In all cases the spectral width was set to 10 ppm for homonuclear and 180 ppm for heteronuclear and 
the frequency carrier was placed at the residual HOD peak. Data were processed and analyzed with 
Bruker TopSpin 2.1 program. 
 
103 
 
References 
 
Akira, S., Uematsu, S., and Takeuchi, O. 2006. Pathogen recognition and innate immunity. Cell. 124 
(4):783-801. 
 
Alexander, C., and Rietschel, E.T. 2001. Bacterial Lipopolysaccharides and innate immunity. J. 
Endotoxin. Res. 7 (3):167-202. 
 
Astronomo, R.D., Kaltgrad, E., Udit, A.K., Wang, S.K., Doores, K.J., Huang, C.Y., Pantophlet, R., 
Paulson, J.C., Wong, C.H., Finn, M.G., and Burton, D.R. 2010. Defining criteria for oligomannose 
immunogens for HIV using icosahedral virus capsid scaffolds. Chem. Biol. 17 (4):357-370. 
 
Barua, S., Yamashino, T., Hasegawa, T., Yokoyama, K., Torii, K., and Ohta, M. 2002. Involvement of 
surface polysaccharides in the organic acid resistance of Shiga Toxin-producing Escherichia coli 
O157:H7. Mol. Microbiol. 43 (3):629-640. 
 
Bergogne-Berezin, E., and Towner, K.J. 1996. Acinetobacter spp. as nosocomial pathogens: 
microbiological, clinical, and epidemiological features. Clin. Microbiol. Rev. 9 (2):148-165. 
 
Berron, S., De La Fuente, L., Martin, E., and Vazquez, J.A. 1998. Increasing incidence of 
meningococcal disease in Spain associated with a new variant of serogroup C. Eur. J. Clin. 
Microbiol. Infect. Dis. 17 (2):85-89. 
 
Bhattacharjee, A.K., Jennings, H.J., Kenny, C.P., Martin, A., and Smith, I.C. 1975. Structural 
determination of the sialic acid polysaccharide antigens of Neisseria meningitidis serogroups B and 
C with carbon 13 nuclear magnetic resonance. J. Biol. Chem. 250 (5):1926-1932. 
 
Birnbaum, G., Roy, R., Brisson, J., and Jennings, H. 1987. Conformations of ammonium 
3-deoxy-d-manno-2-octulosonate (KDO) and methyl -and -ketopyranosides of KDO: X-ray 
structure and 1 H NMR analyses. J. Carbohydr. Chem. 6 (1):17-39. 
 
Bock, K., and Pedersen, C. 1983. Carbon-13 nuclear magnetic resonance spectroscopy of 
monosaccharides. Adv. Carbohydr. Chem. Biochem. 41:27-66. 
 
Bohin, J.P. 2000. Osmoregulated periplasmic glucans in Proteobacteria. FEMS Microbiol. Lett. 186 
(1):11-19. 
 
Brandt, B.L., Smith, C.D., and Artenstein, M.S. 1978. Immunogenicity of serogroup A and C Neisseria 
meningitidis polysaccharide vaccines administered together in humans. J. Infect. Dis. 137 
(2):202-205. 
 
Bruge, J., Bouveret-Le Cam, N., Danve, B., Rougon, G., and Schulz, D. 2004. Clinical evaluation of a 
group B meningococcal N-propionylated polysaccharide conjugate vaccine in adult, male 
volunteers. Vaccine. 22 (9-10):1087-1096. 
 
Burton, D.R., Pyati, J., Koduri, R., Sharp, S.J., Thornton, G.B., Parren, P.W., Sawyer, L.S., Hendry, 
R.M., Dunlop, N., Nara, P.L., and Et Al. 1994. Efficient neutralization of primary isolates of HIV-1 
by a recombinant human monoclonal antibody. Science. 266 (5187):1024-1027. 
 
Byrd, J., Zeph, L., and Casida Jr, L. 1985. Bacterial control of Agromyces ramosus in soil. Can. J. 
Microbiol. 31 (12):1157-1163. 
 
 
 
 
104 
 
Calarese, D.A., Lee, H.K., Huang, C.Y., Best, M.D., Astronomo, R.D., Stanfield, R.L., Katinger, H., 
Burton, D.R., Wong, C.H., and Wilson, I.A. 2005. Dissection of the carbohydrate specificity of the 
broadly neutralizing anti-HIV-1 antibody 2G12. Proc. Natl. Acad. Sci.  U S A 102 
(38):13372-13377. 
 
Calarese, D.A., Scanlan, C.N., Zwick, M.B., Deechongkit, S., Mimura, Y., Kunert, R., Zhu, P., 
Wormald, M.R., Stanfield, R.L., Roux, K.H., Kelly, J.W., Rudd, P.M., Dwek, R.A., Katinger, H., 
Burton, D.R., and Wilson, I.A. 2003. Antibody domain exchange is an immunological solution to 
carbohydrate cluster recognition. Science. 300(5628):2065-2071. 
 
Casida, L.E. 1988. Response in Soil of Cupriavidus necator and Other Copper-Resistant Bacterial 
Predators of Bacteria to Addition of Water, Soluble Nutrients, Various Bacterial Species, or Bacillus 
thuringiensis Spores and Crystals. Appl. Environ. Microbiol. 54 (9):2161-2166. 
Ciucanu, I., and Kerek, F. 1984. A simple and rapid method for the permethylation of carbohydrates. 
Carbohydr. Res. 131 (2):209-217. 
 
Corsaro, M.M., Gambacorta, A., Iadonisi, A., Lanzetta, R., Naldi, T., Nicolaus, B., Romano, I., 
Ummarino, S., and Parrilli, M. 2006. Structural Determination of the O-Chain Polysaccharide from 
the Lipopolysaccharide of the Haloalkaliphilic Halomonas pantelleriensis Bacterium. Eur. J. Org. 
Chem. 2006 (7):1801-1808. 
 
Corti, D., Langedijk, J.P., Hinz, A., Seaman, M.S., Vanzetta, F., Fernandez-Rodriguez, B.M., Silacci, 
C., Pinna, D., Jarrossay, D., Balla-Jhagjhoorsingh, S., Willems, B., Zekveld, M.J., Dreja, H., 
O'sullivan, E., Pade, C., Orkin, C., Jeffs, S.A., Montefiori, D.C., Davis, D., Weissenhorn, W., 
Mcknight, A., Heeney, J.L., Sallusto, F., Sattentau, Q.J., Weiss, R.A., and Lanzavecchia, A. 2010. 
Analysis of memory B cell responses and isolation of novel monoclonal antibodies with neutralizing 
breadth from HIV-1-infected individuals. PLoS One 5 (1):e8805. 
 
De Castro, C., Fregolino, E., Gargiulo, V., Lanzetta, R., and Parrilli, M. 2008. A novel capsular 
polysaccharide from Rhizobium rubi strain DSM 30149. Carbohydr. Res. 343 (9):1482-1485. 
 
De Castro, C., Molinaro, A., Lanzetta, R., Silipo, A., and Parrilli, M. 2008. Lipopolysaccharide 
structures from Agrobacterium and Rhizobiaceae species. Carbohydr. Res. 343 (12):1924-1933. 
 
Defaye, J., and Wong, E. 1986. Structural studies of gum arabic, the exudate polysaccharide from 
Acacia senegal. Carbohydr. Res. 150 (1):221-231. 
 
Dell, A., Oates, J., Lugowski, C., Romanowska, E., Kenne, L., and Lindberg, B. 1984. The 
Enterobacterial common antigen, a cyclic polysaccharide. Carbohydr. Res. 133 (1):95-104. 
 
Ding, L., Seto, B.L., Ahmed, S.A., and Coleman, W.G., Jr. 1994. Purification and properties of the 
Escherichia coli K-12 NAD-dependent nucleotide diphosphosugar epimerase, 
ADP-L-glycero-D-mannoheptose 6-epimerase. J. Biol. Chem. 269 (39):24384-24390. 
 
Dubois, M., Gilles, K., Hamilton, J., Rebers, P., and Smith, F. 1956. Colorimetric method for 
determination of sugars and related substances. Anal. Chem. 28 (3):350-356. 
 
Endimiani, A., Luzzaro, F., Migliavacca, R., Mantengoli, E., Hujer, A.M., Hujer, K.M., Pagani, L., 
Bonomo, R.A., Rossolini, G.M., and Toniolo, A. 2007. Spread in an Italian hospital of a clonal 
Acinetobacter baumannii strain producing the TEM-92 extended-spectrum beta-lactamase. 
Antimicrob. Agents Chemother. 51 (6):2211-2214. 
 
Erbel, P.J., Barr, K., Gao, N., Gerwig, G.J., Rick, P.D., and Gardner, K.H. 2003. Identification and 
biosynthesis of cyclic Enterobacterial common antigen in Escherichia coli. J. Bacteriol. 185 
(6):1995-2004. 
105 
 
Fedonenko, Y.P., Konnova, O.N., Zdorovenko, E.L., Konnova, S.A., Zatonsky, G.V., Shashkov, A.S., 
Ignatov, V.V., and Knirel, Y.A. 2008. Structural analysis of the O-polysaccharide from the 
Lipopolysaccharide of Azospirillum brasilense S17. Carbohydr. Res. 343 (4):810-816. 
 
Fischer, M., Carlone, G.M., Holst, J., Williams, D., Stephens, D.S., and Perkins, B.A. 1999. Neisseria 
meningitidis serogroup B outer membrane vesicle vaccine in adults with occupational risk for 
meningococcal disease. Vaccine. 17 (19):2377-2383. 
 
Fournier, P.E., Vallenet, D., Barbe, V., Audic, S., Ogata, H., Poirel, L., Richet, H., Robert, C., 
Mangenot, S., Abergel, C., Nordmann, P., Weissenbach, J., Raoult, D., and Claverie, J.M. 2006. 
Comparative genomics of multidrug resistance in Acinetobacter baumannii. PLoS Genet. 2 
(1):62-72. 
 
Fregolino, E., Fugazza, G., Galano, E., Gargiulo, V., Landini, P., Lanzetta, R., Lindner, B., Pagani, L., 
Parrilli, M., and Holst, O. 2010. Complete Lipooligosaccharide Structure of the Clinical Isolate 
Acinetobacter baumannii, Strain SMAL. Eur. J. Org. Chem. 2010 (7):1345-1352. 
 
Galanos, C., Luderitz, O., and Westphal, O. 1969. A new method for the extraction of R 
Lipopolysaccharides. Eur. J. Biochem. 9 (2):245-249. 
 
Gamian, A., Romanowska, E., Romanowska, A., Lugowski, C., Dabrowski, J., and Trauner, K. 1985. 
Citrobacter Lipopolysaccharides: structure elucidation of the O-specific polysaccharide from strain 
PCM 1487 by mass spectrometry, one-dimensional and two-dimensional 1H-NMR spectroscopy and 
methylation analysis. Eur. J. Biochem. 146 (3):641-647. 
 
Gargiulo, V., De Castro, C., Lanzetta, R., Jiang, Y., Xu, L.H., Jiang, C.L., Molinaro, A., and Parrilli, M. 
2008. Structural elucidation of the capsular polysaccharide isolated from Kaistella flava. Carbohydr. 
Res. 343 (14):2401-2405. 
 
Gargiulo, V., Garozzo, D., Lanzetta, R., Molinaro, A., Sturiale, L., De Castro, C., and Parrilli, M. 2008. 
Rhizobium rubi(T): a gram-negative phytopathogenic bacterium expressing the Lewis B epitope on 
the outer core of its lipooligosaccharide fraction. Chembiochem. 9 (11):1830-1835. 
 
Germida, J.J., and Casida, L.E. 1983. Ensifer adhaerens Predatory Activity Against Other Bacteria in 
Soil, as Monitored by Indirect Phage Analysis. Appl. Environ. Microbiol. 45 (4):1380-1388. 
 
Gerwig, G.J., Kamerling, J.P., and Vliegenthart, J.F.G. 1978. Determination of the and configuration of 
neutral monosaccharides by high-resolution capillary g.l.c. Carbohydr. Res. 62 (2):349-357. 
 
Goel, V.K., and Kapil, A. 2001. Monoclonal antibodies against the iron regulated outer membrane 
Proteins of Acinetobacter baumannii are bactericidal. BMC Microbiol. 1:16. 
 
Griffin, P.M., and Tauxe, R.V. 1991. The epidemiology of infections caused by Escherichia coli 
O157:H7, other enterohemorrhagic E. coli, and the associated hemolytic uremic syndrome. 
Epidemiol. Rev.13:60-98. 
 
Habeeb, A.F. 1966. Determination of free amino groups in proteins by trinitrobenzenesulfonic acid. 
Anal. Biochem. 14 (3):328-336. 
 
`}	|{
*@{
}{
@{
	{
#@{
{
@{
	{
 @{
	{
¡@{
`		{
`@{


Holst, O. 2008. Structural Analysis of the Capsular Polysaccharide from Acinetobacter lwoffii F78. 
Eur. J. Org. Chem. 2008 (36):6183-6188. 
 
 
 
106 
 
Haseley, S.R., Holst, O., and Brade, H. 1998. Structural studies of the O-antigen isolated from the 
phenol-soluble lipopolysaccharide of Acinetobacter baumannii (DNA group 2) strain 9. Eur. J. 
Biochem. 251 (1-2):189-194. 
 
Higgins, P.G., Wisplinghoff, H., Krut, O., and Seifert, H. 2007. A PCR-based method to differentiate 
between Acinetobacter baumannii and Acinetobacter genomic species 13TU. Clin. Microbiol. Infect. 
13 (12):1199-1201. 
 
Holst, O., Bock, K., Brade, L., and Brade, H. 1995. The structures of oligosaccharide bisphosphates 
isolated from the lipopolysaccharide of a recombinant Escherichia coli strain expressing the gene 
gseA [3-deoxy-D-manno-octulopyranosonic acid (Kdo) transferase] of Chlamydia psittaci 6BC. 
Eur. J. Biochem. 229 (1):194-200. 
 
Holst, O., Brade, H., Opal, S., Vogel, S., and Morrison, D. 1999. Chemical structure of the core region 
of Lipopolysaccharides. In Endotoxin in Health and Disease: Marcel Dekker Inc., NY. 
 
Holst, O., Brade, L., Kosma, P., and Brade, H. 1991. Structure, serological specificity, and synthesis of 
artificial glycoconjugates representing the genus-specific lipopolysaccharide epitope of Chlamydia 
spp. J. Bacteriol. 173 (6):1862-1866. 
 
Jann, B., and Jann, K. 1990. Structure and biosynthesis of the capsular antigens of Escherichia coli. 
Curr. Top. Microbiol. Immunol. 150:19-42. 
 
John, C.M., Liu, M., and Jarvis, G.A. 2009. Natural phosphoryl and acyl variants of Lipid A from 
Neisseria meningitidis strain 89I differentially induce tumor necrosis factor-alpha in human 
monocytes. J. Biol. Chem. 284 (32):21515-21525. 
 
Joly-Guillou, M.L. 2005. Clinical impact and pathogenicity of Acinetobacter. Clin. Microbiol. Infect. 11 
(11):868-873. 
Kajimura, J., Rahman, A., and Rick, P.D. 2005. Assembly of cyclic Enterobacterial common antigen in 
Escherichia coli K-12. J. Bacteriol. 187 (20):6917-6927. 
 
Kaplan, N., Rosenberg, E., Jann, B., and Jann, K. 1985. Structural studies of the capsular polysaccharide 
of Acinetobacter calcoaceticus BD4. Eur. J. Biochem. 152 (2):453-458. 
 
Katzenellenbogen, E., Kocharova, N.A., Zatonsky, G.V., Witkowska, D., Bogulska, M., Shashkov, 
A.S., Gamian, A., and Knirel, Y.A. 2003. Structural and serological studies on a new 
4-deoxy-d-arabino-hexose-containing O-specific polysaccharide from the Lipopolysaccharide of 
Citrobacter braakii PCM 1531 (serogroup O6). Eur. J. Biochem. 270 (13):2732-2738. 
 
Kawahara, K., Brade, H., Rietschel, E.T., and Zahringer, U. 1987. Studies on the chemical structure of 
the Core-Lipid A region of the Lipopolysaccharide of Acinetobacter calcoaceticus NCTC 10305. 
Detection of a new 2-octulosonic acid interlinking the core oligosaccharide and lipid A component. 
Eur. J. Biochem. 163 (3):489-495. 
 
Kittelberger, R., and Hilbink, F. 1993. Sensitive silver-staining detection of bacterial 
Lipopolysaccharides in polyacrylamide gels. J. Biochem. Biophys. Meth. 26 (1):81-86. 
 
Kjaer, M., Andersen, K.V., and Poulsen, F.M. 1994. Automated and semiautomated analysis of homo- 
and heteronuclear multidimensional nuclear magnetic resonance spectra of proteins: the program 
Pronto. Method Enzymol. 239:288-307. 
 
Kondakova, A., and Lindner, B. 2005. Structural characterization of complex bacterial glycolipids by 
Fourier transform mass spectrometry. Eur. J. Mass. Spectrom. 11 (5):535-546. 
 
107 
 
Kuhn, H.M., Brade, L., Appelmelk, B.J., Kusumoto, S., Rietschel, E.T., and Brade, H. 1992. 
Characterization of the epitope specificity of murine monoclonal antibodies directed against lipid A. 
Infect. Immun. 60 (6):2201-2210. 
 
Kuhn, H.M., Meier-Dieter, U., and Mayer, H. 1988. ECA, the Enterobacterial common antigen. FEMS 
Microbiol. Rev. 4 (3):195-222. 
 
Kulshin, V.A., Zahringer, U., Lindner, B., Frasch, C.E., Tsai, C.M., Dmitriev, B.A., and Rietschel, E.T. 
1992. Structural characterization of the Lipid A component of pathogenic Neisseria meningitidis. J. 
Bacteriol. 174 (6):1793-1800. 
 
Kwong, P.D., Wyatt, R., Robinson, J., Sweet, R.W., Sodroski, J., and Hendrickson, W.A. 1998. 
Structure of an HIV gp120 envelope glycoprotein in complex with the CD4 receptor and a 
neutralizing human antibody. Nature. 393 (6686):648-659. 
 
Laemmli, U.K. 1970. Cleavage of structural proteins during the assembly of the head of bacteriophage 
T4. Nature. 227 (5259):680-685. 
 
Leone, S., Sturiale, L., Pessione, E., Mazzoli, R., Giunta, C., Lanzetta, R., Garozzo, D., Molinaro, A., 
and Parrilli, M. 2007. Detailed characterization of the Lipid A fraction from the nonpathogen 
Acinetobacter radioresistens strain S13. J. Lipid Res. 48 (5):1045-1051. 
 
Leontein, K., Lindberg, B., and Lonngren, J. 1978. Assignment of absolute configuration of sugars by 
g.l.c. of their acetylated glycosides formed from chiral alcohols. Carbohydr. Res. 62 (2):359-362. 
 
Lior, H. 1994. Classification of Escherichia coli. In Gyles, C. 1994. Escherichia coli in domestic 
animals and humans.:31-72. 
 
}¢£¢{
@{
#¢}{
@{

¢, J. 2008. Role of structural variations of polysaccharide antigens in 
the pathogenicity of Gram negative bacteria. Clin. Microbiol. Infect. 14 (3):200-206. 
 
Maclean, L.L., Perry, M.B., Chen, W., and Vinogradov, E. 2009. The structure of the polysaccharide 
O-Chain of the LPS from Acinetobacter baumannii strain ATCC 17961. Carbohydr. Res. 344 
(4):474-478. 
 
Männel, D., and Mayer, H. 1978. Isolation and chemical characterization of the Enterobacterial 
common antigen. Eur. J. Biochem. 86 (2):361-370. 
 
Martin, D.R., Walker, S.J., Baker, M.G., and Lennon, D.R. 1998. New Zealand epidemic of 
meningococcal disease identified by a strain with phenotype B:4:P1.4. J. Infect. Dis. 177 
(2):497-500. 
 
Mata-Haro, V., Cekic, C., Martin, M., Chilton, P.M., Casella, C.R., and Mitchell, T.C. 2007. The 
vaccine adjuvant monophosphoryl lipid A as a TRIF-biased agonist of TLR4. Science. 316 
(5831):1628-1632. 
 
Mayer, L.W., Reeves, M.W., Al-Hamdan, N., Sacchi, C.T., Taha, M.K., Ajello, G.W., Schmink, S.E., 
Noble, C.A., Tondella, M.L., Whitney, A.M., Al-Mazrou, Y., Al-Jefri, M., Mishkhis, A., Sabban, S., 
Caugant, D.A., Lingappa, J., Rosenstein, N.E., and Popovic, T. 2002. Outbreak of W135 
meningococcal disease in 2000: not emergence of a new W135 strain but clonal expansion within the 
electophoretic type-37 complex. J. Infect. Dis.185 (11):1596-1605. 
 
Melton-Celsa, A., and O’Brien, A. 1998. Structure, biology, and relative toxicity of Shiga toxin family 
members for cells and animals. Escherichia coli 0157: H7 and other Shiga toxin-producing E. coli 
strains, Am. Soc. Microbiol.:121-128. 
108 
 
Miller, S.I., Ernst, R.K., and Bader, M.W. 2005. LPS, TLR4 and infectious disease diversity. Nat. Rev. 
Microbiol. 3 (1):36-46. 
 
Min, H., and Cowman, M.K. 1986. Combined Alcian blue and Silver staining of Glycosaminoglycans in 
polyacrylamide gels: application to electrophoretic analysis of molecular weight distribution. Anal. 
Biochem. 155 (2):275-285. 
 
Miyake, K. 2004. Innate recognition of Lipopolysaccharide by Toll-like receptor 4-MD-2. Trends 
Microbiol. 12 (4):186-192. 
 
Nataro, J., and Kaper, J. 1998. Diarrheagenic Escherichia coli. Clin. Microbiol. Rev. 11 (1):142. 
 
Neuhaus, F.C., and Baddiley, J. 2003. A continuum of anionic charge: structures and functions of 
D-alanyl-Teichoic acids in Gram-positive bacteria. Microbiol. Mol. Biol. Rev. 67 (4):686-723. 
 
Pantophlet, R. 2008. Lipopolysaccharides of Acinetobacter in Acinetobacter molecular biology. Caister 
Academic Press, Norfolk, UK, 2008, ch.3, pp. 61-98. 
 
Pantophlet, R., and Burton, D.R. 2006. gp120: target for neutralizing HIV-1 antibodies. Annu. Rev. 
Immunol. 24:739-769. 
 
Peeters, C.C., Lagerman, P.R., De Weers, O., Oomen, L.A., Hoogerhout, P., Beurret, M., Poolman, J.T., 
and Reddin, K.M. 2003. Preparation of polysaccharide-conjugate vaccines. Methods Mol. 
Med.87:153-174. 
 
Peleg, A.Y., Seifert, H., and Paterson, D.L. 2008. Acinetobacter baumannii: emergence of a successful 
pathogen. Clin. Microbiol. Rev. 21 (3):538-582. 
 
Perepelov, A., Senchenkova, S., Shashkov, A., Komandrova, N., Tomshich, S., Shevchenko, L., Knirel, 
Y., and Kochetkov, N. 2000. First application of triflic acid for selective cleavage of glycosidic 
linkages in structural studies of a bacterial polysaccharide from Pseudoalteromonas sp. KMM 634. 
J. Chem. Soc., Perkin Trans. 1 2000 (3):363-366. 
 
Pon, R.A., and Jennings, H.J. 2008. Carbohydrate-Based Antibacterial Vaccines, Carbohydrate-Based 
Vaccines and Immunotherapies: John Wiley & Sons, Inc. 
 
Raetz, C.R., and Whitfield, C. 2002. Lipopolysaccharide endotoxins. Annu. Rev. Biochem. 71:635-700. 
 
Ramos-Morales, F., Prieto, A., Beuzon, C., Holden, D., and Casadesus, J. 2003. Role for Salmonella 
enterica Enterobacterial common antigen in bile resistance and virulence. J. Bacteriol. 185 
(17):5328. 
 
Ramsay, M., Kaczmarski, E., Rush, M., Mallard, R., Farrington, P., and White, J. 1997. Changing 
patterns of case ascertainment and trends in meningococcal disease in England and Wales. Commun. 
Dis. Rep. CDR Rev. 7 (4):R49-54. 
 
Rappuoli, R., and Covacci, A. 2003. Reverse vaccinology and genomics. Science. 302 (5645):602. 
 
Rick, P.D., Hubbard, G.L., Kitaoka, M., Nagaki, H., Kinoshita, T., Dowd, S., Simplaceanu, V., and Ho, 
C. 1998. Characterization of the lipid-carrier involved in the synthesis of enterobacterial common 
antigen (ECA) and identification of a novel phosphoglyceride in a mutant of Salmonella 
typhimurium defective in ECA synthesis. Glycobiology. 8 (6):557-567. 
 
Rietschel, E.T. 1976. Absolute configuration of 3-hydroxy fatty acids present in lipopolysaccharides 
from various bacterial groups. Eur. J. Biochem. 64 (2):423-428. 
109 
 
Rinno, J., Golecki, J., and Mayer, H. 1980. Localization of Enterobacterial common antigen: 
immunogenic and nonimmunogenic Enterobacterial common antigen-containing Escherichia coli. 
J. Bacteriol. 141 (2):814. 
 
Roberts, I.S. 1996. The biochemistry and genetics of capsular polysaccharide production in bacteria. 
Annu. Rev. Microbiol. 50:285-315. 
 
Romanowska, E., Romanowska, A., Dabrowski, J., and Hauck, M. 1987. Structure determination of the 
O-specific polysaccharides from Citrobacter O4- and O27-Lipopolysaccharides by methylation 
analysis and one- and two-dimensional 1H-NMR spectroscopy. FEBS Lett. 211 (2):175-178. 
 
Romanowska, E., Romanowska, A., Lugowski, C., and Katzenellenbogen, E. 1981. Structural and 
serological analysis of Citrobacter-036-specific polysaccharide, the homopolymer 
 -(1

2)-linked 4-deoxy-D-arabinohexopyranosyl units. Eur. J. Biochem. 121 (1):119-123. 
 
Seydel, U., Oikawa, M., Fukase, K., Kusumoto, S., and Brandenburg, K. 2000. Intrinsic conformation of 
Lipid A is responsible for agonistic and antagonistic activity. Eur. J. Biochem. 267 (10):3032-3039. 
 
Silipo, A., De Castro, C., Lanzetta, R., Molinaro, A., and Parrilli, M. 2004. Full structural 
characterization of the Lipid A components from the Agrobacterium tumefaciens strain C58 
Lipopolysaccharide fraction. Glycobiology. 14 (9):805-815. 
 
Silipo, A., Lanzetta, R., Amoresano, A., Parrilli, M., and Molinaro, A. 2002. Ammonium hydroxide 
hydrolysis: a valuable support in the MALDI-TOF mass spectrometry analysis of Lipid A fatty acid 
distribution. J. Lipid Res. 43 (12):2188-2195. 
 
Silipo, A., Molinaro, A., Comegna, D., Sturiale, L., Cescutti, P., Garozzo, D., Lanzetta, R., and Parrilli, 
M. 2006. Full Structural Characterisation of the Lipooligosaccharide of a Burkholderia pyrrocinia 
Clinical Isolate. Eur. J. Org. Chem. 2006 (21):4874-4883. 
 
Sillman, C., and Casida Jr, L. 1986. Isolation of non obligate bacterial predators of bacteria from soil. 
Can. J. Microbiol. 32 (9):760-762. 
 
Silvestri, L.J., Hurst, R.E., Simpson, L., and Settine, J.M. 1982. Analysis of Sulfate in complex 
carbohydrates. Anal. Biochem. 123 (2):303-309. 
 
Somogyi, M. 1952. Estimation of sugars by colorimetric method. J. Biol. Chem. 200:245. 
 
Staaf, M., Hoog, C., Stevensson, B., Maliniak, A., and Widmalm, G. 2001. Conformational 
investigation of a cyclic Enterobacterial common antigen employing NMR spectroscopy and 
molecular dynamics simulations. Biochemistry. 40 (12):3623-3628. 
 
Takeda, K., and Akira, S. 2005. Toll-like receptors in innate immunity. Int. Immunol. 17 (1):1-14. 
 
Tozzi, A., Caprioli, A., Minelli, F., Gianviti, A., De Petris, L., Edefonti, A., Montini, G., Ferretti, A., De 
Palo, T., and Gaido, M. 2003. Shiga toxin–producing Escherichia coli infections associated with 
hemolytic uremic syndrome, Italy, 1988–2000. Emerg. Infect. Dis. 9 (1):106. 
 
Turton, J.F., Woodford, N., Glover, J., Yarde, S., Kaufmann, M.E., and Pitt, T.L. 2006. Identification of 
Acinetobacter baumannii by detection of the blaOXA-51-like carbapenemase gene intrinsic to this 
species. J. Clin. Microbiol. 44 (8):2974-2976. 
 
Urwin, R., Russell, J.E., Thompson, E.A., Holmes, E.C., Feavers, I.M., and Maiden, M.C. 2004. 
Distribution of surface protein variants among hyperinvasive meningococci: implications for vaccine 
design. Infect. Immun. 72 (10):5955-5962. 
110 
 
Van Der Ley, P., Steeghs, L., Hamstra, H., Ten Hove, J., Zomer, B., and Van Alphen, L. 2001. 
Modification of Lipid A biosynthesis in Neisseria meningitidis lpxL mutants: influence on 
Lipopolysaccharide structure, toxicity, and adjuvant activity. Infect. Immune. 69 (10):5981. 
 
Van Looveren, M., and Goossens, H. 2004. Antimicrobial resistance of Acinetobacter spp. in Europe. 
Clin. Microbiol. Infect. 10 (8):684-704. 
 
Vinogradov, E.V., Brade, L., Brade, H., and Holst, O. 2003. Structural and serological characterisation 
of the O-antigenic polysaccharide of the Lipopolysaccharide from Acinetobacter baumannii strain 
24. Carbohydr. Res. 338 (23):2751-2756. 
 
Vinogradov, E.V., Duus, J.O., Brade, H., and Holst, O. 2002. The structure of the carbohydrate 
backbone of the Lipopolysaccharide from Acinetobacter baumannii strain ATCC 19606. Eur. J. 
Biochem. 269 (2):422-430. 
 
Vinogradov, E.V., Knirel, Y.A., Thomas-Oates, J.E., Shashkov, A.S., and L'vov V, L. 1994. The 
structure of the cyclic Enterobacterial common antigen (ECA) from Yersinia pestis. Carbohydr. Res. 
258:223-232. 
 
Vinogradov, E.V., Pantophlet, R., Brade, H., and Holst, O. 2001. Structural and serological 
characterisation of the O-antigenic polysaccharide of the Lipopolysaccharide from Acinetobacter 
strain 96 (DNA group 11). J. Endotoxin Res. 7 (2):113-118. 
 
Vinogradov, E.V., Petersen, B.O., Thomas-Oates, J.E., Duus, J., Brade, H., and Holst, O. 1998. 
Characterization of a novel branched tetrasaccharide of 3-deoxy-D-manno-oct-2-ulopyranosonic 
acid. The structure of the carbohydrate backbone of the Lipopolysaccharide from Acinetobacter 
baumannii strain nctc 10303 (atcc 17904). J. Biol. Chem. 273 (43):28122-28131. 
 
Vodopija, I., Baklaic, Z., Hauser, P., Roelants, P., Andre, F.E., and Safary, A. 1983. Reactivity and 
immunogenicity of bivalent (AC) and tetravalent (ACW135Y) meningococcal vaccines containing 
O-acetyl-negative or O-acetyl-positive group C polysaccharide. Infect. Immun. 42 (2):599-604. 
 
Vollmer, W. 2008. Structural variation in the glycan strands of bacterial peptidoglycan. FEMS 
Microbiol. Rev. 32 (2):287-306. 
 
Vollmer, W., Blanot, D., and De Pedro, M.A. 2008. Peptidoglycan structure and architecture. FEMS 
Microbiol. Rev. 32 (2):149-167. 
 
Walker, L.M., Phogat, S.K., Chan-Hui, P.Y., Wagner, D., Phung, P., Goss, J.L., Wrin, T., Simek, M.D., 
Fling, S., Mitcham, J.L., Lehrman, J.K., Priddy, F.H., Olsen, O.A., Frey, S.M., Hammond, P.W., 
Kaminsky, S., Zamb, T., Moyle, M., Koff, W.C., Poignard, P., and Burton, D.R. 2009. Broad and 
potent neutralizing antibodies from an African donor reveal a new HIV-1 vaccine target. Science. 
326 (5950):285-289. 
 
Wang, J.F., Caugant, D.A., Li, X., Hu, X., Poolman, J.T., Crowe, B.A., and Achtman, M. 1992. Clonal 
and antigenic analysis of serogroup A Neisseria meningitidis with particular reference to 
epidemiological features of epidemic meningitis in the People's Republic of China. Infect. Immun. 60 
(12):5267-5282. 
 
Wang, L., and Reeves, P. 1998. Organization of Escherichia coli O157 O antigen gene cluster and 
identification of its specific genes. Infect. Immun. 66 (8):3545. 
 
Westphal, O., and Jann, K. 1965. Bacterial lipopolysaccharides. Extraction with phenol-water and 
further applications of the procedure. Meth. Carbohydr. Chem. 5: 83-91. 
 
111 
 
Whitfield, C., and Roberts, I.S. 1999. Structure, assembly and regulation of expression of capsules in 
Escherichia coli. Mol. Microbiol. 31 (5):1307-1319. 
 
Wyatt, R., Kwong, P.D., Desjardins, E., Sweet, R.W., Robinson, J., Hendrickson, W.A., and Sodroski, 
J.G. 1998. The antigenic structure of the HIV gp120 envelope glycoprotein. Nature. 393 
(6686):705-711. 
 
Zähringer, U., Lindner, B., and Rietschel, E. 1999. Chemical structure of Lipid A: recent advances in 
structural analysis of biologically active molecules. In Endotoxin in Health and Disease: Marcel 
Dekker Inc., NY. 
 
Zehr, B.D., Savin, T.J., and Hall, R.E. 1989. A one-step, low background coomassie staining procedure 
for polyacrylamide gels. Anal. Biochem. 182 (1):157-159. 
 
Zeph, L.R., and Casida, L.E. 1986. Gram-negative versus gram-positive (actinomycete) nonobligate 
bacterial predators of bacteria in soil. Appl. Environ. Microbiol. 52 (4):819-823. 
 
Zwick, M.B., Labrijn, A.F., Wang, M., Spenlehauer, C., Saphire, E.O., Binley, J.M., Moore, J.P., 
Stiegler, G., Katinger, H., Burton, D.R., and Parren, P.W. 2001. Broadly neutralizing antibodies 
targeted to the membrane-proximal external region of human immunodeficiency virus type 1 
glycoprotein gp41. J. Virol. 75 (22):10892-10905. 
